You are on page 1of 79

List of European Pharmacopoeia Reference Standards

Order
Reference Standard
Code
Y0000055 Acamprosate calcium - reference spectrum

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
n/a
1

Information

Monograph

Leaflet

Storage

1585

Extra
Price
charges
79
l

Y0000116 Acamprosate impurity A

50 mg

3-aminopropane-1-sulphonic acid

1585

+5C

79

Y0000500 Acarbose

94.7 mg

94.7 mg CHNO

2089

+5C

79

Y0000354 Acarbose for identification

10 mg

2089

+5C

79

Y0000427 Acarbose for peak identification

40 mg

2089

+5C

79

A0040000 Acebutolol hydrochloride

50 mg

0871

+5C

79

Y0000359 Acebutolol impurity B

10 mg

-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)

0871

+5C

79

Y0000127 Acebutolol impurity C

20 mg

N-(3-acetyl-4-hydroxyphenyl)butanamide

0871

+5C

79

Y0000128 Acebutolol impurity I

0.004 mg

N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide

0871

+5C

79

Y0000056 Aceclofenac - reference spectrum

n/a

1281

79

Y0001094 Aceclofenac for peak identification

10 mg

1281

+5C

79

Y0000085 Aceclofenac impurity F

20 mg

benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate

1281

+5C

79

Y0000086 Aceclofenac impurity H

10 mg

[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid

1281

+5C

79

Y0000810 Acemetacin

100 mg

1686

+5C

79

Y0000811 Acemetacin impurity A

10 mg

+5C

79

Y0000842 Acemetacine impurity mixture

0.06 mg

+5C

79

A0070000 Acesulfame potassium

50 mg

+5C

79

A0070020 Acesulfame potassium impurity B

50 mg

+5C

79

A0100000 Acetazolamide

100 mg

+5C

79

Y0001084 Acetazolamide for system suitability

0.0068 mg

0454

+5C

79

Y0000002 Acetylcholine chloride

50 mg

1485,1971

-20C

79

A0150000 Acetylcysteine

50 mg

Batch 2 is valid until 29 February 2012

0967

+5C

79

A0152000 Acetylcysteine impurity C

10 mg

88.5% CHNOS; N,N'-diacetyl-L-cystine ; Batch 6 is valid until 31


January 2011

0967

+5C

79

A0153000 Acetylcysteine impurity D

10 mg

N,-diacetyl-L-cysteine

0967

+5C

79

Y0000565 -Acetyldigoxin

50 mg

2168

+5C

79

Y0000642 -Acetyldigoxin for peak identification

10 mg

2168

+5C

79

A0200000 Acetylsalicylic acid

15 mg

Batch 3 is valid until 29 February 2012

0309

+5C

79

A0208000 N-Acetyltryptophan

125 mg

Batch 1 is valid until 31 July 2011

1383

+5C

79

A0202000 N-Acetyltyrosine

200 mg

1384

Y0000693 Acholeplasma laidlawii BRP

1 ml

20607

A0220000 Aciclovir

75 mg

Y0001271 Aciclovir for peak identification 1

0.3 mg

0.003 mg

Y0001269 Aciclovir for peak identification 2


Council of Europe, all rights reserved 2012

propoxy]phenyl]

Yes

Yes

1686

4-chlorobenzoic acid

1686

Yes

1282
5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide ; Batch 2 is valid
until 30 June 2011

1282

Yes

0454

Batch 2 is valid until 31 January 2012

Yes

Yes

0968
0968

Yes

Yes

+5C

79

-80C

120

+5C

79

+5C

79

79
0968
Yes
+5C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001264 Aciclovir for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

Storage

0968

+5C

Extra
Price
charges
79
a

A0225000 Acitretin

100 mg

99.7% CHO

1385

+5C

g(b)

79

Y0001121 Adapalene

100 mg

99.9% CHO

2445

+5C

79

Y0001120 Adapalene impurity C

6 mg

1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane ; Batch 1 is valid until 31 July


2011

2245

+5C

79

Y0001119 Adapalene for peak identification

2.022 mg

2445

+5C

79

A0230000 Adenine

50 mg

0800,1486

+5C

79

A0230200 Adenosine

50 mg

1486

+5C

79

Y0000110 Adipic acid

50 mg

1586

+5C

79

Y0000882 Adrenaline

5 mg

2303

+5C

79

Y0000883 Adrenaline with impurity F

10 mg

2303

+5C

79

A0300000 Adrenaline tartrate

100 mg

Batch 4 is valid until 31 August 2011

+5C

79

0.005 mg

Batch 1 is valid until 30 April 2012

+5C

79

New Y0000740 Adrenaline impurity mixture


Y0000707 Adrenaline tartrate with impurity A

15 mg

Y0000728 Agnus castus fruit standardised dry extract

200 mg

0.13% CHO

A0325000 Alanine

60 mg

Batch 2 is valid until 31 July 2011

A0325100 Albendazole

50 mg

A0325200 Alcuronium chloride

50 mg

5 mg

New A0325450 Alfacalcidol

99.8% CHO ; Batch 6 is valid until 31 March 2012

Yes

Yes

0254
0254,2303

Yes

0254

Yes

+5C

79

2147

Yes

-20C

79

0614,0752

+5C

79

1386

+5C

79

1285

-20C

g(c)

79

1286

-20C

e(d)

300

79

+5C

79

79

+5C

79

A0325451 Alfacalcidol - reference spectrum

n/a

A1225000 Alfadex

150 mg

A0325500 Alfentanil hydrochloride - reference spectrum

n/a

1062

A0325800 Alfuzosin hydrochloride

10 mg

1287

Y0000832 Alfuzosin for system suitability

10 mg

1287

+5C

79

A0349000 Allantoin

60 mg

1288

+5C

79

A0350000 Allopurinol

50 mg

99.9% CHNO

0576

+5C

79

A0350010 Allopurinol impurity A

10 mg

5-amino-1H-pyrazole-4-carboxamide

0576

+5C

79

A0350020 Allopurinol impurity B

10 mg

5-formylamino-1H-pyrazole-4-carboxamide

0576

+5C

79

A0350030 Allopurinol impurity C

10 mg

5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide

0576

+5C

79

A0350040 Allopurinol impurity D

10 mg

ethyl 5-amino-1H-pyrazole-4-carboxylate

0576

+5C

79

A0350050 Allopurinol impurity E

20 mg

ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate

0576

+5C

79

A0351000 Allylstrychnine bromide

10 mg

1285

-20C

g(c)

79

Y0000235 Almagate

25 mg

2010

+5C

79

Y0000255 Almagate - reference spectrum

n/a

2010

79

A0357000 Alprazolam - * psy

100 mg

1065

+5C

79

A0360000 Alprenolol hydrochloride

100 mg

0628,0876

+5C

79

Council of Europe, all rights reserved 2012

1286
89.5% [CH0] ; Batch 2 is valid until 31 January 2011

13.4% carbonic acid

1070,1487

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000054 Alprostadil

Reference Standard

Effective from 2012/1/3


Batch n
1

Y0000606 Altizide

Y0000843 Altizide impurity B

Y0000687 Alverine citrate


Y0000595 Alverine for peak identification
Y0000607 Alverine impurity D
A0363000 Amantadine hydrochloride

Quantity Sale
per vial Unit
50 mg
1 99.2% CHO
150 mg
1 99.9% CHClNOS

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
g(c)

1488

-20C

0370,2185

+5C

79

2185

+5C

79

+5C

79

+5C

79

15 mg

5 mg

2156

0.125 mg

2156

10 mg

2156

+5C

79

100 mg

0463

+5C

79

A0363700 Ambroxol hydrochloride

125 mg

1489

+5C

79

A0900000 Amfetamine sulfate - reference spectrum

n/a

0368

79

A0365000 Amidotrizoic acid dihydrate

100 mg

A0368000 Amikacin

200 mg

91.4 % CHNO

A0365900 Amikacin sulfate

200 mg

The batch 3 is not suitable for use in the assay or in the test for related
substances in monograph 1290:01/2010. Amikacin CRS A0368000 is also
needed. See leaflet.

Y0001117 Amikacin for system suitability

20 mg

A0370000 Amiloride hydrochloride

100 mg

Y0000020 Amiloride impurity A

10 mg

methyl-3,5-diamino-6-chloropyrazine-2-carboxylate

Y0000173 4-Aminobenzoic acid

60 mg

Batch 1 is valid until 31 March 2012

A0420000 Aminocaproic acid

50 mg

A0460000 7-Aminodesacetoxycephalosporanic acid

20 mg

A0496000 Aminoglutethimide

125 mg

A0496005 Aminoglutethimide impurity A

20 mg

A0496020 Aminoglutethimide impurity D

10 mg

A0575000 Amiodarone hydrochloride

100 mg

Y0000129 Amiodarone impurity D

20 mg

Y0000130 Amiodarone impurity E

20 mg

10 mg

A0590004 Amisulpride impurity B

Y0000563 Amitriptyline hydrochloride


Y0000049 Amlodipine besilate

3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene

N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine

Yes

+5C

79

1289,1290

Yes

+5C

79

1290

Yes

+5C

79

1289,1290

Yes

+5C

79

0651

+5C

79

0651

+5C

79

1687

+5C

79

0874

+5C

79

0708,0813

+5C

79

1291

+5C

79

(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)

1291

+5C

79

3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)

1291

+5C

79

0803

+5C

g(b)

79

(2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone ; Batch 2
is valid until 31 July 2011

0803

+5C

79

(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

0803

+5C

79

Batch 1 is valid until 31 May 2012

1490

+5C

79

10 mg

4-amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethyl sulphonyl)-2hydroxybenzamide

1490

+5C

79

10 mg

0464

+5C

79

150 mg

1491

+5C

79

Y0001067 Amlodipine for peak identification

10 mg

+5C

79

Y0001068 Amlodipine impurity A

10 mg

+5C

79

New A0590000 Amisulpride

Council of Europe, all rights reserved 2012

0873

Cefadroxyl impurity B

99.7% CHClNOS

1491
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

1491

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001069 Amlodipine impurity B

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
10 mg
1 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate

Y0001070 Amlodipine impurity G

10 mg

Y0000302 Ammonio methacrylate copolymer(type A) - reference


spectrum

n/a

Y0000303 Ammonio methacrylate copolymer(type B) - reference


spectrum

n/a

A0650000 Amobarbital - * psy

A0700000 Amobarbital sodium - * psy

A0800000 Amoxicillin trihydrate

Monograph

Leaflet

Storage

1491

+5C

1491

+5C

Extra
Price
charges
79
g

79

2081

79

2082

79

500 mg

0594

+5C

79

500 mg

0166

+5C

79

100 mg

86.2% CHNOS

0167,0168,02
60,
0577,0578,08
13, 1140,1653

+5C

79

Y0000005 Amphotericin B

100 mg

Batch 4 is not suitable for microbiological assay (see leaflet). ; Batch 3 is valid
until 28 February 2011

1292

Yes

-20C

79

Y0001014 Amphotericin B for peak identification

10 mg

1292

Yes

-20C

79

Y0001361 Amphotericin B for microbiological assay

100 mg

944 IU per mg

20702

Yes

-20C

79

A1000000 Ampicillin (anhydrous)

250 mg

97.6% CHNOS

0167,0168,05
78, 1168,1169

+5C

79

A1100000 Ampicillin trihydrate

150 mg

0168,0260,05
77,
0578,0808,22
11, 2212

+5C

79

Y0001386 Angelica dahuria root

160 mg

2556

-20C

79

A1200000 Anhydrotetracycline hydrochloride

15 mg

93.3% CHNO

0210,0211,16
54

+5C

79

Y0001244 Amylmetacresol

285 mg

99.5% CHO

Y0001245 Amylmetacresol for peak identification

10 mg

A1210000 Antazoline hydrochloride

50 mg

Y0000172 Apomorphine hydrochloride - reference spectrum

A1220000 Alpha-apo-oxytetracycline

A1230000 Beta-apo-oxytetracycline

20 mg

A1250000 Aprotinin solution BRP

0.5 ml

Y0001154 Aprotinin for system suitability

2.7 mg

A1269000 L-Arabinitol

10 mg

Y0000806 Arbutin

100 mg

A1270000 Arginine

50 mg

Council of Europe, all rights reserved 2012

dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate

2405

Yes

+5C

79

2405

Yes

+5C

79

0972

+5C

79

n/a

0136

79

20 mg

0198

+5C

79

+5C

79

0579,0580

0198
Yes

+5C

79

0580

Yes

+5C

79

1381

+5C

79

-20C

79

+5C

79

22.3 Ph. Eur. Units per ml

1054
Arginine CRS 2 is suitable for monographs 01/2008:0806, 04/2008:1654,
0806,0930,16
01/2008:2114 and 01/2008:0930 only ; Batch 2 is valid until 31 January 2012
54, 2114
93.5% CHO

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000304 Arginine aspartate

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
20 mg
1

Information

Monograph

Storage

Extra
Price
charges
79
a

2096

+5C

0805,0885,09
98

+5C

79

A1271000 Arginine hydrochloride

50 mg

Y0001323 Aristolochia

140 mg

Y0001185 Aristolochic acid I

1 mg

Y0001175 Aristolocholic acid for system suitability

1 mg

Y0000079 Articaine hydrochloride

100 mg

Y0000080 Articaine impurity A

15 mg

Y0000081 Articaine impurity E

10 mg

A1300000 Ascorbic acid

100 mg

Vitamin C

Y0001024 Ascorbic acid impurity C

20 mg

Y0001170 Ascorbic acid impurity D

10 mg

Y0000800 Ascorbyl palmitate

10 mg

Y0000305 Asparagine monohydrate

60 mg

A1320000 Aspartame

40 mg

A1321000 Aspartame impurity A

10 mg

A1330000 Aspartic acid

50 mg

Y0001171 Astragaloside IV

40 mg

2435

A1340000 Atenolol

100 mg

0703

Y0001089 Atenolol for system suitability

5 mg

0703

Y0001327 Atorvastatin calcium trihydrate

150 mg

95.2% CHFNO

2191

Y0001328 Atorvastatin impurity A

10 mg

desfluoroatorvastatin

Y0001329 Atorvastatin impurity B

10 mg

3-epi-atorvastatin

Y0001330 Atorvastatin impurity C

10 mg

Y0001331 Atorvastatin impurity D

10 mg

Y0001332 Atorvastatin impurity E

10 mg

New Y0000424 Atracurium besilate

Leaflet

20821

Yes

+5C

79

20821

Yes

+5C

79

20821

Yes

+5C

79

1688

+5C

79

methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate

1688

+5C

79

methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate

1688

+5C

79

0253,0958,17
91

+5C

79

D-xylo-hex-2-ulosonic acid (D-sorbosonic acid)

0253,1791

+5C

79

94.9% CHO; methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate)

0253,1791

+5C

79

0807

+5C

79

2086

+5C

79

0973

+5C

79

0973

+5C

79

0750,0797

+5C

79

-20C

79

+5C

79

Yes

+5C

79

Yes

+5C

79

2191

+5C

79

2191

+5C

79

fluoroatorvastatin

2191

+5C

79

3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide

2191

+5C

79

ent-atorvastatin

2191

+5C

79

98.5% CHNOS ; Batch 1 is valid until 30 April 2012

1.00 mg CHNO

2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)

120 mg

1970

Yes

+5C

g(b)

79

Y0000503 Atracurium for impurity F identification

5 mg

1970

Yes

+5C

g(b)

79

Y0000504 Atracurium for peak identification

5 mg

1970

Yes

+5C

g(b)

79

Y0000878 Atropine

30 mg

2056

+5C

79

Y0000845 Atropine for peak identification

0.25 mg

Y0000816 Atropine impurity B

10 mg

A1400000 Atropine sulfate

50 mg

50 mg

Y0000029 Azaperone
Council of Europe, all rights reserved 2012

0068,2056
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)

+5C

79

0068,2056

Yes

+5C

79

0068

+5C

79

79
1708
+5C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
A1500000 Azathioprine

Reference Standard

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
100 mg
1

Information

Monograph

Leaflet

Storage

0369

+5C

Extra
Price
charges
79
a

Y0001240 Azathioprine impurity A

10 mg

1-methyl-4-nitro-1H-imidazol-5-amine

0369

+5C

79

New Y0001246 Azathioprine impurity G

5 mg

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine) ; Batch 1 is valid until 30 April 2012

0369

+5C

79

Y0000326 Azelastine hydrochloride

25 mg

1633

+5C

79

Y0000327 Azelastine impurity B

5 mg

1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane

1633

+5C

79

Y0000328 Azelastine impurity D

5 mg

4-(4-chlorobenzyl)phthalazin-1(2H)-one

1633

+5C

79

Y0000329 Azelastine impurity E

5 mg

3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one

1633

+5C

79

Y0000306 Azithromycin

200 mg

94.6% CHNO

1649

Yes

+5C

79

Y0000637 Azithromycin for peak identification

15 mg

1649

Yes

+5C

79

Y0000641 Azithromycin for system suitability

0.05 mg

Batch 3 is valid until 30 June 2011

1649

Yes

+5C

79

Y0000307 Azithromycin impurity A

10 mg

6-demethylazithromycin ; Batch 1 is valid until 30 June 2011

+5C

79

Y0000285 B19 virus DNA for NAT testing BRP

150 mg

B19 virus DNA content log 5.8 IU per ml for plasma pool testing by NAT

Yes

-20C

e(d)

242

B0070000 Bacampicillin hydrochloride

120 mg

92.9% CHClNOS

B0100000 Bacitracin zinc

150 mg

62.9 IU per mg

B0200000 Baclofen

50 mg

B0200050 Baclofen impurity A

50 mg

91.5% CHClNO; ()-4-amino-3-(4-chlorophenyl)butyric acid lactam

0653

Y0001273 Baicalin

10 mg

88.5% CHO

2438

B0250000 Bambuterol hydrochloride

100 mg

B0300000 Barbital - * psy

500 mg

Y0000295 Basic butylated methacrylate copolymer -reference


spectrum

n/a

1975

B0305000 Beclometasone dipropionate anhydrous

150 mg

Y0000351 Beclometasone dipropionate monohydrate

10 mg

Y0000352 Beclometasone dipropionate for system suitability

10 mg

Y0000469 Beclometasone dipropionate for peak identification

10 mg

Y0001073 Beclometasone dipropionate impurities F and N

0.052 mg

Y0001025 Benazepril hydrochloride

160 mg

Y0001038 Benazepril for system suitability

0.016 mg

Y0001026 Benazepril impurity A

10 mg

B0400000 Bendroflumethiazide

100 mg

Y0000564 Bendroflumethiazide impurity A

5 mg

Y0000044 Benfluorex hydrochloride

50 mg

Council of Europe, all rights reserved 2012

1649
See leaflet,
0557,
1527,1646
0808,0852

+5C

79

0465,0466,20
702

-20C

79

0653

+5C

79

+5C

79

+5C

79

1293

+5C

79

0170

+5C

79

79

+5C

79

Yes

0654,0809,14
49, 1709

99.1% CHClO

+5C

79

0654,1709

1709
Yes

+5C

79

0654,1709

Yes

+5C

79

1709

Yes

+5C

79

+5C

79

+5C

79

2388

+5C

79

0370

+5C

79

0370

+5C

79

1601

+5C

79

Batch 1 is valid until 31 July 2011

2388

99.5 % CHClNO

2388
[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid
4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000043 Benfluorex hydrochloride for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
360 mg
1

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

1601

+5C

1010,1172,12
54, 1708

+5C

79

B0470000 Benperidol

100 mg

B0477000 Benserazide hydrochloride

50 mg

1173

+5C

79

B0477010 Benserazide impurity A

20 mg

()-2-amino-3-hydroxypropanohydrazide

1173

+5C

79

Y0001071 Benserazide impurity C

10 mg

(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide

1173

+5C

79

Y0001079 Benserazide for peak identification

10 mg

1173

Yes

+5C

79

Y0001064 Benzaldehyde

150 mg

0372,0371

Yes

+5C

79

Y0001060 Benzalkonium chloride for system suitability

20 mg

0371,0372

Yes

+5C

79

B0490000 Benzarone

10 mg

(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone

1393

+5C

79

B0500000 Benzathine benzylpenicillin

125 mg

90.7% CHNOS
24.1% CHN (N,N'-dibenzylethylenediamine)

0373

+5C

79

Y0000775 Benzbromarone

10 mg

1393

+5C

79

B0550000 Benzethonium chloride

100 mg

0974

+5C

79

B0600000 Benzocaine

50 mg

0011,1088

+5C

79

Y0000647 Benzophenone

40 mg

1784

+5C

79

Y0000167 Benzyl alcohol

50 mg

+5C

79

B0670000 Benzyl benzoate - reference spectrum

n/a

0705

79

B0680000 S-Benzylmercaptoacetyltriglycin

10 mg

1372

+5C

79

B0700000 Benzylpenicillin potassium

50 mg

Batch 1 is valid until 31 July 2011

0113,0148,01
49

+5C

79

B0900000 Benzylpenicillin sodium

200 mg

99.4% CHNNaOS; Penicillin G sodium

0113,0114,01
48, 0149

Yes

+5C

79

Y0001149 Berberine chloride

20 mg

84.3% CHClNO

1831,2500

Yes

B0950000 Betadex

200 mg

88.4% [CHO]

New Y0000391 Betahistine dihydrochloride

50 mg

Batch 1 is valid until 31 May 2012

B0990000 Betahistine mesilate

100 mg

B1000000 Betamethasone

75 mg

B1030000 Betamethasone acetate

B1040000 Betamethasone dipropionate


Y0001416 Betamethasone dipropionate for peak identification
Y0001418 Betamethasone dipropionate for system suitability
B1045000 Betamethasone sodium phosphate
B1054000 Betamethasone 17-valerate
Council of Europe, all rights reserved 2012

0256,0371,03
72,1827

See leaflet

Yes

+5C

79

1070,1487,18
04

+5C

79

1665

+5C

79

1071

+5C

79

0312,0354,03
88, 0561,0811

+5C

79

100 mg

0548,0975

+5C

79

100 mg

0809

+5C

79

10 mg

0809

Yes

+5C

79

10 mg

0809

Yes

+5C

79

100 mg

0549,0810

+5C

79

100 mg

0322,0811

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
B1055000 Betamethasone 21-valerate

Effective from 2012/1/3


Batch n
3

Quantity Sale
per vial Unit
15 mg
1

Information

Monograph

Leaflet

0811

Storage
+5C

Extra
Price
charges
79
g

Y0001027 Betamethasone valerate for system suitability

25 mg

0811

Yes

+5C

79

Y0001065 Betamethasone valerate impurity mixture

0.018 mg

0811

Yes

+5C

79

B1103000 Betaxolol hydrochloride

60 mg

1072

+5C

79

B1103100 Betaxolol impurity A

10 mg

(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol

1072

+5C

79

Y0001354 Betaxolol impurity C

5 mg

2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane

1072

-20C

79

Y0001360 Betaxolol for peak identification

15 mg

1072

+5C

79

B1115000 Bezafibrate

100 mg

1394

+5C

79

15 mg

2196

+5C

79

New Y0001448 Bicalutamide for system suitability

Yes
Yes

Y0001078 Bicisate labelling kit

24 mg

2123

+5C

79

B1110000 Bifonazole

100 mg

1395

+5C

79

B1110004 Bifonazole impurity B

10 mg

1395

+5C

79

Y0001421 Bifonazole for system suitability

10 mg

1395

+5C

79

Y0001059 Bilberry dry extract

250 mg

3.44% of cyanidin 3-O-glucoside chloride (CHClO)

2394

-20C

79

B1116000 Biotin

20 mg

Vitamin H ; Batch 1 is valid until 31 May 2011

1073

+5C

79

B1120000 Biperiden hydrochloride

60 mg

1074

+5C

79

B1121000 Biperiden impurity A

20 mg

(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)

1074

+5C

79

B1140000 Bisacodyl

50 mg

Batch 2 is valid until 31 March 2011

0595

+5C

79

Y0000608 Bisacodyl for peak identification

10 mg

0595

+5C

79

Y0000694 Bisacodyl for system suitability

5 mg

0595

+5C

79

Y0000812 Bisoprolol fumarate

50 mg

+5C

79

Y0000877 Bisoprolol for peak identification

1 mg

Bisoprolol for system suitability method A CRS has been renamed as


Bisoprolol for peak identification CRS.

1710

Yes

+5C

79

1 mg

Bisoprolol for system suitability method B CRS has been renamed as


Bisoprolol for system suitability CRS ; Batch 1 is valid until 30 April 2012

1710

Yes

+5C

79

B1141000 Bleomycin sulfate

7 mg

8910 IU per vial; bleomycin A : 67.0%; Bleomycin B : 29.2%;


demethylbleomycin A : 2.6%

0976,20702

Yes

-20C

79

Y0000434 Boldine

30 mg

98.8% CHNO ; Batch 1 is valid until 31 January 2012

1396, 1816

Yes

+5C

79

B1142000 Bordetella pertussis mouse antiserum BRP

0.5 mg

Anti-PT: 19.5 ELU/vial Anti-FHA: 69 ELU/vial


Anti-69k: 17 ELU/vial Anti-Fim 2/3: 28 ELU/vial

See leaflet,
20716

Yes

-20C

90

B1143000 Bromazepam - * psy

60 mg

0778,0879

+5C

79

Y0000645 Bromazepam for system suitability - * psy

10 mg

0879

+5C

79

B1145000 Bromhexine hydrochloride

100 mg

0706

+5C

79

Y0000200 Bromhexine impurity C

10 mg

0706

+5C

79

B1150000 Bromocriptine mesilate

30 mg

0596

-20C

g(c)

79

Y0000677 Bromocriptine mesilate for system suitability

5 mg

0596

-20C

g(c)

79

100 mg

New Y0000813 Bisoprolol for system suitability

B1152000 Bromperidol
Council of Europe, all rights reserved 2012

4-[(RS)-(biphenyl-4-yl)phenylmethyl]-1H-imidazole trifluoroacetate

Yes

Yes

1710

N-(2-aminobenzyl)-N-methylcyclohexanamine

Yes

Yes

79
0616,1178
+5C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
B1152050 Bromperidol decanoate

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
60 mg
1

Information

Monograph

Leaflet

Storage

1397,1431

+5C

Extra
Price
charges
79
a

B1153000 Brompheniramine maleate

100 mg

0977,1196

+5C

79

Y0000468 Brotizolam - * psy

10 mg

2197

+5C

79

Y0000470 Brotizolam impurity B

10 mg

2197

+5C

79

B1155000 Brucella melitensis Rev. 1 strain BRP - * Biotox

1 mg

B1157300 Budesonide

110 mg

Y0001148 Budesonide for system suitability

10 mg

B1156000 Bufexamac

100 mg

B1157400 Buflomedil hydrochloride

100 mg

B1157410 Buflomedil impurity B

20 mg

B1158000 Bumetanide

150 mg

Y0000309 Bumetanide impurity A

5 mg

3-nitro-4-phenoxy-5-sulphamoylbenzoic acid

Y0000310 Bumetanide impurity B

5 mg

3-amino-4-phenoxy-5-sulphamoylbenzoic acid

B1160000 Bupivacaine hydrochloride

100 mg

Y0000088 Bupivacaine impurity B

20 mg

Y0000089 Bupivacaine impurity E

20 mg

Y0001108 Buprenorphine - * psy

10 mg

Y0001109 Buprenorphine hydrochloride - * psy

10 mg

Y0001122 Buprenorphine for system suitability - * psy

10 mg

B1168000 Buserelin

2 mg

B1168020 D-His-Buserelin

0.5 mg

Y0000131 Buspirone hydrochloride

5 mg

Y0000471 Buspirone for system suitability

2 mg

1711

B1170000 Busulfan

50 mg

0542

Y0001304 Butyl methanesulfonate

40 L

20537,20538,
20539

B1217000 Butyl parahydroxybenzoate

100 mg

See leaflet

Y0001357 Butyl parahydroxybenzoate impurity E

15 mg

2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)

B1212000 Butylhydroxyanisole

50 mg

B1215000 Butylhydroxytoluene

50 mg

Plastic additive 07

Y0000472 Cabergoline

100 mg

99.8% CHNO

C0100000 Caffeine

70 mg

See leaflet

Y0000787 Caffeine for system suitability

20 mg

Batch 1 is valid until 30 September 2011

C0166000 Calcifediol
Council of Europe, all rights reserved 2012

5 mg

95.7% CHO ; Batch 2 is valid until 31 March 2011


9

2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)

0793

Yes

+5C

e(b)

79

1075

Yes

+5C

79

1075

Yes

+5C

79

1179

+5C

79

1398

+5C

79

1398

+5C

79

1076

+5C

79

1076

+5C

79

1076

+5C

79

0541

+5C

79

(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

0541

+5C

79

6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide

0541

+5C

79

1180

+5C

79

1181

+5C

79

99.7% CHO

4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one

1180,1181

+5C

79

1077

-20C

79

1077

-20C

79

1711

+5C

79

+5C

79

+5C

79

+5C

79

2.00 mg per vial of CHNO

0881,1216

Yes

Yes

+5C

79

0881

Yes

+5C

79

0880

+5C

79

0581,30103,
30105,30106,
30107

+5C

79

1773

Yes

-20C

79

0267,0268,15
04

Yes

+5C

79

0267, 0268

Yes

+5C

79

150
1295
-20C
e(d)
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C0166001 Calcifediol - reference spectrum

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
n/a
1

Information

Monograph

Leaflet

Storage

79

Yes

+5C

79

1295

Y0000499 Calcipotriol (anhydrous) - reference spectrum

n/a

Y0000473 Calcipotriol monohydrate

5 mg

Y0000474 Calcipotriol monohydrate - reference spectrum

n/a

79

C0200000 Calcitonin (salmon)

0.98 mg

0.98 mg per vial of CHNOS

0471

-20C

79

Y0000632 Calcitonin-Gly

0.4 ml

About 0.9 mg per ml

0471

-20C

79

C0200010 N-acetyl-cys1-calcitonin

20 mg

about 0.1mg N-acetyl-cys-1-calcitonin per vial ; Batch 3 is valid until 31 May


2011

0471

-20C

79

C0225000 Calcitriol

10 mg

100.0% CHO

0883

-20C

e(d)

C0226000 Calcitriol - reference spectrum

n/a

0883

79

C0249000 Calcium ascorbate - reference spectrum

n/a

1182

79

C0250000 Calcium folinate

100 mg

C0299000 Calcium glucoheptonate

60 mg

C0300000 Calcium gluconate

100 mg

C0340000 Calcium levulinate dihydrate

250 mg

C0350000 Calcium oxalate monohydrate

500 mg

C0400000 Calcium pantothenate

60 mg

C0405000 Camphor (racemic)

50 mg

Y0001388 Candesartan cilexetil

60 mg

2375

Y0001387 Candesartan cilexetil for peak identification

50 mg

2375

Yes

Y0001389 Candesartan cilexetil for system suitability

10 mg

2573

Yes

C0410000 Canrenone

50 mg

0688

C0426000 Caprylic acid

200 mg

Y0000671 Capsaicin

50 mg

C0430000 Captopril

10 mg

Y0001182 Captopril for system suitability

20 mg

Y0001219 Captopril impurity B

10 mg

87.4% CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2carboxylic acid

Y0001220 Captopril impurity C

10 mg

Y0001221 Captopril impurity D

10 mg

Y0000435 Captopril impurity E

10 mg

Y0000113 Carbachol

50 mg

C0450000 Carbamazepine

200 mg

Council of Europe, all rights reserved 2012

2011

Extra
Price
charges
79
l

2011,2284

93.9% CHO

2284

85.5 % CHCaNO
Calcium digluconate

0978,1606

+5C

79

1399

+5C

79

0172,0658,09
79,
1047,1399,21
64

+5C

79

+5C

79

+5C

79

0470

+5C

79

0655,1600

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

1296
20234

Loss of 12.1% m/m (U= 0.2%, n=10, k=2.23)

1000

Yes

1401,1471

+5C

79

1859,2336,23
37

+5C

79

1079

+5C

79

1079

+5C

79

1079

+5C

79

84.8% CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid

1079

+5C

79

85.4% CHBrO; (2RS)-3-bromo-2-methylpropanoic acid

1079

+5C

79

(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid

1079

+5C

79

1971

+5C

79

0543

+5C

79

98.6% CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide

100.0% CHNO
10

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000033 Carbamazepine impurity A

Effective from 2012/1/3


Batch n
5

C0451000 Carbasalate calcium - reference spectrum

Y0001161 Carbasalate impurity B


C0455000 Carbenicillin sodium
C0460000 Carbidopa
C0465000 Carbimazole

Quantity Sale
Information
per vial Unit
10 mg
1 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)

Monograph
0543

n/a

5 mg

1185

50 mg

0956

50 mg

100 mg

C0470000 Carbocisteine

60 mg

C0499900 Carbon dioxide - reference spectrum

n/a

C0550000 Carboplatin - reference spectrum

n/a

Y0000475 Carboprost trometamol

40 mg

Y0000536 Carboprost trometamol - reference spectrum

n/a

1712

Y0000035 Carisoprodol

50 mg

Y0000036 Carisoprodol impurity A

10 mg

Y0001214 Carmellose

10 mg

C0580004 Carmustine - reference spectrum

n/a

C0580010 Carmustine impurity A

20 mg

1187

Y0000846 Carprofen for veterinary use

30 mg

2201

Y0000884 Carprofen for system suitability

5 mg

2201

Y0000192 Carteolol hydrochloride - reference spectrum

n/a

1972

Y0000193 Carteolol for system suitability

30 mg

1972

Y0000075 Carvedilol - reference spectrum

n/a

1745

Y0000103 Carvedilol impurity C

10 mg

C0600000 Casein BRP

100000 mg

C0630000 Cefaclor

450 mg

C0640000 Delta-3-Cefaclor

20 mg

C0650000 Cefadroxil

250 mg

93.7% CHNOS

C0675000 Cefalexin monohydrate

150 mg

94.2% CHNOS ; Batch 2 is valid until 31 May 2011

C0682000 Cefalotin sodium

100 mg

98.8% CHNNaOS

Y0000505 Cefalotin for impurity B identification

10 mg

C0682300 Cefamandole nafate

125 mg

Y0000240 Cefapirin sodium

100 mg

C0682400 Cefatrizine propylene glycol

150 mg

81.8% CHNOS

C0682410 Cefatrizine impurity A

60 mg

Council of Europe, all rights reserved 2012

Leaflet

Storage
+5C

1185

Extra
Price
charges
79
a
l

79

+5C

79

+5C

79

0755

+5C

79

0884

+5C

79

0885

+5C

79

0375

79

1081

79

-20C

79

79

1689

+5C

79

1689

+5C

79

2360

+5C

79

1187

79

-20C

g(c)

79

+5C

79

+5C

79

79

79

79

99.1% CHNO

(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate

1,3-bis(2-chloroethyl)urea

1712

Yes

+5C

1745

+5C

79

0350

+5C

131

0986

+5C

79

0986

-20C

79

0260,0577,08
13

+5C

79

+5C

79

0987

+5C

79

0987

+5C

79

99.0% CHNNaOS

1402

+5C

79

98.5% CHNNaOS

1650

+5C

79

(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
propan-2-ol
95.0% CHClNOS

0708,0814

Yes

79
1403
+5C
a
7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-179
1403
+5C
a
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)
11
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
C0682800 Cefazolin

Reference Standard

Effective from 2012/1/3


Batch n
3

Quantity Sale
Information
per vial Unit
150 mg
1 99.6% CHNOS ; Batch 2 is valid until 30 September 2011
150 mg
1 95.2% CHClNOS

Monograph

Leaflet

Storage

0988

Yes

+5C

Y0000633 Cefepime dihydrochloride monohydrate

Y0000634 Cefepime dihydrochloride monohydrate for system


suitability

15 mg

2126

Y0001336 Cefepime impurity E

10 mg

(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C0684000 Cefixime

200 mg

C0684750 Cefoperazone dihydrate

100 mg

C0684800 Cefoperazone sodium - reference spectrum

n/a

Y0000420 Cefotaxime acid

80 mg

C0685000 Cefotaxime sodium

30 mg

Y0000506 Cefotaxime for peak identification

10 mg

C0688000 Cefoxitin sodium

100 mg

97.4% CHNNaOS

0990

Y0001305 Cefpodoxime proxetil

70 mg

97.1% CHNOS

2341

Y0001318 Cefpodoxime proxetil for impurity H identification

10 mg

2341

Y0001306 Cefpodoxime proxetil for peak identification

10 mg

Y0001371 Cefprozil

120 mg

Y0001368 Cefprozil impurity mixture

10 mg

Y0001372 Cefprozil impurity A

20 mg

Y0001367 Cefprozil for peak identification

10 mg

C0690000 Cefradine

300 mg

93.9%
; Batch 3 is valid until 31 May 2011

Y0000568 Cefradine for peak identification

15 mg

Y0001174 Cefradine impurity mixture

0.04 mg

C0690500 Ceftazidime

200 mg

85.3% CHNOS ; Batch 1 is valid until 1 February 2011

Y0001111 Ceftazidime for peak identification

10 mg

C0690510 Ceftazidime impurity A

15 mg

Extra
Price
charges
79
a

+5C

79

+5C

79

2126

-20C

g(c)

79

88.8% CHNOS

1188

-20C

79

94.2% CHNOS ; Batch 1 is valid until 31 December 2011

1404

+5C

79

79

2126

Yes

Yes

1404
94.3% CHNOS

0989

+5C

79

0708,0989

+5C

79

+5C

79

+5C

79

Yes

-20C

79

Yes

-20C

79

2341

Yes

-20C

79

2342

Yes

+5C

79

2342

Yes

+5C

79

+5C

79

0989

Yes

2342

(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)

2342

Yes

+5C

79

Yes

+5C

79

Must be used with Cefradine impurity mixture CRS Y0001174

0167,0168,05
78,
0708,0814
0814

Yes

+5C

79

Must be used with Cefradine for peak identification Y0000568

0814

Yes

+5C

79

+5C

79

+5C

79

1405

+5C

79

0991

+5C

79

0991

+5C

79

1405
1405, 2344

89.9% CHNOS ; (6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(1carboxy-1-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5- thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate (delta-2ceftazidime)

Yes

C0691000 Ceftriaxone sodium

80 mg

Ceftazidime impurity A CRS is currently not available, it has been temporarily


replaced
by Ceftazidime for peak identification CRS (Y0001111)
90.4% CHNNaOS

C0692000 Ceftriaxone impurity A

10 mg

E-isomer

C0694990 Cefuroxime axetil

60 mg

97.4% CHNOS

1300

+5C

79

C0695000 Cefuroxime sodium

150 mg

96.7% CHNNaOS

0988,0992

+5C

79

Y0000311 Celiprolol hydrochloride

10 mg

1632

+5C

79

Y0000312 Celiprolol impurity I

0.02 mg

1632

+5C

79

Council of Europe, all rights reserved 2012

1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea
12

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
New Y0000239 Celiprolol for peak identification

Effective from 2012/1/3


Batch n
2

Quantity Sale
Information
per vial Unit
20 mg
1 Batch 1 is valid until 30 June 2012

Monograph

Leaflet

Storage

1632

Yes

+5C

Y0000784 Cellulose acetate

40 mg

0887

C0698005 Cellulose acetate butyrate - reference spectrum

n/a

1406

Y0001054 Cellulose acetate phthalate

10 mg

0314

C0700000 Cephaline hydrochloride

15 mg

0080,0081,00
93,
0094,1530,18
75

C0980650 Cetirizine dihydrochloride

100 mg

Batch 3 is valid until 31 January 2011

1084

C0980651 Cetirizine impurity A

10 mg

(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine

1084

Y0001197 Cetirizine for peak identification

1.01 mg

Replaces Cetirizine impurity mixture CRS

1084

C0984100 Cetostearyl isononanoate - reference spectrum

n/a

C0990000 Cetyl alcohol

250 mg

Y0000073 Cetyl palmitate 15

60 mg

+5C

79

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

79

0540,0702,08
01,
0802,0847,09
69, 1411

+5C

79

1906

+5C

79

1906

+5C

79

0379

+5C

79

Yes

1085
100% CHO

Extra
Price
charges
79
a

Y0000074 Cetyl palmitate 95

50 mg

New C1000000 Cetylpyridinium chloride

20 mg

C1050000 Chenodeoxycholic acid

125 mg

1189,1275

+5C

79

Y0000104 Chitosan hydrochloride

30 mg

1774

+5C

79

C1100000 Chlorambucil

100 mg

0137

+5C

79

Y0001298 Chlorambucil for system suitability

10 mg

0137

+5C

79

Y0001299 Chlorambucil with impurity G

10 mg

0137

+5C

79

C1200000 Chloramphenicol

500 mg

0071,0473,07
09

+5C

79

C1300000 Chloramphenicol dipalmitate

100 mg

0473

+5C

79

C1350000 Chloramphenicol disodium disuccinate

25 mg

0709

+5C

79

C1400000 Chloramphenicol palmitate isomer

100 mg

0473

+5C

79

C1425000 Chloramphenicol sodium succinate

1500 mg

0709

+5C

79

C1435000 Chlorcyclizine hydrochloride

100 mg

1086

+5C

79

C1450000 Chlordiazepoxide - * psy

50 mg

0656,1974

+5C

79

C1500000 Chlordiazepoxide hydrochloride - * psy

100 mg

0474

+5C

79

Y0000476 Chlordiazepoxide impurity A

10 mg

0474,0656

+5C

79

C1510000 Chlorhexidine

50 mg

0658

+5C

79

C1520000 Chlorhexidine diacetate

10 mg

0657

+5C

79

C1540000 Chlorhexidine dihydrochloride

50 mg

0659

+5C

79

Council of Europe, all rights reserved 2012

Batch 1 is valid until 30 April 2012

91.1% CHClNNaO

7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide

13

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C1530000 Chlorhexidine for performance test

Effective from 2012/1/3


Batch n
5

Quantity Sale
per vial Unit
50 mg
1

Information

Y0000569 Chlorogenic acid

20 mg

96.9% CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5trihydroxycyclohexanecarboxylic acid

C2223030 1-(4-Chlorophenyl)-1-phenylethanol

15 mg

Clemastine fumarate impurity C

C1650000 Chloroquine sulfate

200 mg

C1700000 Chlorothiazide

100 mg

C1800000 Chlorphenamine maleate

100 mg

Y0000436 Chlorphenamine impurity A

0.01 mg

Y0000437 Chlorphenamine impurity C

10 mg

C1900000 Chlorpromazine hydrochloride

200 mg

Y0000507 Chlorpromazine impurity A

10 mg

3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)

Y0000479 Chlorpromazine impurity D

10 mg

Y0000508 Chlorpromazine impurity E

10 mg

New Y0001449 Chlorpromazine impurity F

Monograph

Leaflet

Storage

0657,0658,06
59

Yes

+5C

Extra
Price
charges
79
g

0897,1823,18
24,
1866,1897,23
89

+5C

79

1190

-20C

g(c)

79

0544,0545

+5C

79

0385,0394

+5C

79

0386,0977,10
84, 1196

+5C

79

2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile ; Batch 2 is valid until 30 September 2011

0386

+5C

79

(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1amine

0386

+5C

79

0475,20303

+5C

79

0475

+5C

79

3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)

0475

+5C

79

2-chloro-10H-phenothiazine

0475

+5C

79

3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine

0475

+5C

79

1087

+5C

79

1087

+5C

79

0815,1365

+5C

79

+5C

79

+5C

79

+5C

79

Batch 1 is valid until 31 March 2011

2 mg

C1905000 Chlorpropamide

100 mg

C1905020 Chlorpropamide impurity B

50 mg

1,3-Dipropylurea

C1915000 Chlorprothixene hydrochloride

50 mg

2.0% E-isomer

C1950000 Chlortalidone

150 mg

99.5% CHClNOS

Y0000779 Chlortalidone for peak identification

1.017 mg

C2000000 Chlortetracycline hydrochloride

100 mg

New Y0001451 Chlortetracycline for system suitability

n/a

20 mg

0173

Yes

+5C

79

500 mg

100% CHO ; Vitamin D3

0072,0574,05
75,
0598,1192,11
93

Yes

-20C

g(c)

79

C2150000 Cholecalciferol for system suitability

1 mL

Batch 5 is valid until 30 November 2011

-20C

g(c)

79

C2155000 Cholesterol

100 mg

99.5% CHO ; Batch 2 is valid until 31 December 2011

0072,0082,05
74,
0575,0598
0993

+5C

79

C2158000 Cholic acid

60 mg

Batch 1 is valid until 31 July 2011

1189

+5C

79

Y0000280 Chondroitin sulfate sodium

250 mg

100% HO(CHNNaOS)

2064

+5C

79

Y0000593 Chondroitin sulfate sodium (marine)

100 mg

2064

+5C

79

New C2100000 Cholecalciferol

Council of Europe, all rights reserved 2012

0546
0546

89.7% CHClNO
5.5% CHClNO

14

Yes

0173

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C2160000 Chymotrypsin BRP

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
100 mg
1 6.01 microkatals per mg

Information

Monograph

Leaflet

Storage

0476,0694

+5C

Extra
Price
charges
79
a

Y0000040 Ciclopirox

100 mg

1407

+5C

79

C2162701 Ciclopirox impurity A

20 mg

()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid

1302,1407

+5C

79

C2162702 Ciclopirox impurity B

20 mg

6-cyclohexyl-4-methyl-2H-pyran-2-one

1302,1407

-20C

79

New C2162700 Ciclopirox olamine

150 mg

Batch 1 is valid until 31 May 2012

1302

+5C

79

C2163000 Ciclosporin

120 mg

98.5% CHNO

0994

+5C

79

Y0000361 Ciclosporin for system suitability

5 mg

0994

+5C

79

C2170000 Cilastatin sodium

10 mg

1408

+5C

79

C2174000 Cilazapril

50 mg

1499

+5C

79

C2174002 Cilazapril impurity A

25 mg

1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate

1499

+5C

79

C2174005 Cilazapril impurity D

10 mg

(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid

1499

+5C

79

C2175000 Cimetidine

50 mg

0756

+5C

79

C2175500 Cimetidine hydrochloride

100 mg

1500

+5C

79

Y0001130 Cimetidine for peak identification

10 mg

0756

Yes

+5C

79

Y0001146 Cimetidine for system suitability

0.5085 mg

756

Yes

+5C

79

C2177000 Cinchocaine hydrochloride

60 mg

1088

+5C

79

Y0000176 Cineole

180 mg

1973

+5C

79

C2180000 Cinnarizine

100 mg

0816

+5C

79

Y0000362 Ciprofibrate

5 mg

2013

+5C

79

Y0000363 Ciprofibrate for system suitability

5 mg

2013

+5C

79

Y0000198 Ciprofloxacin

20 mg

1089

+5C

79

C2190000 Ciprofloxacin hydrochloride

100 mg

+5C

79

Y0000199 Ciprofloxacin hydrochloride for peak identification

10 mg

+5C

79

C2190050 Ciprofloxacin impurity A

10 mg

7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)

+5C

79

C2210000 Cisplatin

100 mg

99.7% [PtCl(NH)]

0599

+5C

79

Y0001018 Cisplatin impurity A

10 mg

trans-diamminedichloroplatinum (II)

0599

+5C

79

Y0001019 Cisplatin impurity B

10 mg

94.1% [PtCl(NH)]-; amminetrichloroplatinate(-)

0599

+5C

79

Y0001008 Citalopram hydrobromide

5 mg

2288

+5C

79

Y0001007 Citalopram hydrochloride

5 mg

2203

+5C

79

Y0000855 Citalopram for system suitability

0.06 mg

2203,2288

+5C

79

A1202000 Citric acid (anhydrous)

50 mg

0455

+5C

79

C2219000 Citric acid monohydrate

50 mg

0456

+5C

79

Y0000639 Cladribine

50 mg

+5C

g(b)

79

Y0000609 Cladribine for peak identification

10 mg

+5C

g(b)

79

Council of Europe, all rights reserved 2012

0888,1353

93.6% CHClFNO

0888,1089

99.1% CHClNO

Yes

0888,1089,22
29
Yes

Yes

2174
2174

15

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000610 Cladribine impurity C

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
5 mg
1 2-chloro-7H-purin-6-amine
160 mg
1 97.7% CHNO ; Batch 2 is valid until 31 March 2012

Monograph

Leaflet

2174

Storage
+5C

Extra
Price
charges
79
g(b)

Y0000320 Clarithromycin

1651

Yes

+5C

79

Y0000321 Clarithromycin for peak identification

30 mg

1651

Yes

+5C

79

Y0000269 Clazuril for system suitability

10 mg

1714

Yes

+5C

79

Y0001193 Clazuril

10 mg

1714

+5C

79

C2221000 Clebopride malate

100 mg

1303

+5C

79

C2223000 Clemastine fumarate

100 mg

1190

+5C

79

C2248000 Clenbuterol hydrochloride

30 mg

1409

+5C

79

C2248010 Clenbuterol impurity B

10 mg

1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone

1409

+5C

79

C2250000 Clindamycin hydrochloride

200 mg

94.4% CHClNOS

0582,0583,09
96

+5C

79

C2269000 Clindamycin phosphate

250 mg

95.7% CHClNOPS

0996

+5C

79

Y0000364 Clioquinol

5 mg

2111

+5C

79

Y0000205 Clobazam - reference spectrum

n/a

79

Y0000241 Clobazam impurity A

10 mg

7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione

1974

+5C

79

Y0000559 Clobetasol propionate

40 mg

99.6% CHClFO

2127

+5C

79

Y0000570 Clobetasol for peak identification

2 mg

+5C

79

Y0000571 Clobetasol impurity J

0.4 mg

+5C

79

C2285000 Clobetasone butyrate

50 mg

1090

+5C

79

Y0001137 Clobetasone butyrate for system suitability

30 mg

1090

+5C

79

Y0000888 Clodronate disodium tetrahydrate

5 mg

1777

+5C

79

Y0000885 Clodronate impurity D

5 mg

1777

+5C

79

Y0000313 Clofazimine

150 mg

2054

+5C

79

Y0000358 Clofazimine for system suitability

10 mg

2054

+5C

79

C2300000 Clofibrate

0.5 ml

0318

+5C

79

C2320000 Clomifene citrate

50 mg

0997,1046

+5C

79

C2332000 Clomifene citrate for performance test

50 mg

0997

+5C

79

C2360000 Clomipramine hydrochloride

100 mg

0889

+5C

79

Y0000132 Clomipramine impurity C

10 mg

94.5% CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine

0889

+5C

79

Y0000133 Clomipramine impurity D

10 mg

3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine

0889

+5C

79

Y0000134 Clomipramine impurity F

5 mg

3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine

0889

+5C

79

C2385000 Clonazepam - * psy

50 mg

1974,0415

+5C

79

Y0000286 Clonazepam - reference spectrum

n/a

C2385015 Clonazepam impurity B

5 mg

Council of Europe, all rights reserved 2012

1974

2127
(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)

(chloromethylene)bis(phosphonic acid)

44% of Z-isomer CHClNO

Yes

2127

Yes

Yes

Yes

79
0890
l
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one ; Batch 1 is valid until
79
0890
+5C
a
28 February 2011
16
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C2400000 Clonidine hydrochloride

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
100 mg
1

Information

Monograph

Leaflet

Storage

0477

+5C

Extra
Price
charges
79
f

Y0000801 Clonidine impurity B

20 mg

0477

+5C

79

Y0000833 Clopamide

40 mg

1747

+5C

79

Y0000848 Clopamide for system suitability

10 mg

1747

+5C

79

Y0001333 Clopidogrel hydrogen sulfate

60 mg

2531

+5C

79

Y0001335 Clopidogrel impurity A

10 mg

+5C

79

Y0001334 Clopidogrel for system suitability

100 mg

2531

+5C

79

Y0000392 Closantel sodium dihydrate

20 mg

1716

+5C

79

Y0000393 Closantel for system suitability

20 mg

1716

Yes

+5C

79

C2424400 Clostridia (multi-component) rabbit antiserum(for


vaccines-vet.use)BRP

1 mg

see information on the accompanying leaflet

0362,0363,03
64, 0697

Yes

-20C

90

C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP

1 mg

0.20 IU per vial (determined using toxin neutralisation test)

20708

Yes

-20C

90

C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP

1 mg

34 IU per vial

See leaflet,
0697

Yes

-20C

90

C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.


use) BRP

1 mg

15 IU per vial

See leaflet,
0697

Yes

-20C

90

C2430000 Clotrimazole

100 mg

0757

+5C

79

Y0000818 Clotrimazole impurity E

15 mg

0757

+5C

79

Y0000849 Clotrimazole for peak identification

1 mg

C2450000 Cloxacillin sodium

200 mg

93.9% CHClNNaOS

C2460000 Clozapine

60 mg

Batch 1 is valid until 29 February 2012

Y0000758 Clozapine for peak identification

0.41 mg

1 mg

1191
Factor V : 0.73 IU per vial, Factor VIII : 0.74 IU per vial, Factor XI : 0.59 IU per 0903,1646,20
vial, Factor XIII : 0.79 IU per vial
740,20722

Y0000162 Cocaine hydrochloride - reference spectrum

n/a

C2480000 Cocoyl caprylocaprate

40 mg

Y0000722 Codeine - * narc

20 mg

C2500000 Codeine - reference spectrum

n/a

Y0000334 Codeine impurity A

10 mg

C2500100 Codeine hydrochloride dihydrate - reference spectrum

n/a

C2510000 Codergocrine mesilate

60 mg

C2580000 Colchicine

15 mg

Y0000209 Colchicine for system suitability

10 mg

0758

Y0000374 Colestyramine

10 mg

1775

New Y0001472 Coagulation Factors V, VIII, XI and XIII plasma

Council of Europe, all rights reserved 2012

1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole

(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid

Batch 1 is valid until 31 October 2011

Yes

2531

0757

Yes

+5C

79

0661,0663,06
68, 2260

Yes

+5C

79

1191

+5C

79

Yes

+5C

79

Yes

-20C

90

79

+5C

79

+5C

79

79

79

79

0073
1411
0076,1839,18
41

See leaflet

Yes

0074,0075,00
76
7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan

0074,0075,00
76, 1412

+5C

1412
Batch 1 is valid until 30 September 2011

17

1416,2060

+5C

79

0758

+5C

79

+5C

79

+5C

79

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
C2600000 Colistimethate sodium

Effective from 2012/1/3


Batch n
2

Y0000277 Colistin sulfate

C2700000 Colistin sulfate for microbiological assay

C2725000 Copovidone - reference spectrum


C2800000 Cortisone acetate

Quantity Sale
Information
per vial Unit
20 mg
1 285000 IU per vial CHNNaOS
25 mg
1 33.7% colistin E2, 2.6% colistin E3, 3.3% colistin E1-I, 3.1% colistin
E1-7MOA, 44.2 % colistin E1.
25.0 mg of colistin sulphate per vial

Monograph

Leaflet

0319,20702
0320

Storage
+5C

Extra
Price
charges
79
a

Yes

-20C

79

Yes

-20 C

79

79

0321,0736,07
67

+5C

79

2120

+5C

79

25 mg

n/a

250 mg

Batch 5 is valid until 31 July 2011

Y0000438 Coumarin

80 mg

99.9% CHO

C2900000 Cotton wool standard for neps

1000 mg

0036

+5C

79

Y0001053 Crospovidone

5 mg

0892

+5C

79

C2970000 Crotamiton

100 mg

99.2% CHNO (sum of E and Z-isomers); 3.5% Z-isomers

1194

-20C

79

70 mg

N-ethyl-N-(2-methylphenyl)but-3-enamide ; Batch 2 is valid until 31 March


2012

1194

-20C

79

Y0001061 Cyanidin chloride

20 mg

99.1% CHClO

2394

+5C

79

C3000000 Cyanocobalamin

20 mg

Vitamin B12

+5C

79

C3090000 Cyclizine hydrochloride

50 mg

0269,0270,05
47,
0710,1505
1092

+5C

79

Y0000886 Cyclizine impurity A

15 mg

1-methylpiperazine

1092

+5C

g(b)

79

Y0000887 Cyclizine impurity B

10 mg

diphenylmethanol (benzhydrol)

1092

+5C

79

C3200000 Cyclobenzaprine hydrochloride

100 mg

0408,0464

+5C

79

C3245000 Cyclopentolate hydrochloride

50 mg

1093

+5C

79

Y0001088 Cyclopentolate for system suitability

60 mg

1093

+5C

79

C3250000 Cyclophosphamide

50 mg

0711

+5C

79

C3280000 Cyproheptadine hydrochloride

30 mg

0817,0846

+5C

79

Y0001095 Cyproheptadine impurity C

5 mg

0817

+5C

79

C3283000 Cyproterone acetate

30 mg

1094

+5C

79

Y0001390 Cyproterone acetate for peak identification

5 mg

1094

Yes

+5C

79

Y0001223 Cyproterone impurity mixture

0.01 mg

1094

Yes

+5C

79

C3290000 Cysteine hydrochloride monohydrate

50 mg

0895

+5C

79

C3300000 Cystine

100 mg

0998

+5C

79

C3350000 Cytarabine

150 mg

0760

+5C

79

Y0000733 Dacarbazine

20 mg

1691

+5C

79

Y0000734 Dacarbazine impurity A

20 mg

89.4% CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine) ; Batch 1 is valid until 31 December 2011

1691

+5C

79

Y0000735 Dacarbazine impurity B

10 mg

87.9% CHO; 5-amino-1H-imidazole-carboxamide

1691

+5C

79

D0070000 Dalteparin sodium

250 mg

0828

+5C

79

Y0000600 Danaparoid sodium

10 mg

+5C

79

New C2970005 Crotamiton impurity A

Council of Europe, all rights reserved 2012

576 000 IU per vial; For microbiological assay only


0891

147 anti-factor Xa units per ampoule, 4.3 anti-factor IIa units per ampoule
18

2090

Yes

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
D0100000 Dapsone

Reference Standard

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
100 mg
1

Information

Monograph

Leaflet

Storage

0077

+5C

Extra
Price
charges
79
a

D0125000 Daunorubicin hydrochloride

100 mg

98.5% CHClNO

0662

+5C

79

D0120000 Daunorubicinone

10 mg

Daunorubicin aglycone

0662

+5C

79

D0160000 Deferoxamine mesilate

30 mg

0896

-20C

79

D0201000 Dehydrohexetidine

50 mg

1221

+5C

79

Y0000611 Dembrexine hydrochloride monohydrate

10 mg

2169

+5C

79

D0300000 Demeclocycline hydrochloride

100 mg

D0350000 N-Demethylerythromycin A

10 mg

Y0000228 Demethylflumazenil - reference spectrum

n/a

D0406000 Deoxyminoxidil

0.25 mg

D0406200 Deptropine citrate

60 mg

D0430000 Dequalinium chloride

50 mg

D0431000 Dequalinium chloride for performance test

50 mg

Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate

1 mL

D0480000 Desacetylvinblastine

1 mg

1276

Y0000879 Desflurane - reference spectrum

n/a

1666

Y0000807 Desflurane impurity A

1 ml

D0500000 Desipramine hydrochloride

100 mg

D0600000 Deslanoside

150 mg

D0630000 Desmethylmetrifonate

30 mg

D0650000 Desmopressin

0.99 mg

Y0000509 Desogestrel

50 mg

Y0000510 Desogestrel for system suitability

10 mg

1717

D0400000 Desoxycortone acetate

100 mg

0322,0809,08
50, 1327

Y0000001 Detomidine hydrochloride

100 mg

D0660020 Detomidine impurity B

20 mg

D0700000 Dexamethasone

60 mg

D0710000 Dexamethasone acetate

100 mg

0548,0933,09
75, 2237

Y0001169 Dexamethasone acetate impurity E

0.013 mg

Y0001177 Dexamethasone for system suitability

10 mg

Council of Europe, all rights reserved 2012

2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine

0176

+5C

79

0179,0274,04
90,
0552,1098
1917

+5C

79

79

0937

+5C

79

1308

+5C

79

1413

+5C

79

1413

+5C

79

-20C

79

-80C

g(d)

79

79

92.4% CHClNO

Batch 4 is valid until 31 March 2012

0332,0333

Dermatan sulfate 10 mg/mL


Oversulfated chondroitin sulfate 2.5 mg/mL

Yes

1666

+5C

79

0481

+5C

79

0482

+5C

79

1133

+5C

79

0.99 mg per vial of CHNOS

0712

-20C

79

99.9% CHO

1717

+5C

79

+5C

79

+5C

79

1414

+5C

79

1414

+5C

79

0312,0388,05
48,
0768,1376,22
37

+5C

79

+5C

79

+5C

79

+5C

79

1,1'-oxybis(1,2,2,2-tetrafluoroethane)
98.8% CHO

(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol

9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate

Yes

0548
0388

19

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000538 Dexamethasone isonicotinate

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

2237

Storage
+5C

Y0000511 Dexamethasone isonicotinate for impurity C identification

10 mg

2237

+5C

79

D0718000 Dexamethasone pivalate

50 mg

1327

+5C

79

D0720000 Dexamethasone sodium phosphate

100 mg

0549,0735,08
10

+5C

79

D0720800 Dexchlorpheniramine maleate

60 mg

1196

+5C

79

D0730000 Dexpanthenol

5 mg

0761

+5C

79

D0731000 Dextran

25 mg

0999,1000,10
01

+5C

79

D0731005 Dextran 1

50 mg

+5C

79

D0732000 Dextran Vo

10 mg

20239

+5C

79

D0733000 Dextran 4 for calibration

50 mg

M 3050-M 3850

20239

+5C

79

D0734000 Dextran 10 for calibration

50 mg

M 8800 - M 10450

20239

+5C

79

D0735000 Dextran 40 for calibration

50 mg

M 30500- M 40900

20239

+5C

79

D0736000 Dextran 70 for calibration

50 mg

M 58900- M 70300

20239

+5C

79

D0737000 Dextran 250 for calibration

50 mg

M 121800- M 238200

20239

+5C

79

D0738000 Dextran 40 for performance test

50 mg

20239

+5C

79

D0739000 Dextran 60/70 for performance test

50 mg

20239

+5C

79

Y0000744 Dextranomer

50 mg

2338

+5C

79

D0740000 Dextromethorphan hydrobromide

100 mg

0020

+5C

79

Y0000261 Dextromethorphan impurity A

5 mg

0020

+5C

79

Y0001058 Dextropropoxyphene hydrochloride - * narc

10 mg

0713

+5C

79

Y0001150 Dextropropoxyphene for system suitability - * narc

5 mg

0713

+5C

79

D0940000 Diazepam - * psy

30 mg

0022

+5C

79

Y0000596 Diazepam for system suitability - * psy

0.5 mg

0022

+5C

79

D0950000 Diazoxide

50 mg

0550

+5C

79

D0970000 Dibenzocycloheptene

20 mg

0817

+5C

79

D1000000 Dibenzosuberone

100 mg

0464,0817,09
41

+5C

79

Y0000480 Dibrompropamidine diisetionate

10 mg

2300

+5C

79

Y0000481 Dibrompropamidine for system suitability

20 mg

2300

+5C

79

D1010000 Dibutyl phthalate

1 ml

0762

+5C

79

Y0000275 Dichlorodiaminocyclohexaneplatinum

10 mg

2017

+5C

79

Y0000264 Diclazuril for veterinary use - reference spectrum

n/a

1718

79

Y0000259 Diclazuril for system suitability

20 mg

1718

+5C

79

D1039990 Diclofenac potassium


Council of Europe, all rights reserved 2012

100 mg

Dexamethasone sodium phosphate CRS 4 is suitable for 01/2008:0810,


01/2008:0549 and 01/2008:0735 only. ; Batch 3 is valid until 28 February
2011

Average molecule mass : 930-1000


Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%

ent-3-methoxymorphinan

20

1506

Yes

Extra
Price
charges
79
a

Yes

Yes
Yes

Yes

79
1508
+5C
g
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
New D1040000 Diclofenac impurity A

Effective from 2012/1/3


Batch n
7

Quantity Sale
Information
per vial Unit
0.005 mg 1 1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 5 is valid until 1
February 2011
Batch 6 is valid until 31 March 2012

Monograph

Leaflet

Storage

Extra
Price
charges
79
g

1002,1281,15
08

+5C

0661,0663,06
68

+5C

79

1197

+5C

79

2200

+5C

79

D1050000 Dicloxacillin sodium

250 mg

93.0% CHClNNaOS

D1060000 Dicycloverine hydrochloride

100 mg

Batch 1 is valid until 31 March 2012

Y0000439 Didanosine

10 mg

Y0000440 Didanosine for system suitability

10 mg

+5C

79

Y0000441 Didanosine impurity A

10 mg

1,7-dihydro-6H-purin-6-one (hypoxanthine)

2200

+5C

79

Y0000442 Didanosine impurity G

10 mg

9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)

2200

+5C

79

D1200000 Dienestrol

150 mg

100% CHO

0483,0484

+5C

79

D1250000 Diethanolamine fusidate

50 mg

0798,0848

+5C

79

D1300000 Diethylcarbamazine citrate

250 mg

0271

+5C

79

Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum

n/a

79

D1410000 Diethyl phthalate

1 ml

D1500000 Diethylstilbestrol

100 mg

D1600000 Diethylstilbestrol dimethyl ether

10 mg

D1700000 Diethylstilbestrol monomethyl ether

10 mg

Y0001423 Difloxacin hydrochloride

60 mg

Y0001429 Difloxacin impurity G

15 mg

D1750000 Diflunisal

30 mg

D1800000 Digitoxin

250 mg

Y0000640 Digoxigenin

5 mg

D1900000 Digoxin

30 mg

Y0000554 Digoxin for peak identification

10 mg

0079

D1940001 Dihydralazine sulfate (hydrated) - reference spectrum

n/a

1310

Y0000232 Dihydralazine for system suitability

10 mg

1310

Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum

n/a

Y0000053 17 alpha-dihydroequilin

10 mg

D1945000 Dihydroergocristine mesilate

250 mg

D1950000 Dihydroergotamine mesilate

100 mg

Y0000831 Dihydroergotamine for peak identification

10 mg

D1952000 Dihydroergotamine tartrate

150 mg

100.0% CHNO. Dried at 100-105C at constant weight

0600

D1954000 Dihydrostreptomycin sulfate

25 mg

23.9 mg per vial of CHNOS

0485

Y0000544 Dihydrotachysterol

30 mg

99.6% CHO ; Batch 1 is valid until 31 January 2011

2014

5 mg

Y0000482 Dihydrotachysterol for system suitability


Council of Europe, all rights reserved 2012

2200

99.9% CHNO

Yes

1198
0897

+5C

79

0483,0484

+5C

79

0484

+5C

79

0484

+5C

79

2239

+5C

79

2239

+5C

79

0818,0864

+5C

79

0078,0117

+5C

79

0079

+5C

79

Dried at 100-105C for 2 h. 100% CHO

7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid
99.0% CHO

+5C

79

Yes

+5C

79

79

Yes

+5C

79

79

1512

-20C

79

1416,2060

+5C

79

0551

+5C

79

+5C

79

+5C

79

-20C

79

-20C

g(d)

79

98.5% CHO

0079

1776
98.2% CHO

0551

21

Yes
Yes

79
2014
Yes
-20C
g(d)
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
D1980000 Diltiazem hydrochloride

Effective from 2012/1/3


Batch n
5

Quantity Sale
per vial Unit
300 mg
1

Information

Monograph

Leaflet

Storage

1004

+5C

Extra
Price
charges
79
g

Y0001141 Diltiazem for system suitability

10 mg

1004

+5C

79

D2000000 Dimenhydrinate

100 mg

0601

+5C

79

Y0000234 N,N-Dimethylacetamide - reference spectrum

n/a

1667

79

Y0001103 Dimenhydrinate for peak identification

1 mg

0601

+5C

79

D2050000 Dimethyl sulfoxide

1 ml

+5C

79

D2200000 Dimeticone

200 mg

+5C

79

D2205000 Dimetindene maleate

50 mg

1417

+5C

79

D2255000 Dinoprost trometamol

60 mg

98.2% CHNO

1312

-20C

79

D2250000 Dinoprostone

100 mg

99.8% CHO

D2250015 Dinoprostone impurity C

10 mg

(E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)

Y0000094 Diosmin

50 mg

93.7% CHO

Y0000095 Diosmin for system suitability

5 mg

D2600000 Diphenhydramine hydrochloride

100 mg

Y0000135 Diphenhydramine impurity A

10 mg

D2630000 Diphenoxylate hydrochloride - reference spectrum

Replaces Diltiazem impurity A CRS

Yes

0763
0138,1470

99.9% dimeticone ; Batch 3 is valid until 31 October 2011

Yes

1311

-20C

79

1311,1488

-20C

240

1611

+5C

79

1611

+5C

79

0023,0601,11
90

+5C

79

0023,0601

+5C

79

79

+5C

79

2-(diphenylmethoxy)-N-methylethanamine

n/a

0819

New Y0001415 Diphenoxylate hydrochloride - * narc

15 mg

0819

New Y0001430 Diphenoxylate for system suitability - * narc

10 mg

+5C

Y0000258 Diphtheria toxin BRP - * Biotox

1 ml

Nominal concentration of Diphtheria toxin: 1 Lf/ml (0.4l/ml)


Systemic toxicity: 77.6 LD/ml (determined in the subcutaneous challenge
test in guinea pigs)
Maximum intradermal toxicity: 75,000Lr/Lf (determined in the guinea pig
intradermal skin test)
Toxicity in the Vero cell assay: concentrations of 5x10- Lf/ml and below
cause cytotoxic effects.

See leaflet,
0443

Yes

+5C

g(b)

90

D2700000 Diphtheria vaccine (adsorbed) BRP

32 mg

97 IU per vial

See leaflet,
20706

Yes

-20C

90

Y0000376 Dipivefrine hydrochloride

100 mg

1719

+5C

79

Y0000394 Dipivefrine for system suitability

10 mg

1719

+5C

79

D2750100 Dipotassium clorazepate - reference spectrum

n/a

0898

79

D2800000 Diprophylline

100 mg

0486

+5C

79

D2850000 Dipyridamole

50 mg

1199

+5C

79

Y0000802 Dipyridamole for peak identification

2 mg

1199

+5C

79

D2880000 Dirithromycin

100 mg

1313

+5C

79

D2900000 Disodium edetate

100 mg

0232

+5C

79

D2920000 Disopyramide

100 mg

1006

+5C

79

D2922000 Disopyramide phosphate

100 mg

1005

+5C

79

Council of Europe, all rights reserved 2012

0819

97.4% CHNO

22

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
D2950000 Disulfiram

Reference Standard

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
100 mg
1

Information

Monograph

Leaflet

Storage

0603

+5C

Extra
Price
charges
79
g

D2953000 Dithranol

50 mg

1007

+5C

79

D2953025 Dithranol impurity C

20 mg

Dithranol-dimer
4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione

1007

+5C

79

D2953050 Dithranol impurity D

20 mg

94.9% CHO; 1-hydroxyanthracen-9(10H)-one

1007

+5C

79

D2954000 Dobutamine hydrochloride

100 mg

1200

+5C

79

Y0001239 Dobutamine impurity mixture

0.1 mg

1200

+5C

79

Y0001133 Docetaxel trihydrate

160 mg

+5C

79

Y0001155 Docetaxel for system suitability

10 mg

+5C

79

D2954600 Docosahexaenoic acid ethyl ester

150 mg

+5C

79

D2954500 Docusate sodium - reference spectrum

n/a

79

Y0000365 Dodecyl gallate

30 mg

D2955000 Domperidone

150 mg

D2957000 Domperidone maleate

150 mg

D2960000 Dopamine hydrochloride

50 mg

Y0000612 Dopexamine dihydrochloride

10 mg

Y0000613 Dopexamine impurity B

10 mg

2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol

Y0000614 Dopexamine impurity F

10 mg

4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol

Y0000726 Dorzolamide hydrochloride

50 mg

Y0000727 Dorzolamide impurity A

5 mg

Y0000750 Dorzolamide for system suitability

5 mg

2359

D2962000 Dosulepin hydrochloride

100 mg

1314

D2962005 Dosulepin impurity A

50 mg

1314

Y0001385 Angelica pubescent root

500 mg

2557

D2963000 Doxapram hydrochloride

50 mg

1201

Y0000208 Doxapram impurity B

10 mg

(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one

Y0000553 Doxazosin mesilate

60 mg

99.2% CHNOS

Y0000551 Doxazosin impurity D

10 mg

Y0000552 Doxazosin impurity F

10 mg

Y0000838 Doxepin hydrochloride

5 mg

1096

Y0000851 Doxepin for system suitability

1 mg

1096

Yes

New D2975000 Doxorubicin hydrochloride

150 mg

99.4% CHClNO ; Batch 5 is valid until 31 May 2012

0714,0662,15
90

D3000000 Doxycycline hyclate

50 mg

92.9% CHClNO corresponding to 85.9% CHNO

0272,0820

Y0000163 Doxylamine hydrogen succinate - reference spectrum

n/a

Council of Europe, all rights reserved 2012

Yes

2449

93.6% CHNO

2449

Yes

2063,20429

98.4% DHA ethyl ester

1418
2078

+5C

79

1009

+5C

79

1008

+5C

79

0664,1200

+5C

79

1748

+5C

79

1748

-20C

79

1748

-20C

79

2359

+5C

79

2359

+5C

79

+5C

79

+5C

79

+5C

79

-20C

79

+5C

79

1201

+5C

79

2125

+5C

79

6,7-dimethoxyquinazoline-2,4(1H,3H)-dione

2125

+5C

79

2-chloro-6,7-dimethoxyquinazolin-4-amine

2125

+5C

79

+5C

79

+5C

79

Yes

-20C

g(c)

79

Yes

+5C

79

79

Batch 1 is valid until 30 April 2011

(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide

(E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide

1589
23

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
New Y0000160 Doxylamine impurity A

Effective from 2012/1/3


Batch n
2

Quantity Sale
Information
per vial Unit
10 mg
1 N,N-dimethyl-2-[1(RS)-1-phenyl-1-(pyridin-4-yl)ethoxy]ethanamine ; Batch 1
is valid until 30 April 2012

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

1589

+5C

1008,1009,10
10, 1172

+5C

79

D3100000 Droperidol

150 mg

Y0001105 Drospirenone

60 mg

99.9% CHO

2404

+5C

79

Y0001115 Drospirenone impurity E

0.06 mg

3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)

2404

+5C

79

New Y0001455 Duloxetine impurity A

10 mg

(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine

2594

+5C

79

Y0001004 Dydrogesterone

50 mg

99.5% CHO

2357

+5C

79

Y0001005 Dydrogesterone impurity A

6 mg

9,10-pregna-4,6,8(14)-triene-3,20-dione

2357

+5C

79

Y0001006 Dydrogesterone impurity B

5 mg

pregna-4,6-diene-3,20-dione

2357

+5C

79

Y0000249 Ebastine - reference spectrum

n/a

79

Y0000247 Ebastine impurity C

10 mg

4-(diphenylmethoxy)piperidine

2015

+5C

79

Y0000248 Ebastine impurity D

10 mg

1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one

2015

+5C

79

Y0001236 Econazole

10 mg

2049

+5C

79

E0050000 Econazole nitrate

100 mg

0513,0665,09
21, 0935,
1017,1018

+5C

79

Y0000254 Econazole for system suitability

20 mg

0665,2049

Yes

+5C

79

E0085000 Eicosapentaenoic acid ethyl ester

200 mg

2063,20429

Yes

Y0000537 Emedastine difumarate

10 mg

Y0000512 Emedastine impurity E

10 mg

E0100000 Emetine hydrochloride

100 mg

E0110000 Enalapril for system suitability

20 mg

1420

Y0001211 Enalapril impurity mixture

0.06 mg

1420

E0109000 Enalapril maleate

50 mg

1420

Y0000615 Enalaprilat dihydrate

100 mg

1749

Y0000629 Enalaprilat for system suitability

10 mg

1749

Y0000678 Enalaprilat impurity G

0.005 mg

Y0000136 Enilconazole

60 mg

Y0000137 Enilconazole impurity E

20 mg

(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol

E0150000 Endotoxin standard BRP

11 mg

10000 IU per vial

E0180000 Enoxaparin sodium

200 mg

E0180500 Enoxolone

100 mg

Y0001259 Enrofloxacin

5 mg

Council of Europe, all rights reserved 2012

2015

93.6% EPA ethyl ester CHO


1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.

(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid

+5C

79

2242

+5C

79

2242

+5C

79

0080,0081,00
93,
0094,1530,18
75

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

1749

+5C

79

1720

+5C

79

1720

+5C

79

Yes

-20C

79

0828,1097

+5C

79

1511

+5C

79

2229

+5C

79

24

20614

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001160 Enrofloxacin for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

Storage

2229

Yes

+5C

Yes

Extra
Price
charges
79
g

Y0001249 Entacapone

160 mg

99.9% CHNO

2574

+5C

79

Y0001250 Entacapone impurity A

10 mg

Z isomer of entacapone

2574

+5C

79

E0200000 Enterokinase BRP

500 mg

0350

+5C

79

E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor

50 mg

0715

+5C

79

E0300000 Ephedrine hydrochloride - * Drug Precursor

150 mg

99.8% CHClNO

Yes

+5C

79

E0400000 4-Epianhydrotetracycline hydrochloride

20 mg

87.1% CHNO.HCl ; Batch 5 is valid until 29 February 2012

Yes

+5C

79

E0430000 4-Epichlortetracycline hydrochloride

20 mg

94,8% CHClNO

0173

+5C

79

E0440000 4-Epidemeclocycline hydrochloride

20 mg

0176

+5C

79

E0500000 6-Epidoxycycline hydrochloride

50 mg

0272,0820

+5C

79

Y0001139 Epinastine hydrochloride

20 mg

2411

+5C

79

Y0001128 Epinastine hydrochloride for system suitability

10 mg

E0530000 4-Epioxytetracycline

40 mg

81.1% CHNO

E0550000 Epirubicin hydrochloride

100 mg

96.4% CHClNO

E0600000 4-Epitetracycline hydrochloride

30 mg

Y0000052 Equilin

15 mg

Y0001325 Equisetum palustre

200 mg

E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 Horse


Antiserum BRP

1 mg

Assigned SRH antibody titre: 125 mm +/-20%; Common standard OIE


Strain A/eq/Newmarket/77

See leaflet,
0249

E0850021 Eq Influenza Subtype 2 American-like/Newmarket Horse


Antiserum BRP

1 mg

Assigned SRH antibody titre: 180 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/1/93

E0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse


Antiserum BRP

1 mg

Assigned SRH antibody titre: 155 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/2/93

Y0000712 Eq Influenza Subtype 2 American-like/South Africa Horse


Antiserum BRP

1 mg

E0900000 Ergocalciferol

500 mg

E1000000 Ergometrine maleate - * Drug Precursor

50 mg

20 mg

E1200000 Ergotamine tartrate - * Drug Precursor

100 mg

Y0000051 Erysipelas ELISA coating antigen BRP

0.4 mg

Y0000177 Erythritol

1
4

New E1100000 Ergosterol

E1300000 Erythromycin for microbiological assay


Council of Europe, all rights reserved 2012

0487,0488,04
89,
1367,2451
0210,0211,16
54

2411

99.7% CHO

100.0% CHO ; Vitamin D2

+5C

79

0198,0199

Yes

+5C

79

0662,0714,15
90

-20C

79

0210,0211,16
54

+5C

79

1512

-20C

79

1825

+5C

79

Yes

-20C

90

See leaflet,
0249

Yes

-20C

90

See leaflet,
0249

Yes

-20C

90

See leaflet,
0249

Yes

-20C

90

-20C

g(c)

79

0082,0574,05
75,
0598,1192,11
93
0223

+5C

79

Batch 4 is valid until 31 March 2012

0082

-20C

g(c)

79

0.5ml Freeze dried (0.367g protein)

See leaflet,
0064

1000 mg

99.8% CHO

250 mg

960 IU per mg
25

0224

1803

Yes

+5C

79

-20C

90

+5C

79

79
20702
-20C
a
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
E1305000 Erythromycin A

Reference Standard

Effective from 2012/1/3


Batch n
3

Quantity Sale
per vial Unit
250 mg
1 97.0% CHNO

Information

Monograph

Leaflet

Storage

0179,0274,02
93,
0490,0552,10
98

Yes

-20C

E1310000 Erythromycin B

50 mg

98.4% CHNO

-20C

79

E1320000 Erythromycin C

50 mg

97.6% CHNO

-20C

79

E1400000 Erythromycin estolate

100 mg

+5C

79

E1500000 Erythromycin ethylsuccinate

10 mg

E1500800 Erythromycin stearate

50 mg

0274

+5C

79

0490

+5C

79

E1515000 Erythropoietin BRP

37.5 mg

Y0000324 Esketamine hydrochloride - reference spectrum

n/a

-20C

150

79

Y0000338 Esketamine impurity D

10 mg

1742

Y0001028 Esomeprazole magnesium trihydrate

10 mg

2372

+5C

79

+5C

79

Y0000749 Essential oil

1000 mg

2098

E1600000 Estradiol benzoate

250 mg

0139

+5C

79

+5C

79

Y0000852 Estradiol benzoate for system suitability

10 mg

0139

Y0000045 Estradiol butyrate

10 mg

1614

+5C

79

+5C

79

E1620000 Estradiol hemihydrate

100 mg

Y0000314 Estradiol for peak identification

10 mg

0821

+5C

79

+5C

79

Y0000046 Estradiol valerate

50 mg

E1680000 Estriol

50 mg

1614

+5C

79

1203

+5C

79

E1680005 Estriol impurity A

20 mg

9,11-didehydroestriol

1203

15 mg

100.0% CHO ; Batch 3 is valid until 31 March 2012

1512

+5C

79

+5C

79

E1800000 Etacrynic acid

100 mg

0457

Y0001263 Etacrynic acid for system suitability

10 mg

0457

+5C

79

+5C

79

E1830000 Etamsylate

30 mg

E1840000 Ethacridine lactate monohydrate

50 mg

1204

+5C

79

1591

+5C

79

E1850000 Ethambutol hydrochloride

250 mg

Y0000803 Ethambutol for system suitability

10 mg

0553

+5C

79

0553

+5C

79

A1202800 Ethanol (anhydrous) - reference spectrum

E1860100 Ethanol 96% - reference spectrum

n/a

1318

79

n/a

1317

79

200 mg

Y0001124 Ethinylestradiol for system suitability

25.31 mg

E2000000 Ethionamide

100 mg

E2150000 Ethosuximide

30 mg

New E1700000 Estrone

New E1900000 Ethinylestradiol

Council of Europe, all rights reserved 2012

0179,0274,04
90,
0552,1098
0179,0274,04

Extra
Price
charges
79
g

90,
0552,1098
0552

Batch 1 is valid until 31 July 2011

1316

35280 IU per vial

Yes

Yes

1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)

Batch 2 is valid until 30 June 2011

Yes
Yes

0821,1203
Yes

Yes
Yes

0140,0821,09
40

Yes

+5C

79

0140

Yes

+5C

79

0141

+5C

79

0764

+5C

79

Batch 3 is valid until 31 March 2012

26

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
E2250000 Ethosuximide impurity A

Effective from 2012/1/3


Batch n
4

Quantity Sale
Information
Monograph
per vial Unit
30 mg
1 (2RS)-2-ethyl-2-methylbutanedioic acid ; Batch 3 is valid until 1 February 2012
0764

Leaflet

Storage
+5C

Extra
Price
charges
79
a

E2195000 Ethyl acetate - reference spectrum

n/a

0899

79

E2195900 Ethylcellulose - reference spectrum

n/a

0822

79

E2202000 1-N-Ethylgaramine sulfate

50 mg

+5C

79

E2205500 1,1'-Ethylidenebistryptophan

+5C

79

Y0000617 Ethyl indole-3-carboxylate

10 mg

2102

+5C

79

E2300000 Ethylmorphine hydrochloride - reference spectrum

n/a

0491

79

E2400000 Ethylnicotinamide

150 mg

E2425000 Ethyl parahydroxybenzoate

150 mg

E2450000 Etifenin

25 mg

E2451000 Etilefrine hydrochloride

75 mg

E2451010 Etilefrine impurity A

20 mg

Y0000572 Etidronate disodium

10 mg

E2470000 Etodolac

60 mg

E2470050 Etodolac impurity H

10 mg

Y0000768 Etodolac for peak identification

10 mg

E2499900 Etofenamate

40 mg

E2499901 Etofenamate for peak identification

15 mg

Batch 1 is valid until 31 December 2011

1513

E2499914 Etofenamate impurity G

20 mg

2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate

E2500000 Etofylline

100 mg

E2503000 Etomidate

50 mg

E2503004 Etomidate impurity B

25 mg

E2600000 Etoposide

150 mg

Y0001365 Etoposidefor for system suitability

10 mg

E5000000 Eugenol

500 l

F0005000 Famotidine

100 mg

Y0000382 Famotidine for system suitability

10 mg

Y0000409 Famotidine impurity D

10 mg

3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide

1012

Y0000556 Febantel

110 mg

99.9% CHNOS

Y0000660 Febantel for system suitability

10 mg

Y0000731 Felbinac

10 mg

Y0000732 Felbinac impurity A

20 mg

4-acetyl biphenyl

F0030000 Felodipine

120 mg

Batch 1 is valid until 31 October 2011

1013

Y0000415 Felypressin

0.994 mg

Council of Europe, all rights reserved 2012

0.00167 mg 2

1351

84.4% of 1-N-Ethylgaramin sulphate


0.00167 mg per vial of CHNO ; Batch 3 is valid until 28 February 2011

1272,1383

Yes

0233

+5C

79

0409,0431,09
00,
1262,1263,21
34

+5C

79

0585

+5C

79

1205

+5C

79

1205

+5C

79

1778

+5C

79

1422

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

1513

+5C

79

0492

+5C

79

Batch 1 is valid until 31 July 2011

1514

+5C

79

methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate

1514

+5C

79

98.4% CHO

0823

+5C

79

+5C

79

1100

+5C

79

1012

+5C

79

+5C

79

+5C

79

2176

+5C

79

2176

+5C

79

2304

+5C

79

2304

+5C

79

+5C

79

-20C

79

100.0% CHO; batch 2 valid until 31/12/10 excepted for use with
monograph 0900.

2-ethylamino-1-(3-hydroxyphenyl)ethanone

1422

2-(7-ethylindol-3-yl)ethanol

1422

Yes

1513

0823

1012

1634
27

Yes

Yes

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
F0040000 Fenbendazole

Reference Standard

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
150 mg
1

Information

Monograph

Leaflet

Storage

1208,1458

+5C

Extra
Price
charges
79
g

F0040010 Fenbendazole impurity A

20 mg

methyl(1-benzimidazol-2-yl)carbamate

1208

+5C

79

F0040020 Fenbendazole impurity B

20 mg

methyl[5(6)-chlorobenzimidazol-2-yl]carbamate

1208

+5C

79

F0041000 Fenbufen

100 mg

1209

+5C

79

F0048000 Fenofibrate

100 mg

100.0% CHClO

1322

+5C

79

F0048005 Fenofibrate impurity A

20 mg

(4-chlorophenyl)(4-hydroxyphenyl)methanone

1322

+5C

79

F0048010 Fenofibrate impurity B

10 mg

2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)

1322

+5C

79

F0048035 Fenofibrate impurity G

25 mg

1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate

1322

+5C

79

Y0000756 Fenoterol for peak identification

1.2 mg

0901

+5C

79

F0050000 Fenoterol hydrobromide

100 mg

0901

+5C

79

F0054990 Fentanyl - reference spectrum

n/a

1210

79

F0055000 Fentanyl citrate - reference spectrum

n/a

1103

79

F0060000 Fenticonazole nitrate

50 mg

F0060040 Fenticonazole impurity D

20 mg

F0100000 Ferrous gluconate

100 mg

Y0001013 Ferulic acid

20 mg

Y0000789 Fexofenadine hydrochloride

60 mg

Y0000751 Fexofenadine impurity A

5 mg

Y0000752 Fexofenadine impurity B

Y0000753 Fexofenadine impurity C

Y0001173 Filgrastim
Y0000090 Finasteride

contains 1.3% of impurity A

1211

+5C

79

1211

+5C

79

0493

+5C

79

99.8% CHO

1834

+5C

79

99.8% CHClNO

2280

+5C

79

2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid

2280

+5C

79

0.01 mg

2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid

2280

+5C

79

5 mg

(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol

2280

+5C

79

0.2 ml

1.95 mg per ml of CHNOS

2206

-80C

79

60 mg

99.7% CHNO

1615

+5C

79

Y0000091 Finasteride for system suitability

100 mg

Contains 0.7% of impurity A

1615

+5C

79

Y0000736 Flavoxate hydrochloride

10 mg

1692

+5C

79

Y0000737 Flavoxate impurity A

10 mg

3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid

1692

+5C

79

Y0000738 Flavoxate impurity B

10 mg

ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate

1692

+5C

79

F0120000 Flecainide acetate

200 mg

1324

+5C

79

F0120005 Flecainide impurity A

50 mg

3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine

1324

+5C

79

F0120010 Flecainide impurity B

25 mg

(RS)-(piperidin-2-yl)methanamine

1324

+5C

79

Y0001274 Flecainide for system suitability

10 mg

1324

+5C

79

Y0000138 Flubendazole

25 mg

1721

+5C

79

Y0000139 Flubendazole for system suitability

20 mg

1721

+5C

79

Council of Europe, all rights reserved 2012

()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate

28

Yes

Yes
Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000892 Flucloxacillin magnesium octahydrate

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
5 mg
1

Information

Monograph

Leaflet

Storage

2346

+5C

Extra
Price
charges
79
a

Y0000889 Flucloxacillin impurity C

5 mg

6-aminopenicillanic acid

2346

+5C

79

Y0000890 Flucloxacillin impurity D

5 mg

3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid

2346

+5C

79

Y0000891 Flucloxacillin impurity E

5 mg

6-aminopenicillanic acid flucloxacillin amide

250 mg

95.1% CHClFNNaOS ; Batch 6 is valid until 31 May 2012

Y0000557 Fluconazole

50 mg

Y0000558 Fluconazole for peak identification

10 mg

Y0000573 Fluconazole impurity B

10 mg

93.2% CHNOF ; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis


(1H-1,2,4 -triazol-1-yl)propan-2-ol

2287

Y0000574 Fluconazole impurity C

5 mg

1,1'-(1,3-phenylene)di-1H-1,2,4-triazole

F0175000 Flucytosine

100 mg

Y0001262 Flucytosine for system suitability

10 mg

Y0000419 Fludarabine phosphate

100 mg

F0180000 Fludrocortisone acetate

100 mg

F0188000 Flumazenil - reference spectrum

n/a

Y0000335 Flumazenil impurity B

5 mg

F0189000 Flumequine

60 mg

F0189020 Flumequine impurity B

0.1 mg

F0188500 Flumetasone pivalate

100 mg

F0189900 Flunarizine dihydrochloride

100 mg

Y0000265 Flunarizine dihydrochloride - reference spectrum

Y0000266 Flunarizine dihydrochloride for system suitability

F0190000 Flunitrazepam - * psy

Y0000169 Flunitrazepam - reference spectrum

Y0000443 Flunixin meglumine


Y0000444 Flunixin impurity B
Y0000445 Flunixin impurity C
F0200000 Fluocinolone acetonide

2346

Yes

+5C

79

0661,0663,06
68,2346

Yes

-20C

79

+5C

79

+5C

79

+5C

79

2287

+5C

79

0766

+5C

79

0766

+5C

79

1781

+5C

79

0767

+5C

79

79

1326

+5C

79

1517

+5C

79

1517

+5C

79

1327

+5C

79

0816

+5C

79

n/a

1722

79

20 mg

1722

+5C

79

100 mg

1280

+5C

79

n/a

0717

79

10 mg

1696

+5C

79

10 mg

2-methyl-3-(trifluoromethyl)aniline

1696

+5C

79

50 mg

ethyl 2-chloropyridine-3-carboxylate

1696

+5C

79

100 mg

0494

+5C

79

F0230000 Fluocortolone pivalate

100 mg

1212

+5C

79

Y0000796 Fluorescein

120 mg

99.2% CHO

2348

+5C

79

Y0000804 Fluorescein impurity C

0.01 mg

2-(2,4-dihydroxybenzoyl)benzoic acid

2348

+5C

79

Y0000454 Diacetylfluorescein

100 mg

99.6% CHO

1213

+5C

79

F0245000 Fluoresceine sodium - reference spectrum

n/a

79

F0250000 Fluorouracil

40 mg

+5C

79

New F0150000 Flucloxacillin sodium

Council of Europe, all rights reserved 2012

2287
2287

97.6% CHFNOP

Yes

1326
ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate

Yes

1213
Batch 1 is valid until 30 September 2011
29

0611,0766

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000762 Fluorouracil impurity A

Effective from 2012/1/3


Batch n
1

Y0000763 Fluorouracil impurity B

Y0000764 Fluorouracil impurity C

Y0000765 Fluorouracil impurity F


Y0000791 Fluorouracil impurity mixture

Quantity Sale
Information
per vial Unit
10 mg
1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
10 mg
1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)

Monograph

Leaflet

Storage

0611

+5C

Extra
Price
charges
79
a

0611

+5C

79

10 mg

pyrimidine-2,4(1H,3H)-dione (uracil)

0611

+5C

79

10 mg

2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)

0611

+5C

79

0.0002 mg

+5C

79

F0253000 Fluoxetine hydrochloride

250 mg

99.9% CHClFNO

1104

+5C

79

F0253020 Fluoxetine impurity B

10 mg

methyl(3-phenylpropyl)amine ; Batch 4 is valid until 31 December 2011

1104

+5C

79

New F0253030 Fluoxetine impurity C

5 mg

()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine ; Batch 3


is valid until 30 April 2012

1104

+5C

79

Y0000064 Flupentixol dihydrochloride

100 mg

43.6% of Z-isomer CHClFNOS

1693

+5C

79

Y0000067 Flupentixol impurity D

15 mg

2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol

1693

+5C

79

Y0000078 Flupentixol impurity F

25 mg

80.9% CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol

1693

+5C

79

F0260000 Fluphenazine decanoate

60 mg

1014,1015

+5C

g(b)

79

Y0000009 Fluphenazine enantate

100 mg

1014,1015

+5C

79

F0280000 Fluphenazine dihydrochloride

50 mg

0904,1014

+5C

79

Y0000708 Fluphenazine impurity mixture

0.07 mg

Y0000298 Fluphenazine octanoate

20 mg

Y0000299 Fluphenazine sulfoxide

10 mg

Y0000211 Flurazepam monohydrochloride - reference spectrum

F0285200 Flurbiprofen

F0285202 Flurbiprofen impurity A

20 mg

Y0000236 Fluspirilene

20 mg

Y0000375 Fluspirilene impurity C

10 mg

F0285600 Flutamide

50 mg

F0285603 Flutamide impurity C

20 mg

N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide

Y0000284 Fluticasone propionate

100 mg

Y0000221 Fluticasone impurity D

20 mg

F0290000 Flutrimazole

100 mg

F0290010 Flutrimazole impurity B

60 mg

Y0001090 Fluvastatin sodium

110 mg

2333

Y0001082 Fluvastatin for system suitability

0.5 mg

2333

Y0000854 Fluvoxamine maleate

5 mg

1977

Council of Europe, all rights reserved 2012

0611

0904

Yes

+5C

79

1014,1015

+5C

79

0904,1014,10
15

+5C

79

n/a

0905

79

50 mg

1519

+5C

79

1519

+5C

79

1723

+5C

79

1723

+5C

79

1423

+5C

79

1423

+5C

79

99.6% CHFOS

1750

+5C

79

S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative) ; Batch 1 is valid until 31 December 2011

1750

+5C

79

1424

+5C

79

1424

+5C

79

+5C

79

+5C

79

+5C

79

Batch 2 is valid until 31 October 2011

(2RS)-2-(biphenyl-4-yl)propanoic acid
8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one

(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol

30

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000853 Fluvoxamine for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
1.004 mg 1

Information

Monograph

Leaflet

Storage

1977

Yes

+5C

Extra
Price
charges
79
g

Y0000916 Fluvoxamine impurity D

10 mg

5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one

1977

+5C

79

Y0000386 Foeniculin for peak identification

100 mg

Anise oil

0804

Yes

+5C

79

F0300000 Folic acid

150 mg

91.3 % CHNO ; Batch 7 is valid until 30 September 2011

0067

Yes

+5C

79

Y0001242 Folic acid impurity A

15 mg

(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)

0067

+5C

79

Y0001243 Folic acid impurity D

70 mg

4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid) ; Batch 1 is valid until 31 October 2011

0067

+5C

79

F0372000 Formoterol fumarate dihydrate

10 mg

1293,1724

+5C

79

Y0000339 Formoterol for impurity I identification

10 mg

1724

+5C

79

Y0000340 Formoterol fumarate for system suitability

10 mg

1724

Yes

+5C

79

F0380000 Formylfolic acid

30 mg

0978,1606

Yes

F0389000 Foscarnet sodium hexahydrate

50 mg

F0389004 Foscarnet impurity B

10 mg

Y0001222 Foscarnet impurity D

50 mg

Y0001213 Foscarnet impurity mixture

0.012 mg

1520

Y0000782 Fosfomycin calcium

10 mg

1328

F0399950 Fosfomycin sodium - reference spectrum

n/a

F0400000 Fosfomycin trometamol

1500 mg

Y0001227 Fosinopril sodium

60 mg

Y0001228 Fosinopril impurity A

5 mg

(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid

Y0001229 Fosinopril impurity B

5 mg

Y0001230 Fosinopril impurity C

10 mg

Y0001231 Fosinopril impurity D

Y0001232 Fosinopril impurity I

Yes

-20C

79

1520

+5C

79

1520

+5C

79

1520

+5C

79

+5C

79

+5C

79

79

+5C

79

1751

+5C

79

1751

+5C

79

(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751

+5C

79

mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751

+5C

79

10 mg

(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751

+5C

79

5 mg

[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
acetic acid

1751

+5C

79

Y0001233 Fosinopril impurity K

5 mg

(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid

1751

+5C

79

Y0001212 Fosinopril impurity mixture

0.02 mg

25 mg

New F0450000 Framycetin sulfate

Council of Europe, all rights reserved 2012

91.4% CHNO; 10-Formylfolic acid ; Batch 2 is valid until 31 August 2011


disodium (ethoxyoxydophosphanyl)formate

Yes

1329
1425

99.7% CHNOP ; Batch 1 is valid until 31 March 2011

17640 IU per vial CHNO,xHSO ; Batch 4 is valid until 30 April 2012

31

Yes

1751

Yes

+5C

79

0180,0197,20
702

Yes

-20C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
F0550000 Fructose

Reference Standard

Effective from 2012/1/3


Batch n
1

New Y0001399 Fulvestrant

New Y0001413 Fulvestrant for system suitability

Quantity Sale
per vial Unit
100 mg
1

120 mg

Information

Monograph

98.8% CHFOS

Leaflet

Storage
+5C

Extra
Price
charges
79
a

0177,0178,01
87,
0188,0204,02
09,
1061,1570
2443

Yes

+5C

79

Yes

40 mg

2443

+5C

79

F0600000 Fumaric acid

100 mg

0365,0902,11
90, 1592

+5C

79

F0700000 Furosemide

100 mg

0391,2185

+5C

79

F0702000 Furosemide impurity A

5 mg

0391

+5C

79

-20C

79

79

New Y0001411 Fusidic acid

2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid ; Batch 3 is valid until


30 June 2011

10 mg

0798

F1000000 Fusidic acid - reference spectrum

n/a

0798,0848

New Y0001394 Fusidic acid for peak identification

5 mg

0798,0848

Yes

-20C

79

Y0001280 Gabapentin

300 mg

99.9% CHNO

2173

Yes

+5C

79

Y0001281 Gabapentin impurity A

20

2-azaspiro[4.5]decan-3-one

2173

+5C

79

Y0001348 Gabapentin impurity B

20 mg

(1-cyanocyclohexyl)acetic acid

2173

-20C

79

Y0001349 Gabapentin impurity D

10 mg

[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid

2173

+5C

79

G0049000 Galactitol

50 mg

Batch 1 is valid until 30 September 2011

1381

+5C

79

G0050000 Galactose

60 mg

1215

+5C

79

Y0001279 Galantamine hydrobromide

10 mg

2366

+5C

79

Y0001190 Galantamine natural for system suitability

10 mg

2366

+5C

79

Y0001201 Galantamine racemic mixture

10 mg

2366

+5C

79

Y0001191 Galantamine synthetic for system suitability

5 mg

2366

+5C

79

G0100000 Gallamine triethiodide

100 mg

0181

+5C

79

G0150000 Gammacyclodextrin

50 mg

1070,1487

+5C

79

Y0001129 Ganciclovir

220 mg

1752

+5C

79

Y0001144 Ganciclovir impurity mixture

0.005 mg

+5C

79

Y0000675 Gemcitabine hydrochloride

50 mg

99.9% CHClFNO

2306

+5C

79

Y0000676 Gemcitabine impurity A

20 mg

4-aminopyrimidin-2(1H)-one (cytosine)

2306

+5C

79

Y0000513 Gemfibrozil

5 mg

1694

+5C

79

Y0000514 Gemfibrozil for system suitability

0.196 mg

G0200000 Gentamicin sulfate

25 mg

16500 IU per vial ; Batch 6 is valid until 31 October 2011

Y0001112 Gestodene

100 mg

99.4% CHO

Y0001363 Gentamicin for peak identification

10 mg

Y0001110 Gestodene for system suitability

10 mg

Y0001116 Gestodene impurity I

0.01 mg

Council of Europe, all rights reserved 2012

1752

Yes

Yes

1694

Yes

+5C

79

0331,20702

Yes

-20C

79

+5C

79

0331

Yes

-20C

79

1726

Yes

+5C

79

+5C

79

1726

13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20yn-3-one
32

Yes

1726

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001012 Ginkgo dry extract for peak identification
New Y0001010 Ginkgolic Acids

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
150 mg
1

Information

Monograph

Leaflet

Storage

1827

Yes

-20C

1827

Yes

Extra
Price
charges
79
c

20 mg

-20C

79

G0300000 Gitoxin

30 mg

0078,0079,21
68

+5C

79

G0325000 Glibenclamide

100 mg

0718

+5C

79

G0325010 Glibenclamide impurity A

10 mg

4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide

0718

+5C

79

Y0000242 Glibenclamide impurity B

20 mg

methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]
sulphonyl]carbamate ; Batch 1 is valid until 31 December 2011

0718

+5C

79

G0326000 Gliclazide

20 mg

0718,1524

+5C

79

G0326004 Gliclazide impurity B

25 mg

2-nitroso-octahydrocyclopenta[c]pyrrole

1524

+5C

79

G0326012 Gliclazide impurity F

50 mg

1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea ; Batch 3 is valid until 31 March 2012

1524

+5C

79

Y0000515 Glimepiride

60 mg

99.4% CHNOS

2223

+5C

79

Y0000516 Glimepiride for system suitability

0.012 mg

2223

+5C

79

G0340000 Glipizide

50 mg

0906

+5C

79

G0342000 Glipizide impurity A

10 mg

4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide

0906

+5C

79

Y0000523 Glipizide impurity C

10 mg

ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate

0906

+5C

79

Y0000643 Glipizide impurity D

10 mg

6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide

0906

Y0001140 Glipizide impurity mixture

0.002 mg

Y0001406 Glucosamine hydrochloride

10 mg

2.94 mg

Y0001381 Glucosamine for system suitability

40 mg

Y0001407 Glucosamine sulfate sodium chloride

15 mg

100 mg

G0355000 Glutamic acid

50 mg

Y0000517 Glutathione

G0360000 Glutethimide - * psy


G0400000 Glycerol (85 per cent) - reference spectrum

New Y0000191 Human glucagon

0.37% of ginkgolic acid C17 ; Batch 1 is valid until 31 May 2012

Yes

Yes

+5C

79

Yes

+5C

79

+5C

79

Yes

-20C

79

2446,2447

+5C

79

0906
2446
2.94 mg pure human glucagon per vial CHNOS ; Batch 1 is valid until
30 April 2012

1635

2447

+5C

79

0177,0178,01
87,
0188,0204,02
09,
1061,1215,15
70

+5C

79

0750,0797,14
45, 2076

+5C

79

10 mg

1670

+5C

79

50 mg

1291

+5C

79

n/a

0496,0497

79

G0400002 Glycerol dibehenate

2000 mg

1427

+5C

79

G0400004 Glycerol distearate

2000 mg

1428

+5C

79

Y0001391 Glycerol formal

20 mg

1671

+5C

79

Y0000794 Glycerol monocaprylate

400 mg

2213

+5C

79

New G0350500 Glucose

Council of Europe, all rights reserved 2012

Batch 1 is valid until 30 April 2012

33

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000795 Glycerol monocaprylocaprate

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
500 mg
1 In the chromatogram supplied within the leaflet (Rev 02) of the current CRS
batch 1, some peaks have been mislabelled, the correct version of the leaflet
(Rev 03) is now available on the website. The quality of the product itself is
not questioned and can still to be used.

Monograph

Leaflet

Storage

2392

Yes

+5C

G0400006 Glycerol monolinoleate

2000 mg

1429

+5C

79

G0400007 Glycerol mono-oleate

2000 mg

1430

+5C

79

G0400008 Glycerol monostearate 40-55

2000 mg

0495

+5C

79

G0400101 Glyceryl trinitrate - reference spectrum

n/a

79

G0400100 Glyceryl trinitrate solution

0.5 ml

1331,1355

+5C

79

G0450000 Glycine

50 mg

0614,0752

+5C

79

Y0001308 Glycopyrronium bromide

10 mg

1783

+5C

79

Y0001309 Glycopyrronium for peak identification

10 mg

Y0001358 Glycopyrronium impurity N

10 mg

Y0000433 Ammonium glycyrrhizate

70 mg

G0460000 Glycyrrhizate (monoammonium)

300 mg

78.6% CHNO

G0525000 Gonadorelin

5 mg

Y0000125 Goserelin

2 mg

Y0000126 Gosereline - reference spectrum

n/a

1636

Y0000019 4-D-Ser-goserelin

0.1 mg

1636

Y0000194 Goserelin validation mixture

1 mg

Supplied with the Ph. Eur. reference chromatogram

G0550000 Gramicidin

250 mg

1081 IU per mg

Y0000396 Granisetron hydrochloride

120 mg

99.8% CHClNO

Y0000477 Granisetron impurity A

1 mg

Y0000478 Granisetron impurity B

1 mg

Y0000395 Granisetron impurity E

G0600000 Griseofulvin
Y0000619 Guaiacol

1331
1% m/m in ethanol CHNO

94.0% CHNO+; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)


oxy]-1,1-dimethylpyrrolidinium

Extra
Price
charges
79
g

1783

Yes

+5C

79

1783

Yes

+5C

79

+5C

79

1772
0277,1536,
2378

Yes

+5C

79

4.96 mg per vial of CHNO ; Batch 4 is valid until 31 March 2012

0827

Yes

-20C

79

1.87 mg per vial of CHNO

1636

-20C

79

79

-20C

79

1636

Yes

-20C

79

0907,1662,20
702

Yes

+5C

79

1695

+5C

79

2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide ; Batch 1 is valid until 31 January 2011

1695

+5C

79

N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide ; Batch 1 is valid until 31 March 2011

1695

+5C

79

15 mg

(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine ; Batch 2 is valid until


31 July 2011

1695

+5C

79

50 mg

0182

+5C

79

2200 mg

1978

+5C

79

G0700000 Guaifenesin

100 mg

Y0000117 Halofantrine hydrochloride

125 mg

99.6% CHClFNO

Y0000118 Halofantrine impurity C

10 mg

[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol

H0100000 Haloperidol

50 mg

H0100100 Haloperidol decanoate

60 mg

1397,1431

Council of Europe, all rights reserved 2012

99.5% CHO

0615

34

Yes

+5C

79

1979

Yes

+5C

79

1979

+5C

79

0616,0995,11
78, 1503

+5C

79

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
H0150000 Halothane - reference spectrum

Effective from 2012/1/3

Quantity Sale
per vial Unit
n/a
1

1.03 mg

1.01mg per vial CHO

1 mg

Anti-IIa activity : 31 IU per vial; Anti-Xa activity : 104 IU per vial ; Batch 5 is
valid until 31 January 2011
Batch 6 is valid until 30 April 2012

H0190000 Heparin Low-Molecular-Mass for calibration CRS

25 mg

Mna = 3800

H0200000 Heparin sodium BRP

2 ml

1010 IU per ml

Y0001287 Heparin calcium for NMR identification

30 mg

Y0001283 Heparin sodium for NMR identification

Y0001282 Heparin for physico-chemical analysis

H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP

0.5 ml

262 IU per ml; Please contact us for information on the type needed for your
use

Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed)

0.8 ml

Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal


free)

0.5 ml

H0210010 Hepatitis B vaccine (rDNA) BRP method B

H0215000 Hepatitis C Virus RNA for NAT testing BRP

Y0000673 Harpagoside
New H0185000 Heparin Low-Molecular-Mass for assay BRP

Batch n

Information

Monograph

Leaflet

Storage

0393
1095, 1871

Extra
Price
charges
79
l

+5C

79

0828

Yes

+5C

90

0828

Yes

+5C

90

Yes

+5C

79

0332,0333,05
69,
0686,20705
0332

Yes

+5C

79

30 mg

0333

Yes

+5C

79

300 mg

0333

+5C

79

See leaflet,
20714

Yes

+5C

90

To be stored below -50C

20714,1526,1
935, 1107

Yes

-80C

90

16.6 micrograms per ml

See leaflet,
20715

Yes

+5C

90

1 ml

20 micrograms per ml

See leaflet,
1056

Yes

+5C

90

40 mg

HCV-RNA content 500 IU per vial; For plasma pool testing by NAT

See leaflet,
20621

Yes

-20C

e(d)

242

H0220000 Heptadecanol

600 mg

97.9% CHO

0801,0802,08
47

+5C

79

Y0000063 Heptaminol hydrochloride

150 mg

1980

+5C

79

Y0000057 Heptaminol impurity A

20 mg

1980

+5C

79

H0250000 alpha-Hexachlorocyclohexane

10 mg

0772

+5C

79

H0330000 Hexamidine diisetionate

50 mg

1436

+5C

79

H0325000 Hexetidine

100 mg

1221

+5C

79

H0400000 Hexobarbital

500 mg

0183

+5C

79

H0420000 Hexylresorcinol

100 mg

1437

+5C

79

H0500000 Hide powder

500 mg

20814

+5C

79

H0600000 Histamine dihydrochloride

250 mg

0143

+5C

79

H0700000 Histamine phosphate

250 mg

0144

+5C

79

H0750000 Histidine

100 mg

0911

+5C

79

H0755000 Histidine hydrochloride monohydrate

100 mg

0910

+5C

79

H0800000 Homatropine hydrobromide

100 mg

0500,0720

+5C

79

H0830000 Homatropine methylbromide

25 mg

0720

+5C

79

5 mg

0720

+5C

79

New Y0001383 Homatropine methylbromide for system suitability


Council of Europe, all rights reserved 2012

93.4% CHN; (2RS)-6-methylhept-5-en-2-amine

Batch 1 is valid until 31 May 2011

35

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
H0837000 L-Homocysteine thiolactone hydrochloride - reference
spectrum

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
n/a
1

Information

Monograph

Leaflet

Storage

0255

Yes

-20C

79

1617

Extra
Price
charges
79
l

H0900000 Human albumin for electrophoresis BRP

1 ml

96,7% to 99,2% of the total protein is the main band (albumin), protein
content : 5%

Y0000219 Human anti-D immunoglobulin BRP

1 uc

285 IU anti-D immunoglobulin per ampoule

See leaflet,
20713

Yes

-20C

90

Y0000667 Human coagulation factor VII concentrate BRP

26 mg

9.9 IU per vial

See leaflet,
20710

Yes

-20C

79

New H0920000 Human coagulation factor VIII concentrate BRP

37 mg

10.4 IU per vial; Common standard with FDA ; Batch 3 is valid until 31 March
2012

See leaflet,
20704

Yes

-20C

90

H0920500 Human coagulation factor IX concentrate BRP

30 mg

7.9 IU/vial; Common standard with FDA

See leaflet,
20711

Yes

-20C

90

H0950000 Human hepatitis A immunoglobulin BRP

10 mg

10.2 IU per vial

See leaflet,
0338, 0769

Yes

-20C

90

H0990000 Human immunoglobulin BRP

15800 mg

Instructions for use: see leaflet

See leaflet,
0338, 0918

Yes

+5C

90

H1000000 Human immunoglobulin for electrophoresis BRP

96 mg

75.7% to 80.9% of the total protein is the main band (Ig),


protein content: 5%

0338,0918

Yes

+5C

79

Y0000488 Human immunoglobulin (molecular size) BRP

700 mg

Each vial contains 0.7 gram of immunoglobulin G

See leaflet,
0338,
0918,1928

Yes

+5C

90

H1005000 Human Plasma Pools for NAT validation

3502 mg

Set of 103 plasma pool samples

See leaflet,
20621

Yes

-20C

400

H1100000 Human rabies immunoglobulin BRP

170 mg

91 IU per vial

See leaflet,
0723

Yes

-20C

90

H1110000 Human tetanus immunoglobulin BRP

87 mg

120 IU per vial

0398

Yes

-20C

90

Y0000502 Human vaccinia immunoglobulin

1 ml

23 IU per vial

See leaflet

Yes

-20C

270

H1115000 Hyaluronidase BRP

50 mg

328 IU per mg

0912

+5C

79

H1120000 Hydralazine hydrochloride

20 mg

0829

+5C

79

Y0001151 Hydrastine hydrochloride

20 mg

H1200000 Hydrochlorothiazide

160 mg

Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc

10 mg

1784

Y0000710 Hydrocodone for peak identification - * narc

10 mg

1784

H1300000 Hydrocortisone

100 mg

0335,0353,05
61

Y0001092 Hydrocortisone for peak identification

5 mg

H1400000 Hydrocortisone acetate

125 mg

H1425000 Hydrocortisone hydrogen succinate

100 mg

H1426000 Hydrogenated wool fat

250 mg

Council of Europe, all rights reserved 2012

99.7% CHClNOS ; Batch 5 is valid until 31 March 2012

1831,2500

Yes

-20C

79

0394,0546

Yes

+5C

79

+5C

79

+5C

79

+5C

79

0335

Yes

+5C

79

0321,0334,07
34, 0767

+5C

79

0768,1131

-20C

79

0969

+5C

79

Hydrocortisone acetate CRS 8 is suitable for monographs 01/2011:0335,


01/2008:334, 01/2008:0321, 01/2008:0767 and 01/2008:0734 only.

36

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000446 Hydromorphone hydrochloride - * narc

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

2099

Storage
+5C

Extra
Price
charges
79
k

B0650000 Hydrous benzoyl peroxide - reference spectrum

n/a

0704

79

H1428000 Hydroxocobalamin

10 mg

0913,0914,09
15

+5C

79

Y0000119 Hydroxycarbamide

175 mg

1616

+5C

79

H1429400 Hydroxyethyl salicylate

125 mg

H1429700 4-Hydroxyphenoxymethylpenicillin potassium

20 mg

98.4% CHKNOS

H1430000 D-alpha-(4-Hydroxy-phenyl)glycine

50 mg

(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A

0813

Y0001277 Hydroxyethyl starch (medium MW)

1200 mg

Average Mw 130100 Da

1785

Yes

Y0001322 Hydroxyethyl starch (high Mw)

800 mg

507900 Da

1785

Yes

Y0000186 Hydroxypropylbetadex

10 mg

1804

H1435000 Hydroxyzine hydrochloride

600 mg

Y0000011 Hymecromone

100 mg

Y0000012 Hymecromone impurity A

25 mg

Resorcinol

Y0000013 Hymecromone impurity B

25 mg

7-hydroxy-2-methyl-4H-1-benzopyran-4-one.

Y0000483 Hyoscine

10 mg

Y0000484 Hyoscine impurity A

10 mg

H1450000 Hyoscine butylbromide

20 mg

Y0000447 Hyoscine butylbromide impurity E

10 mg

H1500000 Hyoscine hydrobromide

50 mg

Y0000448 Hyoscine hydrobromide impurity B

10 mg

H1600000 Hyoscyamine sulfate

100 mg

Y0000449 Hyoscyamine impurity E

10 mg

Y0000915 Hypromellose phthalate

10 mg

250 mg

B1220000 Ibuprofen impurity B

Y0000140 Ibuprofen impurity F

99.9% CHNO

+5C

79

-20C

79

+5C

79

+5C

79

+5C

79

+5C

79

0916,1086,10
92

+5C

79

1786

+5C

79

1786

+5C

79

1786

+5C

79

2167

+5C

79

2167

+5C

79

0737

+5C

79

0737

+5C

79

0106,0500

+5C

79

0106

+5C

79

0501

+5C

79

(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate

0501

+5C

79

347

+5C

79

Batch 4 is valid until 31 May 2012

0721

+5C

79

1.15 mL

solution of 0.06% m/V in acetonitrile - to be diluted as appropriate.; (2RS)-2(4-Butylphenyl)propanoic acid ; Batch 5 is valid until 31 December 2011

0721

+5C

79

5 mg

3-[4-(2-methylpropyl)phenyl]propanoic acid ; Batch 1 is valid until 31 August


2011

0721

+5C

79

Y0000881 Ibuprofen for peak identification

0.09 mg

Batch 2 is valid until 31 January 2011

0721

I0050000 Idoxuridine

50 mg

I0060000 Ifosfamide

50 mg

I0060100 Ifosfamide - reference spectrum

n/a

New I0020000 Ibuprofen

Council of Europe, all rights reserved 2012

1225
0148,0149

(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
(1R,2R,4S,5S,7S)-9-butyl -7-[[(2S)-3-hydroxy2-phenylpropanoyl]oxy]-3-oxa -9-azoni atricyclo
[3.3.1.02,4]nonane
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate

100.0% CHClNOP

+5C

79

0669

+5C

79

1529

+5C

79

79

1529
37

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
New I0060002 Ifosfamide impurity A

Effective from 2012/1/3


Batch n
3

Quantity Sale
Information
per vial Unit
100 mg
2 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate ; Batch 1 is valid until
28 February 2011
Batch 2 is valid until 30 April 2012

Monograph

Leaflet

Storage

1529

-20C

Extra
Price
charges
79
g(c)

I0060004 Ifosfamide impurity B

20 mg

bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate

1529

+5C

79

I0060010 Ifosfamide impurity E

10 mg

3-chloro-N-(2-chloroethyl)propan-1-amine

1529

+5C

79

I0060012 Ifosfamide impurity F

10 mg

(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide

I0086000 Imidazole

100 mg

I0090000 Imipenem

100 mg

I0100000 Imipramine hydrochloride

50 mg

Y0000893 Imipramine for system suitability

10 mg

Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test BRP

45 mg

Y0001152 Immunoglobulin panel for anti-A, anti-B antibodies test

96 mg

Y0000540 Immunoglobulin panel for anti-D antibodies test BRP

2 uc

Y0001205 Imperatorin

20 mg

I0150000 Indapamide

150 mg

I0150020 Indapamide impurity B

5 mg

Y0000788 Indinavir

100 mg

Y0000880 Indinavir sulfate - reference spectrum

n/a

2214

Y0000746 Indinavir for system suitability

20 mg

2214

I0200000 Indometacin

50 mg

0092,0922,16
86

8 mg

I0305000 Insulin (bovine)

7.99 mg

I0310000 Insulin (human)

8 mg

Y0000348 Insulin lispro

I0320000 Insulin (porcine)

I0320300 Interferon alfa-2a

I0320301 Interferon alfa-2b


Y0001101 Interferon beta-1a

New Y0000349 Insulin aspart

New I0320330 Interferon gamma 1b

1529

+5C

79

0757,1424

+5C

79

1226

-20C

79

0029,0408,08
17,
0889,1787
0029

+5C

79

+5C

79

Yes

-20C

79

Yes

-20C

120

See leaflet,
20626

Yes

-20C

90

98.8 % CHO

2556

Yes

+5C

79

97.6% CHClNOS

1108

+5C

79

4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide

1108

+5C

79

97.2% CHNO

2214

+5C

79

79

+5C

79

+5C

79

92.9% CHNOS

Yes

7.45 mg of insulin aspart + B28iso insulin aspart + A21Asp insulin aspart +


B3Asp insulin
8 aspart + B3iso Asp insulin aspart per vial ; Batch 1 is valid until 30 April
2012
7.99 mg insulin + A21 desamido per vial CHNOS

2084

Yes

-20C

90

0854,1637

Yes

-20C

90

6.94 mg insulin + A21 desamido per vial CHNOS ; Batch 3 is valid


until 30 November 2011

0838,0854,16
37, 1638

Yes

-20C

90

5.93 mg

5.93 mg insulin lispro per vial

8.61 mg

8.61 mg insulin + A21-desamido per vial


see recommandations for use on accompagnying leaflet CHNOS

1 ml

About 1.52 mg per mL

200 L

About 9.74 mg per mL ; Batch 4 is valid until 31 July 2011

0.5 ml

2085

Yes

-20C

90

0838,0854,16
37, 1638

Yes

-20C

90

1110

Yes

-80C

90

1110

Yes

-80C

90

1639

Yes

-80C

90

Yes

0.5 mL

about 1 mg per ml ; Batch 1 is valid until 31 March 2012

1440

-80C

90

I0320331 Interferon gamma-1b validation solution

0.2 ml

about 1 mg per ml

1440

-80C

79

I0328000 Iobenguane sulfate

25 mg

97.2% CHINOS

1111,1112,111
3,2351

+5C

79

Council of Europe, all rights reserved 2012

38

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000839 Iobenguane sulfate - reference spectrum

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
n/a
1

Information

Monograph

Leaflet

Storage

2351

Extra
Price
charges
79
l

Y0001294 Iodixanol

60 mg

2215

+5C

79

Y0001292 Iodixanol impurity C

10 mg

5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide

2215

+5C

79

Y0001291 Iodixanol impurity E

10 mg

5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

2215

+5C

79

Y0001293 Iodixanol impurity H

10 mg

5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide

2215

+5C

79

I0320800 Iohexol

150 mg

1114

+5C

79

I0320810 Iohexol impurity A

50 mg

5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide

1114

+5C

79

I0320820 Iohexol impurity J

125 mg

5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide

1114,2215

+5C

79

Y0000672 Iohexol for peak identification

10 mg

+5C

79

I0329000 Iopamidol

50 mg

1115

+5C

79

I0329010 Iopamidol impurity A

10 mg

N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide

1115, 1754

+5C

79

Y0000406 Iopamidol impurity H

10 mg

4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide

1115

+5C

79

I0330000 Iopanoic acid

100 mg

0700

+5C

79

Y0001297 Iopentol

10 mg

+5C

79

Y0001020 Iopromide

100 mg

98.7% CHINO

1753

+5C

79

Y0001077 Iopromide impurity A

0.125 mg

5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide

1753

+5C

79

Y0001021 Iopromide for system suitability 1

5 mg

1753

+5C

79

Y0001022 Iopromide for system suitability 2

5 mg

1753

+5C

79

I0340000 Iotalamic acid

150 mg

0751

+5C

79

A0560000 Iotalamic acid impurity A

20 mg

0751

+5C

79

Y0000555 Iotrolan

100 mg

1754

+5C

79

Y0000658 Iotrolan for system suitability

5 mg

1754

+5C

79

Y0000141 Ioxaglic acid

125 mg

Y0000142 Ioxaglic acid impurity A

20 mg

I0360000 Ipratropium bromide

120 mg

Y0000276 Ipratropium impurity A

10 mg

Council of Europe, all rights reserved 2012

1114

Yes

2215

5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid

2009
3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid
(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane
39

Yes

Yes

+5C

79

2009

Yes

+5C

79

0919

+5C

79

0772

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
I0361000 Ipratropium bromide impurity B

Effective from 2012/1/3


Batch n
3

Quantity Sale
Information
per vial Unit
10 mg
1 (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

0919

+5C

2465

+5C

79

2465

+5C

79

Y0001166 Irbesartan

60 mg

Y0001156 Irbesartan impurity A

10 mg

I0375000 Isoconazole

200 mg

1018

+5C

79

I0380000 Isoconazole nitrate

200 mg

1017

+5C

79

I0400000 Isoemetine hydrobromide

25 mg

0080,0081

+5C

79

Y0000858 Isoflurane

1.5 ml

1666

+5C

79

Y0000037 Isoflurane - reference spectrum

n/a

1673

79

I0460000 Isoleucine

50 mg

0770

+5C

79

I0465000 Isomalt

3000 mg

1531

+5C

79

Y0000070 Isomaltooligosaccharide

0.9 mg

1506

+5C

79

I0500000 Isoniazid

100 mg

0146

+5C

79

I0599990 Isoprenaline hydrochloride

50 mg

1332

+5C

79

I0600000 Isoprenaline sulfate

500 mg

0502

+5C

79

I0725000 Isopropyl hexadecanoate

100 mg

94.3% CHO

0839

+5C

79

I0750000 Isopropyl tetradecanoate

2 ml

97.9% CHO

0725

+5C

79

I0775000 Isosorbide dinitrate

300 mg

39.9% CHNO

1117,1118

+5C

79

I0775010 Isosorbide mononitrate

100 mg

99.9% CHNO; Isosorbide-5-nitrate

1117,1118

+5C

79

I0775020 Isosorbide-2-nitrate

50 mg

1117,1118

+5C

79

I0800000 Isotretinoin

60 mg

0693,1019

+5C

g(b)

79

Y0001218 Isotretinoin for peak identification

10 mg

1019

+5C

g(b)

79

I0900000 Isoxsuprine hydrochloride

50 mg

+5C

79

Y0000366 Isradipine

125 mg

99.2% CHNO

2110

+5C

79

Y0000367 Isradipine impurity D

5 mg

methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)


-2,6-dimethylpyridine-3,5-dicarboxylate

2110

+5C

79

I7000000 Itraconazole

150 mg

1335

+5C

79

Y0001100 Itraconazole for system suitability

15 mg

1335

Yes

+5C

79

Yes

New I8000010 Ivermectin

1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide

96.4% CHO (45.8% of 1,1 GPM, 50,6% of 1,6 GPS) CHO

Yes

1119
Yes

150 mg

90.6% of C48H74O14 (component H2B1a) ; Batch 1 is valid until 30 April 2012

1336

+5C

79

Y0000575 Ivy leaf standardised tincture

2 ml

0.20% (m/m) of hederacoside C

2148

-20C

g(c)

79

Y0000041 Josamycin

150 mg

1000 Ph. Eur. units per mg

1982,1983,20
702

+5C

79

Y0000042 Josamycin propionate

150 mg

975 Ph. Eur. units per mg

1982,1983,20
702

+5C

79

Y0001315 Josamycin for peak identification

25 mg

+5C

79

K0100000 Kanamycin B sulfate

20 mg

Batch 2 is valid until 31 January 2012

0032,0033,06
45

+5C

79

Council of Europe, all rights reserved 2012

1983

40

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
K0200000 Kanamycin monosulfate

Effective from 2012/1/3


Batch n
2

Quantity Sale
Information
per vial Unit
150 mg
1 799 IU per mg of CHNOS,HO

Monograph

Leaflet

Storage

0032,0033,00
53,
0485,0645,12
89,
1290,20702
1020

Yes

+5C

Y0000450 Ketamine hydrochloride - * narc

10 mg

K0551000 Ketamine impurity A

50 mg

Y0000246 Ketobemidone hydrochloride - reference spectrum

n/a

Y0000244 Ketobemidone impurity B

5 mg

1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone

1746

Y0000245 Ketobemidone impurity C

5 mg

1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one

1746

K0600000 Ketoconazole

150 mg

Batch 1 is valid until 31 December 2011

K1000000 3-Ketofusidic acid

10 mg

K2000000 Ketoprofen

50 mg

K2000010 Ketoprofen impurity A

10 mg

K2000015 Ketoprofen impurity C

5 mg

Y0000486 Ketorolac trometamol

10 mg

Y0000626 Ketorolac trometamol for peak identification

5 mg

1755

Y0000164 Ketotifen hydrogen fumarate - reference spectrum

n/a

1592

Y0000161 Ketotifen impurity G

0.0225 mg

Y0001200 Kudzuvine root dry extract

Extra
Price
charges
79
a

+5C

79

+5C

79

79

+5C

79

+5C

79

0921,1067,12
70

+5C

79

0798,0848

+5C

79

0922,1157,12
09

+5C

79

1-(3-benzoylphenyl)ethanone

0922

+5C

79

3-[(1RS)-1-carboxyethyl]benzoic acid

0922

+5C

79

1755

+5C

79

+5C

79

79

79

1020,1742

1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol

1746

4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione ; Batch 2 is valid until 28 February 2011

Yes

1592

+5C

n/a

200 mg

2434,2483

-20C

79

L0050000 Labetalol hydrochloride

80 mg

0923

+5C

79

L0129000 Lactitol monohydrate

60 mg

1337

+5C

79

Y0000257 Lactobionic acid

100 mg

1647

+5C

79

A1206000 Lactose (anhydrous)

100 mg

1061

+5C

79

L0100000 Lactose

100

Batch 1 is valid until 31 January 2012

+5C

79

L0130000 Lactulose

3000 mg

99.7% CHO

0177,0178,01
87,
0188,0204,02
09,
1215,1570
0924,1230

+5C

79

Y0000188 Lactulose for system suitability

12 mg

Y0000425 Lamivudine

150 mg

Y0000518 Lamivudine for system suitability 1

10 mg

Y0000426 Lamivudine for system suitability 2

10.3 mg

Y0001030 Lamotrigine

10 mg

1756

Y0001031 Lamotrigine for peak identification

20 mg

1756

Yes

Y0001085 Lamotrigine for system suitability

10 mg

1756

Yes

Y0001032 Lamotrigine impurity E

10 mg

Council of Europe, all rights reserved 2012

93.8% CHO

0924,1230
99.7% CHNOS
Batch 1 is valid until 30 November 2011

2,3-dichlorobenzoic acid
41

Yes

+5C

79

2217

+5C

79

2217

+5C

79

2217

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

1756

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000773 Lansoprazole

Reference Standard

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
60 mg
1

Information

Monograph
2219

Y0000774 Lansoprazole for peak identification

1 mg

2219

Y0000654 Leflunomide

100 mg

2330

Y0000487 Leflunomide impurity A

25 mg

Y0000674 Leflunomide for peak identification

1 mg

Y0000685 Letrozole

70 mg

L0375000 Leucine

50 mg

L0376000 Leuprorelin

1 mg

L0376001 Leuprorelin - reference spectrum

n/a

Y0000047 Levamisole hydrochloride for system suitability

60 mg

L0380000 Levamisole hydrochloride

50 mg

0726

Y0000048 Levamisole - reference spectrum

n/a

1728

Y0001253 Levetiracetam

110 mg

100.0% CHNO

2535

Y0001254 Levetiracetam impurity A

10 mg

(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid

2535

Y0001255 Levetiracetam impurity B

10 mg

(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide

Y0001256 Levetiracetam impurity C

10 mg

pyridin-2-ol

Y0001257 Levetiracetam impurity D

10 mg

(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam)

L0390000 Levocabastine hydrochloride

125 mg

L0390008 Levocabastine impurity D

20 mg

L0399900 Levocarnitine

125 mg

L0399905 Levocarnitine impurity A

50 mg

(E)- or (Z)-4-(trimethylammonio)but-2-enoate ; Batch 1 is valid until 28


February 2011

L0400000 Levodopa

100 mg

Batch 1 is valid until 30 June 2011

L0420000 Levodropropizine

60 mg

L0420002 Levodropropizine impurity A

20 mg

(2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol (dextrodropropizine)

Y0001033 Levodropropizine impurity B

50 mg

1-phenylpiperazine

1535

Y0001048 Levodropropizine impurity C

300 mg

2,3-epoxypropan-1-ol

1535

L0500000 Levomepromazine hydrochloride

100 mg

0505

L0505000 Levomepromazine maleate

50 mg

0925

L0551000 Levonorgestrel

30 mg

Y0001379 Levonorgestrel impurity B

10 mg

Y0001431 Levonorgestrel for system suitability

10 mg

L0570000 Levothyroxine sodium

100 mg

Y0001382 Levothyroxine for peak identification

10 mg

0401

L0595000 Lidocaine

50 mg

0727,1362

Council of Europe, all rights reserved 2012

Leaflet

4-(trifluoromethyl)aniline ; Batch 1 is valid until 28 February 2011


99.7% CHN
0.99 mg per vial of pure leuprorelin peptide CHNO ; Batch 4 is valid
until 1 February 2012

Storage
+5C

Yes

2330

+5C

79

+5C

79

+5C

79

2330

Yes

+5C

79

2334

Yes

+5C

79

0771,0874

+5C

79

1442

-20C

79

79

+5C

79

+5C

79

79

+5C

79

+5C

79

2535

+5C

79

2535

+5C

79

2535

+5C

79

1484

+5C

79

1484

+5C

79

1339

+5C

79

1339

+5C

79

0038

+5C

79

1535

+5C

79

1535

+5C

79

+5C

79

-20C

g(c)

79

+5C

79

+5C

79

0926

+5C

79

0926

+5C

79

+5C

79

-20C

79

-20C

79

+5C

79

1442
0726,1728

Batch 2 is valid until 31 July 2011

1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic
acid

13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one

0926
89.3% CHINNaO

42

Extra
Price
charges
79
a

Yes

Yes

Yes

0401,0728
Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
L0600000 Lidocaine hydrochloride
L0650000 Lincomycin hydrochloride
New Y0001393 Lincomycin chlorhydrate for system suitability

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
100 mg
1

250 mg

10 mg

Information

Monograph

95.4% CHClNOS

Leaflet

Storage

Extra
Price
charges
79
g

0227,1242,13
63

+5C

0582,0583,09
96

+5C

79

-20C

79

0401,0728

-20C

79

0728

-20C

79

+5C

79

+5C

79

+5C

79

+5C

79

0583

Yes

L0700000 Liothyronine sodium

50 mg

Y0000860 Liothyronine for peak identification

0.0046 mg

L0702000 Lisinopril dihydrate

50 mg

Y0001235 Lisinopril for system suitability

2 mg

Lisinopril for performance test CRS 3 renamed as lisinopril for system


suitability CRS 1 for the implementation of 01/2011:1120

1120

Y0001234 Lisinopril impurity F

0.01 mg

(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)

1120

L0720000 Lithium clavulanate

125 mg

97.6% CHLiNO; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO ;


Batch 4 is valid until 31 August 2011

1140,1653

L0720800 Lithocholic acid

60 mg

Batch 1 is valid until 31 May 2011

1189,1275

+5C

79

Y0000112 Lobeline hydrochloride

50 mg

1988

+5C

79

L0745000 Lomustine

50 mg

0928

+5C

79

L0750000 Loperamide hydrochloride

50 mg

0921,0929,17
29

+5C

79

Y0000322 Loperamide hydrochloride for system suitability

15 mg

0929

+5C

79

Y0000341 Loperamide oxide monohydrate

20 mg

1729

+5C

79

Y0000688 Loratadine

60 mg

2124

+5C

79

Y0000603 Loratadine for system suitability

20 mg

2124

+5C

79

Y0000604 Loratadine impurity F

10 mg

ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate

2124

+5C

79

Y0000605 Loratadine impurity H

50 mg

ethyl 4-oxopiperidine-1-carboxylate

2124

+5C

79

L0750500 Lorazepam - * psy

100 mg

1121

+5C

79

Y0000576 Lorazepam for system suitability - * psy

0.8 mg

Y0000718 Lorazepam impurity D

10 mg

Y0001062 Losartan potassium

50 mg

Y0001072 Losartan impurity D

6 mg

Y0001076 Losartan for system suitability

0.0015 mg

L0790000 Lovastatin

40 mg

Y0001136 Lovastatin for peak identification

20 mg

Y0001284 Lufenuron

140 mg

Y0001261 Lufenuron for peak identification

0.4028 mg

Council of Europe, all rights reserved 2012

96.6 % CHINNaO

1120

(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
2-butyl-4-chloro-1H-imidazole-5-carbaldehyde ; Batch 1 is valid until 31 May
2011

99.5% CHClFNO

43

Yes

Yes

Yes

1121

+5C

79

1121

+5C

79

2232

+5C

79

2232

+5C

79

+5C

79

-20C

79

2232
99.7% CHO

Yes

Yes

1538,1563
1538

Yes

-20C

79

2177

Yes

+5C

79

2177

Yes

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001265 Lufenuron impurity G

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
15 mg
1 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate

Monograph

Leaflet

Storage

Extra
Price
charges
79
g

2177

+5C
+5C

79

L0800000 Lynestrenol

50 mg

0558

Y0001034 Lynestrenol for peak identification

20 mg

0558

+5C

79

Y0000397 Lysine acetate

60 mg

2114

+5C

79

L0900000 Lysine hydrochloride

50 mg

0805,0806,09
30, 1654

+5C

79

Y0000745 Macrogol 40 sorbitol heptaoleate

20 mg

2396

+5C

79

Y0001157 Macrogol polyvinyl alcohol grafted copolymer

400 mg

2523

+5C

79

Y0001369 Macrogol 30 dipolyhydroxystearate

100 mg

2584

+5C

79

M0088000 Magnesium aspartate dihydrate

60 mg

1445

+5C

79

M0120000 Malathion

250 mg

99.4% CHOPS

1343

+5C

79

M0120005 Malathion impurity A

10 mg

diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate

1343

-20C

g(c)

79

M0120010 Malathion impurity B

10 mg

diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate

1343

-20C

g(c)

79

M0100000 Maleic acid

100 mg

0365,0925

+5C

79

Y0000143 Malic acid - reference spectrum

n/a

79

M0160000 Maltitol

1200 mg

99.7% CHO

1235,1236

+5C

79

M0200000 Mannitol

1200 mg

98.8% CHO

0435,0559,13
81, 1531

+5C

79

M0206000 Maprotiline hydrochloride

100 mg

1237

+5C

79

M0206040 Maprotiline impurity D

25 mg

1237

+5C

79

Y0000819 Marbofloxacin

10 mg

2233

+5C

79

Y0000820 Marbofloxacin for peak identification

20 mg

2233

Yes

+5C

79

M0210000 Measles vaccine (live) BRP

5 uc

1057,0213

Yes

-20C

90

M0215000 Mebendazole

20 mg

1208,1254

+5C

79

Y0000144 Mebendazole for system suitability

20 mg

0845

+5C

79

Y0000168 Mebendazole - reference spectrum

n/a

0845

79

Y0001086 Mebrofenin

120 mg

2393

+5C

79

M0220000 Meclozine dihydrochloride

150 mg

Renammed for 01/2011:0622

0622

+5C

79

Y0001310 Meclozine impurity B

15 mg

4-chlorobenzhydrol

0622

+5C

79

Y0001311 Meclozine impurity H

15 mg

1-(4-chlorobenzhydryl)piperazine

0622

+5C

79

M0240000 Medronic acid

20 mg

Batch 1 is valid until 31 December 2011

0641, 2350

+5C

79

Y0001107 Medronic acid impurity A

60 l

Tris(1-methylethoxy)phosphane

2350

+5C

79

Y0001106 Medronic acid impurity B

40 l

Tetrakis(1-methylethyl)methhylenediphosphonate

2350

+5C

79

M0250000 Medroxyprogesterone acetate

100 mg

0673,1094,15
93

+5C

79

M0250010 Medroxyprogesterone acetate for performance test

50 mg

0673

+5C

79

Council of Europe, all rights reserved 2012

Yes

2080

3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine

4.3 log (ie 20000) infective viral units per vial

44

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000598 Medroxyprogesterone acetate for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

M0252600 Mefenamic acid

50 mg

Y0001081 Mefenamic acid impurity A

100 mg

M0253000 Mefloquine hydrochloride

100 mg

M0260100 Megestrol acetate - reference spectrum

n/a

Y0001209 Meglumine

Y0001080 Meloxicam

Y0001035 Meloxicam impurity A


Y0001036 Meloxicam impurity B

Information

Monograph

Leaflet

Storage

0673

Yes

-20C

Extra
Price
charges
79
c

1240

+5C

79

1240

+5C

79

1241

+5C

79

1593

79

10 mg

2055

+5C

79

50 mg

2373

+5C

79

5 mg

ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2373

Yes

+5C

79

5 mg

5-methylthiazol-2-amine

2373

Yes

+5C

79

Y0001037 Meloxicam impurity C

5 mg

N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide ; Batch 1 is valid until 31 July 2011

2373

Yes

+5C

79

Y0001039 Meloxicam impurity D

5 mg

N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide ; Batch 1 is valid until 31 July 2011

2373

Yes

+5C

79

Yes

New Y0001457 Melphalan for system suitability

2,3-dimethylaniline

10 mg

1698

+5C

79

M0300000 Menadione

100 mg

0507

+5C

79

M0350000 Menthol

150 mg

0619,0623

+5C

79

M0370000 Mepivacaine hydrochloride

100 mg

1242

+5C

79

M0370020 Mepivacaine impurity B

60 mg

M0400000 Meprobamate - * psy

100 mg

M0500000 Mepyramine maleate

1000 mg

Y0000679 Mepyramine impurity A

10 mg

N-(4-methoxybenzyl)pyridin-2-amine

Y0000680 Mepyramine impurity C

10 mg

pyridin-2-amine

0278

Y0001252 Meropenem trihydrate

110 mg

87.0% CHNOS,3HO

2234

Y0000297 Mesalazine

125 mg

1699,1993

Y0001040 Mesityl oxide

100 mg

2358

Y0000337 Mesna - reference spectrum

n/a

Y0000316 Mesna impurity C

10 mg

2-(acetylsulphanyl)ethanesulphonic acid

1674

Y0000317 Mesna impurity D

10 mg

2,2'-(disulphanediyl)bis(ethanesulphonic acid)

1674

Y0000227 Meso-rich exametazime

0.5 mg

Y0000097 Mesterolone

60 mg

99.3% CHO

Y0000096 Mesterolone impurity A

30 mg

17-hydroxy-1alpha-methylandrost-4-en-3-one

M0600000 Mestranol

100 mg

Y0000301 Metacresol - reference spectrum

n/a

M0600500 Metacycline hydrochloride

M0600900 Metamizole sodium

M0600905 Metamizole impurity A

15 mg

M0605000 Metformin hydrochloride

50 mg

Council of Europe, all rights reserved 2012

1242

+5C

79

0407,1689

+5C

79

0278

+5C

79

0278

+5C

79

+5C

79

+5C

79

+5C

79

+5C

g(b)

79

79

+5C

79

+5C

79

+5C

79

1730

+5C

79

1730

+5C

79

0509

+5C

79

2077

79

50 mg

0272,0820

+5C

79

100 mg

1346

+5C

79

1346

+5C

79

0931

+5C

79

(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

Yes

1674

1925

4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
45

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2012/1/3

Order
Reference Standard
Code
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A

Batch n

Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B

200 mg

M0610000 Methacrylic acid-ethylacrylate copolymer(1:1) - reference


spectrum

n/a

M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),


dispersion 30%-ref.sp

M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

1128

+5C

1128

+5C

79

1128

79

n/a

1129

79

n/a

1127

79

M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum

n/a

1130

79

M0800000 Methadone hydrochloride - reference spectrum

n/a

0408,1787

79

Y0000428 Methanol - reference spectrum

n/a

1989

79

M0900000 Methaqualone - reference spectrum

n/a

0510

79

Y0000754 Methenamine

10 mg

1545

+5C

79

M0950000 DL-Methionine

50 mg

0624

+5C

79

M0960000 Methionine

50 mg

0788,1027

+5C

79

M1000000 Methotrexate

100 mg

0560

+5C

79

Y0000602 Methotrexate for peak identification

20 mg

+5C

79

Y0000663 Methotrexate impurity C

10 mg

(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)

0560

+5C

79

M1000008 Methotrexate impurity D

10 mg

4-[[(2-amino-4hydroxypteridin-6-yl)methyl]methyl-amino] benzoic acid

0560

+5C

79

Y0000664 Methotrexate impurity E

10 mg

4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)

0560

+5C

79

M1300000 Methylatropine bromide

100 mg

0511,0919

+5C

79

M1400000 Methylatropine nitrate

100 mg

0512

+5C

79

M1450000 Methylcarbidopa

1 mg

0755

+5C

79

M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate

0.5 ml

0318

+5C

79

M1500000 Methyldopa

50 mg

0045,0755

+5C

79

Y0001374 Racemic methyldopa

5 mg

0045

+5C

79

Y0001083 Methyldopa for system suitability

0.024 mg

0045

+5C

79

M1550000 Methylene chloride

2 ml

0932

+5C

79

M1551000 2-(1-Methylethyl) pentanoic acid

25 mg

0678,1378

+5C

79

M1556000 Methyl 12-hydroxystearate

100 mg

1497

+5C

79

Y0000398 Methyl nicotinate

25 mg

2129

+5C

79

Y0000776 Methylergometrine maleate

10 mg

1788

+5C

79

Y0000777 Methylergometrine for system suitability

0.53 mg

+5C

79

M1625000 Methylnitrosoindoline

110 mg

+5C

79

Council of Europe, all rights reserved 2012

Quantity Sale
per vial Unit
200 mg
1

88.9% CHNO

0560

1788
Batch 2 is valid until 31 January 2012
46

1108

Yes

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2012/1/3

Order
Reference Standard
Code
M1650000 Methyl parahydroxybenzoate

Batch n

Y0001017 Methylphenidate hydrochloride - * narc

40 mg

Y0000910 Methylphenidate impurity mixture

M1700000 Methylphenobarbital - * psy

M1750000 Methylprednisolone
M1755000 Methylprednisolone acetate

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

0409,1262,21
34,1999

+5C

2235

+5C

79

0.04 mg

2235

+5C

79

500 mg

0189

+5C

79

150 mg

0312,0561

+5C

79

100 mg

0933

+5C

79

M1755200 Methylprednisolone hydrogen succinate

125 mg

0768,1131

+5C

79

M1755220 Methylprednisolone hydrogen succinate for performance


test

50 mg

1131

+5C

79

Y0001376 2-methylpyrazine

100 mg

2446

+5C

79

Y0000190 N-Methylpyrrolidone - reference spectrum

n/a

1675

79

M1770180 Methyl ricinoleate

125 mg

0051,2367

+5C

79

Y0000418 Methylrosanilinium chloride

40 mg

1990

+5C

79

Y0000407 Methylrosanilinium for system suitability

10 mg

1990

+5C

79

M1770200 Methyl stearate

100 mg

0051,1497

+5C

79

M1800000 Methyltestosterone

100 mg

0410

+5C

79

Y0000861 Methyltestosterone for system suitability

10 mg

0410

+5C

79

M1800900 Methylthioninium chloride

50 mg

1132

+5C

79

M1800902 Methylthioninium impurity A

20 mg

M1808000 Metixene hydrochloride

75 mg

M1824990 Metoclopramide

100 mg

M1825000 Metoclopramide hydrochloride

50 mg

M1824995 Metoclopramide impurity A

25 mg

M1825010 Metoclopramide impurity E

20 mg

Y0000701 Metolazone

80 mg

Y0000702 Metolazone for system suitability

10 mg

1757

Y0000171 Metoprolol succinate - reference spectrum

n/a

1448

M1830000 Metoprolol tartrate

60 mg

Y0000145 Metoprolol impurity A

10 mg

M1845000 Metrifonate

100 mg

M1850000 Metronidazole

50 mg

M1851000 Metronidazole benzoate

Y0000069 Metronidazole benzoate - reference spectrum

Y0000087 Metronidazole impurity A


M1860000 Mexiletine hydrochloride
Council of Europe, all rights reserved 2012

Quantity Sale
Information
per vial Unit
150 mg
1 100.0% CHO; batch 2 valid until 31/12/10 for use with monograph 2134
and 1999.

Yes

Yes

Yes

1132

+5C

79

1347

+5C

79

1348

+5C

79

0674,0856,13
03

+5C

79

4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide

1348

+5C

79

N,N-diethylethane-1,2-diamine

1575

+5C

79

99.4% CHClNOS

1757

+5C

79

+5C

79

79

3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium

Yes

1028

+5C

79

1028,1448

+5C

79

1133

+5C

79

0675,0934

+5C

79

50 mg

1424

+5C

79

n/a

0934

79

10 mg

100 mg

(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

2-methyl-4-nitroimidazole
47

0675

+5C

79

1029

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000202 Mexiletine impurity C

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
2 mg
1 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine
2 mg
1 (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine

Monograph

Leaflet

Storage

1029

+5C

Extra
Price
charges
79
a

Y0000203 Mexiletine impurity D

1029

+5C

79

M1875000 Mianserin hydrochloride

100 mg

Batch 1 is valid until 31 January 2012

0846

+5C

79

Y0001041 Mianserin impurity B

10 mg

(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid

0846

+5C

79

Y0000862 Mianserin for system suitability

1.01 mg

0846

+5C

79

M1880000 Miconazole

70 mg

0935,1335

+5C

79

M1900000 Miconazole nitrate

100 mg

0513,1148

+5C

79

M2200000 Midazolam - * psy

50 mg

0936,1065

+5C

79

Y0000562 Midazolam impurity C

0.08 mg

acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique ; Batch 1 is valid until 31 March 2011

Yes

+5C

79

+5C

79

Yes

-20C

79

New Y0000599 Midazolam for system suitability - * psy

0936

Yes

1 mg

Batch 1 is valid until 30 June 2012

Y0000539 Milk thistle standardised dry extract

120 mg

26.6% of silibinin (A+B)

M2280000 Minocycline hydrochloride

125 mg

90.8% CHClNO

1030

+5C

79

M2300000 Minoxidil

50 mg

0937

+5C

79

+5C

79

+5C

79

New Y0001432 Minoxidil for system suitability

0936
2071,1860

10 mg

0937

Y0000705 Mirtazapine

10 mg

2338

Y0000721 Mirtazapine for system suitability

10 mg

Y0000490 Misoprostol

60 mg

Y0001162 Misoprostol for system suitability

5 mg

Y0000378 Mitomycin

120 mg

99.1% CHNO

1655

M2305000 Mitoxantrone hydrochloride

50 mg

97.7% CHClNO

M2305005 Mitoxantrone impurity A

5 mg

1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione

Y0000635 Modafinil

110 mg

100.0% CHNOS

Y0000636 Modafinil for system suitability

0.1 mg

Y0000251 Molgramostim

0.3 ml

Y0000821 Molsidomine

5 mg

1701

Y0000822 Molsidomine impurity B

10 mg

N-nitrosomorpholine

1701

Y0000823 Molsidomine impurity D

10 mg

morpholine-4-carbaldehyde

M2900000 Mometasone furoate

100 mg

Y0001436 Montelukast dicyclohexylamine

150 mg

Y0001433 Montelukast racemate

20 mg

2583

Y0001434 Montelukast sodium

150 mg

2583

Y0001435 Montelukast for peak identification

20 mg

2583

Y0000028 Morantel hydrogen tartrate

50 mg

1546

Council of Europe, all rights reserved 2012

98.5% CHO ; Batch 2 is valid until 28 February 2012

13.45 mg protein per ml CHNOS

99.4% CHClNOS

48

Yes

2338

Yes

+5C

79

1731

Yes

-20C

g(c)

79

1731

Yes

-20C

g(c)

79

+5C

79

1243

+5C

79

1243

+5C

79

2307

+5C

79

2307

Yes

+5C

79

1641

Yes

-80C

79

+5C

79

+5C

g(b)

79

1701

+5C

79

1449

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

2583

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000451 Morphine hydrochloride (trihydrate) - * narc

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
25 mg
1 See leaflet

Information

Monograph

Leaflet

Storage

0097,1839,18
41

Yes

+5C

Y0000452 Morphine sulfate - * narc

40 mg

Y0000830 Morphine for system suitability - * narc

10 mg

70 mg

10 mg

110 mg

Y0000717 Moxifloxacin for peak identification

10 mg

Y0000226 Moxonidine

50 mg

99.7% CHClNO

Y0000222 Moxonidine impurity A

10 mg

4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine

M3600000 Mumps vaccine (live) BRP

5 uc

4.6 log (ie40000) infective viral units per vial

M3805000 Mupirocin - reference spectrum

n/a

M3805500 Mupirocin calcium - reference spectrum

n/a

M3806000 Mupirocin lithium

100 mg

Y0000489 Mycophenolate mofetil

30 mg

Y0000519 Mycophenolate mofetil for peak identification

10 mg

1700

Y0000692 Mycoplasma fermentans BRP

1 ml

20607

Y0000690 Mycoplasma hyorhinis BRP

1 ml

Y0000691 Mycoplasma orale BRP

1 ml

Y0000689 Mycoplasma synoviae BRP

1 ml

Y0000485 Myo-inositol

1020 mg

99.8% CHO

1805

N0020000 Nabumetone

60 mg

99.8% CHO

N0020020 Nabumetone impurity D

10 mg

(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one

N0020030 Nabumetone impurity F

10 mg

6,6'-dimethoxy-2,2'-binaphthalenyl

Y0000146 Nadolol

100 mg

Y0001215 Nadolol impurity mixture

0.01 mg

1789

N0025000 Nadroparin calcium

250 mg

0828,1134

Y0000077 Naftidrofuryl - reference spectrum

n/a

Y0000120 Naftidrofuryl impurity A

10 mg

2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid

Y0000121 Naftidrofuryl impurity B

25 mg

Y0000331 Naftidrofuryl impurity F

10 mg

N0050000 Nalidixic acid

100 mg

N0075000 Naloxone hydrochloride dihydrate

100 mg

Y0000695 Naloxone for peak identification

Y0000400 Naltrexone hydrochloride

New Y0000772 Moxidectin


Y0000747 Moxidectin for system suitability
New Y0000703 Moxifloxacin hydrochloride

Council of Europe, all rights reserved 2012

1244,1784
97.4% CHNO ; Batch 1 is valid until 31 May 2012
96.1 % CHClFNO ; Batch 1 is valid until 31 May 2012

+5C

Extra
Price
charges
79
k
k

79

1244, 0097

Yes

+5C

79

1656

Yes

+5C

79

1656

Yes

+5C

79

2254

Yes

+5C

79

2254

Yes

+5C

79

+5C

79

+5C

79

-80C

90

1450

79

1451

79

1758
1758
0538,1057

Yes

1450,1451

+5C

79

1700

+5C

79

Yes

+5C

79

Yes

-80C

120

20607

Yes

-80C

120

20607

Yes

-80C

120

20607

Yes

-80C

120

+5C

79

1350

+5C

79

1350

+5C

79

1350

+5C

79

1789

+5C

79

+5C

79

+5C

79

79

1594

+5C

79

98% CHO; ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)


propanoate

1594

+5C

79

2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)


propanoate

1594

+5C

79

0701

+5C

79

0729,2099

+5C

79

10 mg

0729

+5C

79

50 mg

1790

+5C

79

93.7% CHOLi

Yes

1594

49

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000410 Naltrexone impurity C

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
15 mg
1 N-(3-butenyl)-noroxymorphone

Monograph
1790

Y0000542 Nandrolone decanoate

5 mg

1992

Y0000547 Nandrolone decanoate for peak identification

10 mg

1992

Y0000548 Nandrolone decanoate for system suitability

10 mg

1992

N0080000 Naphazoline hydrochloride

50 mg

0730,1162

N0100000 Naphazoline nitrate

10 mg

N0200000 Naphazoline impurity A

10 mg

N0250000 Naproxen

100 mg

Y0000399 Naproxen (racemic)

10 mg

Y0000631 Naproxen impurity L

10 mg

1-(6-methoxynaphthalen-2-yl)ethanone

New Y0001437 Nateglinide

200 mg

99.9% CHNO

2575

New Y0001440 Nateglinide impurity A

10 mg

trans-4-(1-methylethyl)cyclohexanecarboxylic acid

2575

New Y0001441 Nateglinide impurity B

15 mg

N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)

2575

New Y0001442 Nateglinide impurity C

N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)

Storage
+5C

Yes

Extra
Price
charges
79
a

-20C

79

-20C

79

-20C

79

+5C

79

0147

+5C

79

0147,0730

+5C

79

0731,1702

+5C

79

0731,1702

+5C

79

1702

+5C

79

+5C

79

+5C

79

+5C

79

10 mg

N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)

N0300000 Neamine

0.5 mg

76.3% CHNO ; Batch 3 is valid until 31 March 2011

N0399000 Neohesperidin-dihydrochalcone

125 mg

N0399004 Neohesperidin-dihydrochalcone impurity B

10 mg

N0400000 Neomycin sulfate

50 mg

Not to be used for microbiological assay

N0401000 Neomycin sulfate for microbiological assay

25 mg

19850 IU per vial

N0500000 Neostigmine bromide

50 mg

N0550000 Neostigmine metilsulfate

50 mg

N0559000 Netilmicin sulfate

25 mg

14656 IU per vial

Y0000520 Nevirapine (anhydrous)

30 mg

99.8% CHNO

2255

Y0000521 Nevirapine for peak identification

0.058 mg

Y0000388 Newcastle Disease Vaccine (inactivated) BRP

4 uc

Y0001373 Nicergoline

50 mg

Y0000287 Nicergoline - reference spectrum

n/a

Y0000283 Nicergoline impurity A

10 mg

[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10aoctahydroindol[4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate

Y0001356 Nicergoline impurity D

20 mg

5-bromopyridine-3-carboxylic acid

Council of Europe, all rights reserved 2012

Leaflet

Yes

+5C

79

0180,0197

2575
Yes

+5C

79

89.9% CHO

1547

Yes

-20C

79

86.4% CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin) ; Batch 1 is valid until 31 October 2011

1547

Yes

+5C

79

0032,0033,00
53,
0180,0197,04
85, 0645

Yes

-20C

79

0197,20702

Yes

-20C

79

+5C

79

0626

+5C

79

1351,20702

-20C

79

0046

The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody

+5C

79

2255

Yes

+5C

79

0870

Yes

-20C

180

+5C

79

79

1998

+5C

79

1998

+5C

79

1998
1998

50

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001362 Nicergoline for peak identification

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
1 mg
1

Information

Monograph

Leaflet

1998

Storage
+5C

Y0001352 Nicergoline for system suitability

10 mg

1998

+5C

79

N0560000 Niclosamide (anhydrous)

50 mg

0679,0680

+5C

79

N0600000 Nicotinamide

50 mg

0047

+5C

79

N0590000 Nicotine - reference spectrum

n/a

1452,1792

79

N0590200 Nicotine ditartrate

120 mg

1792

+5C

79

15 mg

2599

+5C

79

Y0001023 Nicotine for system suitability

1.25 mg

1452, 1792,
2599

-20C

g(c)

79

N0700000 Nicotinic acid

100 mg

0459,0859

+5C

79

Y0001268 Nicotinic acid impurity mixture

0.12 mg

0459

+5C

79

N0750000 Nifedipine

50 mg

0627,1013

+5C

79

N0750010 Nifedipine impurity A

20 mg

Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate

0627

+5C

79

N0750015 Nifedipine impurity B

20 mg

Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate

0627

+5C

79

Y0000824 Niflumic acid

10 mg

2115

+5C

79

Y0000825 Niflumic acid impurity A

10 mg

2-chloropyridine-3-carboxylic acid

2215

+5C

79

Y0000826 Niflumic acid impurity B

10 mg

2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide

2115

+5C

79

Y0000827 Niflumic acid impurity E

15 mg

6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid

2115

+5C

79

Y0000836 Nifuroxazide

10 mg

1999

+5C

79

N0800000 Nikethamide

1 ml

0233

+5C

79

Y0000829 Nilutamide

110 mg

2256

+5C

79

Y0000894 Nilutamide impurity B

5 mg

2256

+5C

79

N0845000 Nimesulide

100 mg

1548

+5C

79

Y0001237 Nimesulide for peak identification

10 mg

+5C

79

N0845008 Nimesulide impurity D

0.004 mg

+5C

79

N0850000 Nimodipine

50 mg

+5C

79

N0850010 Nimodipine impurity A

1 ml

+5C

79

N0900000 Nitrazepam - * psy

100 mg

0415,0898,11
21

+5C

79

N0900010 Nitrazepam impurity A

25 mg

0415

+5C

79

N0905000 Nitrendipine

60 mg

1246

+5C

79

10 mg

1246

+5C

79

N0905005 Nitrendipine impurity A

30 mg

+5C

79

N0930000 Nitric oxide - reference spectrum

n/a

79

N0950000 Nitrofural

100 mg

+5C

79

New Y0001425 Nicotine ditartrate dihydrate

New Y0001456 Nitrendipine for peak identification

Council of Europe, all rights reserved 2012

92.8% CHN x 2 CHO

4-nitro-3-(trifluoromethyl)aniline

1548

Yes

Extra
Price
charges
79
g

Yes

Yes

Yes

1548

4-nitro-2-phenoxyaniline

1245
1245

2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)


pyridine-3,5-dicarboxylate

3-amino-6-nitro-4-phenylquinol-2-one

ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;


(nitrophenylpyridine analogue)

1246

Yes

Yes

1550
99.8% CHNO
51

1135

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001377 Nitrofural for peak identification

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
0.11 mg
1

Information

Monograph

Leaflet

Storage

1135

+5C

Extra
Price
charges
79
a

N1000000 Nitrosotriaminopyrimidine

50 mg

0058

+5C

79

N1090000 Nizatidine

250 mg

99.3% CHNOS

1453

+5C

79

N1090060 Nizatidine impurity F

10 mg

(EZ)-N,N'-[thiazole-2,4-diylbis(methylenesulphanediylethylene)]bis(N'methyl-2-nitroethene-1,1-diamine)

1453

+5C

79

N1080000 Nomegestrol acetate

100 mg

1551

+5C

79

N1080005 Nomegestrol acetate impurity A

50 mg

1551

+5C

79

Y0001314 1-nonadecanol

400 mg

0801,0802,08
47

+5C

79

Y0000670 Nonivamide

10 mg

2336,2337

+5C

79

Y0000755 Nonoxinol 9

10 mg

1454

+5C

79

N1100000 Noradrenaline tartrate

200 mg

0254,0285,07
32, 2303

+5C

79

Y0000681 Noradrenaline impurity D

15 mg

+5C

79

Y0000682 Noradrenaline impurity E

10 mg

4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732


2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732

+5C

79

Y0000686 Noradrenaline impurity F

10 mg

N-benzyl-1-phenylmethanamine

0285,0732

+5C

79

N1130000 Norcyclobenzaprine

25 mg

0941

+5C

79

N1140000 Nordazepam -* psy

50 mg

Dipotassium clorazepate impurity B

0898,1466

+5C

79

N1200000 Norethisterone

100 mg

0234,1212

+5C

79

N1225000 Norethisterone acetate

100 mg

0850

+5C

79

Y0000522 Norethisterone for system suitability

10 mg

0234

-20C

79

N1230000 Norfloxacin

50 mg

1248

+5C

79

N1230010 Norfloxacin impurity A

20 mg

7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)

1460

+5C

79

Y0001015 Norfloxacin for system suitability

8 mg

Batch 1 is valid until 31 January 2012

1248

Yes

+5C

79

Y0001301 Norfloxacin for peak identification

10 mg

1248

Yes

+5C

79

Y0000724 Norgestimate

10 mg

1732

+5C

79

Y0000725 Norgestimate for system suitability

5 mg

1732

+5C

79

N1250000 Norgestrel

30 mg

0940

+5C

79

N1279000 Norpseudoephedrine hydrochloride - * psy

50 mg

0683

+5C

79

N1280000 Nortriptyline hydrochloride

10 mg

0941

+5C

79

Y0001296 Nortriptyline for system suitability

20 mg

0941

+5C

79

N1300000 Noscapine

100 mg

0102,0515,05
16

+5C

79

N1400000 Nystatin

100 mg

-20C

79

O0100900 Octoxinol 10

300 mg

+5C

79

Council of Europe, all rights reserved 2012

6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate ; Batch 1 is valid


until 30 September 2011

99.1% CHNO

Cathine hydrochloride

5825 IU per mg CHNO

0517,1292,20
702
1553

52

Yes

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0000368 Octyl gallate

Reference Standard

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
30 mg
1

O0101000 Octyldodecanol

400 mg

O0120000 Ofloxacin

50 mg

O0120010 Ofloxacin impurity A

20 mg

O0120050 Ofloxacin impurity E

20 mg

Y0001370 Olanzapine

Y0001392 Olanzapine impurity A

Y0001380 Olanzapine for system suitability


Y0000805 Oleuropein

Information

Monograph

Leaflet

Storage

2057

+5C

Extra
Price
charges
79
a

1136

+5C

79

1455

+5C

79

(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA)

1455

+5C

79

(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid

1455

+5C

79

200 mg

99.8% CHNS

2258

+5C

79

5 mg

5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile

2258

+5C

79

10 mg

+5C

79

20 mg

+5C

79

Y0001424 Olmesartan medoxomil for system suitability

10 mg

2600

+5C

79

O0146000 Olsalazine sodium

60 mg

1457

+5C

79

O0146010 Olsalazine sodium for performance test

60 mg

50 mg

Y0001043 Omeprazole magnesium

10 mg

2374

Y0001042 Omeprazole for peak identification

10 mg

0942,2372,23
74

O0151000 Omeprazole impurity D

10 mg

Omeprazole sulphone

Y0000218 Ondansetron hydrochloride dihydrate

200 mg

90.2% CHClNO

Y0000197 Ondansetron for LC system suitability

10 mg

Y0000196 Ondansetron for TLC system suitability

30 mg

Y0001345 Ondansetron impurity A

10 mg

(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one

Y0000195 Ondansetron impurity D

10 mg

Y0001326 Ondansetron impurity E

10 mg

Y0001320 Ondansetron impurity F

10 mg

Y0001346 Ondansetron impurity G

10 mg

Y0001125 Orbifloxacin

200 mg

2259

Y0001147 Orbifloxacin impurity mixture

0.0008 mg

2259

O0180000 Orciprenaline sulfate

100 mg

1033,1332

Y0000895 Orciprenaline for system suitability

5 mg

1033

Y0000100 Orphenadrine hydrochloride

100 mg

Y0000101 Orphenadrine citrate

100 mg

Y0001337 Oseltamivir phosphate (impurity B free)

300 mg

Y0001181 Orphenadrine for peak identification

0.42 mg

New O0150000 Omeprazole

Council of Europe, all rights reserved 2012

94.8% CHO

2258

Yes
Yes

1878

82.2% CHO

Yes

1457

Yes

+5C

79

0942,1032

Yes

-20C

79

+5C

79

Yes

-20C

79

0942,1032

-20C

79

2016

+5C

79

2016

+5C

79

2016

+5C

79

2016

+5C

79

9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one

2016

+5C

79

Imidazole

2016

+5C

79

2016

+5C

79

2016

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

1760

+5C

79

1759

+5C

79

Batch 3 is valid until 31 May 2012

(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)

99.7% CHNOP

53

Yes
Yes

2422

Yes

+5C

79

1759,1760

Yes

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001338 Oseltamivir impurity A

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
per vial Unit
10 mg
1 (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

2422

+5C

1759,1760

+5C

79

Y0000102 Orphenadrine impurity E

30 mg

(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer)

Y0001339 Oseltamivir impurity B

10 mg

ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate

2422

+5C

79

Y0001340 Oseltamivir impurity C

10 mg

(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid

2422

+5C

79

Y0001341 Oseltamivir impurity H

30 mg

tributylphosphane oxide

2422

+5C

79

Y0001207 Osthole

20 mg

98.3 % CHO

2557

Yes

+5C

79

O0200000 Ouabain

150 mg

80.0% CHO ; Batch 1 is valid until 30 June 2011

0048

Yes

+5C

79

Y0000638 Oxacillin sodium monohydrate

110 mg

93.8% CHNNaOS

2260

+5C

79

Y0000560 Oxacillin for peak identification

10 mg

+5C

79

Y0000271 Oxaliplatin

250 mg

99.8 % CHNOPt

2017

+5C

79

Y0000272 Oxaliplatin impurity B

15 mg

(SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']
platinum (diaquodiaminocyclohexaneplatinum) ; Batch 5 is valid until 31 July
2011

2017

+5C

79

Y0000273 Oxaliplatin impurity C

15 mg

(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum

2017

+5C

79

Y0000274 Oxaliplatin impurity D

10 mg

(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin)

2017

+5C

79

O0225000 Oxazepam - * psy

50 mg

0778

+5C

79

Y0000543 Oxazepam for peak identification

0.008 mg

0778

+5C

79

Y0000350 Oxeladin hydrogen citrate

50 mg

1761

+5C

79

Y0000404 Oxeladin impurity C

10 mg

2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate

1761

+5C

79

Y0000390 Oxeladin impurity D

20 mg

2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate

1761

+5C

79

O0225800 Oxfendazole for veterinary use

50 mg

1458

+5C

79

Y0000224 Oxfendazole impurity B

10 mg

1458

+5C

79

Y0000225 Oxfendazole with impurity D

10 mg

1458

+5C

79

Y0000709 Oxitropium bromide

50 mg

2170

+5C

79

Y0000715 Oxitropium bromide impurity B

15 mg

(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)

2170

+5C

79

Y0000713 Oxitropium bromide impurity D

10 mg

(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)

2170

+5C

79

O0240000 Oxolinic acid

50 mg

1353

+5C

79

O0240005 Oxolinic acid impurity A

20 mg

8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid

1353

+5C

79

O0240010 Oxolinic acid impurity B

20 mg

ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate

1353

+5C

79

O0250000 Oxprenolol hydrochloride

50 mg

0628,0876,10
72

+5C

79

Council of Europe, all rights reserved 2012

2260

methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate

54

Yes
Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
O0260000 Oxibendazole

Reference Standard

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
100 mg
1

Information

Monograph

Leaflet

Storage

1386

+5C

Extra
Price
charges
79
a

O0270000 Oxybuprocane hydrochloride

150 mg

1251

+5C

79

O0288000 Oxybutynin hydrochloride

150 mg

1354

+5C

79

O0288005 Oxybutynin impurity A

10 mg

+5C

79

Y0000492 Oxycodone hydrochloride - * narc

100 mg

Y0000453 Oxycodone impurity D

50 mg

O0290000 Oxymetazoline hydrochloride

80 mg

Y0001044 Oxymetazoline impurity A

10 mg

N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide

O0400000 Oxytetracycline

100 mg

90.2% CHNO

O0500000 Oxytetracycline hydrochloride

20 mg

O0700000 Oxytocin

1 mg

0.96 mg per vial of CHNOS

O0770000 Oxytocin/Desmopressin validation mixture

0.2 mg

about 0.1 mg oxytocin + 0.1 mg desmopressin per vial

Y0000698 Paclitaxel

40 mg

99.4% CHNO ; Batch 1 is valid until 31 August 2011

1794

Y0000699 Paclitaxel impurity C

5 mg

N-debenzoyl-N-hexanoylpaclitaxel

1794

Y0000700 Paclitaxel natural for peak identification

10 mg

1794

Y0000719 Paclitaxel semi-synthetic for peak identification

10 mg

1794

Y0000739 Paclitaxel semi-synthetic for system suitability

1 mg

1794

P0090000 Palmitic acid

100 mg

Y0000524 Pamidronate disodium pentahydrate

10 mg

P0100000 Pancreas powder (amylase and lipase) BRP

2000 mg

41.4 Ph. Eur. U. lipolytic activity per mg; 56.3 Ph. Eur. U. amylolytic activity
per mg

P0200000 Pancreas powder (protease) BRP

2000 mg

P0250000 Pancuronium bromide

20 mg

Y0000577 Pancuronium bromide for system suitability

20 mg

Y0000835 Pantoprazole sodium sesquihydrate

20 mg

Y0001001 Pantoprazole for system suitability

0.5055 mg

P0270000 Papaverine hydrochloride

25 mg

0102,0573

P0300000 Paracetamol

50 mg

Y0000780 Paraffin (hard)

10 mg

Y0000058 Paraffin (liquid) - reference spectrum

n/a

0239,0240

Y0000913 Paraffin (White soft)

10 mg

Y0000912 Paraffin (Yellow soft)

10 mg

Council of Europe, all rights reserved 2012

4-(diethylamino)but-2-ynyl()-2-(cyclohex-3-enyl)-2- cyclohexyl-2hydroxyacetate
7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone) ; Batch 1 is valid until 31
December 2011

1354

Yes

1793

+5C

79

1793

+5C

79

0943

+5C

79

0943

+5C

79

0198,0199

+5C

79

0198,1030

+5C

79

0779,0780

-20C

g(c)

90

0712,0779,07
80

-20C

g(c)

79

+5C

79

+5C

79

Yes

+5C

79

Yes

+5C

79

Yes

Yes

+5C

79

0229,0882,14
74,2058

+5C

79

1779

+5C

79

0350

+5C

79

1.48 Ph. Eur. U. per mg

0350

+5C

79

Vecuronium impurity B

0681,1769

+5C

79

0681

+5C

79

2296

+5C

79

+5C

79

+5C

79

0049

+5C

79

1034

+5C

79

79

1799

+5C

79

1554

+5C

79

Batch 3 is valid until 29 February 2012

Batch 3 is valid until 31 December 2011

55

2296

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2012/1/3

Order
Reference Standard
Code
P0305000 Parnaparin sodium

Batch n

Y0000578 Paroxetine hydrochloride (anhydrous)

100 mg

Y0000281 Paroxetine hydrochloride hemihydrate

200 mg

97.4% CHClFNO

Y0000233 Paroxetine impurity A

15 mg

(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine)

Y0000579 Paroxetine hydrochloride (anhydrous) impurity C

10 mg

Y0000256 Paroxetine impurity D

5 mg

Y0000580 Paroxetine impurity E

Y0000581 Paroxetine hydrochloride (anhydrous) impurity H


Y0000630 Paroxetine for system suitability

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

0828,1252

+5C

2283

+5C

79

2018,2283

+5C

79

2018,2283

+5C

79

(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluo- rophenyl)
piperidine (N-benzylparoxetine)

2283

+5C

79

(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
((+)-trans-paroxetine)

2018,2283

+5C

79

5 mg

(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)

2283

+5C

79

10 mg

[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol

2283

+5C

79

5 mg

2018

+5C

79

P0309000 Pefloxacin mesilate dihydrate

200 mg

1460

+5C

79

P0309020 Pefloxacin impurity B

10 mg

1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydro- quinoline-3carboxylic acid (chlorinated homologue of pefloxacin)

1460

+5C

79

P0309030 Pefloxacin impurity C

0.01 mg

1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydro- quinoline-3carboxylic acid (isopefloxacin)

1460

+5C

79

P0307000 Penbutolol sulfate

100 mg

1461

+5C

79

P0307005 Penbutolol impurity A

20 mg

1461

+5C

79

P0310000 Penicillamine

100 mg

0566

+5C

79

P0320000 Penicillamine disulfide

100 mg

0566

+5C

79

P0405000 Pentamidine diisetionate

30 mg

1137,1436

+5C

79

P0405500 Pentazocine - reference spectrum

n/a

1462

79

P0405510 Pentazocine hydrochloride - reference spectrum

n/a

1463

79

Y0000417 Pentazocine lactate - reference spectrum

n/a

2000

Y0001051 Pentetate sodium calcium

100 mg

2353

+5C

P0500000 Pentobarbital - * psy

500 mg

0200,0419

P0510000 Pentoxifylline

100 mg

0851

Y0000076 Pentoxyverine hydrogen citrate - reference spectrum

n/a

Y0000098 Pentoxyverine impurity A

10 mg

1-phenylcyclopentanecarboxylic acid

Y0000099 Pentoxyverine impurity B

10 mg

P0525000 Pepsin powder

2000 mg

Y0000010 Pergolide mesilate

150 mg

Y0000237 Perindopril impurity A

10 mg

Y0000207 Perindopril for stereochemical purity

40 mg

Council of Europe, all rights reserved 2012

Quantity Sale
per vial Unit
250 mg
1

(2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]
propan-2-ol
93.0% CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid

79

79

+5C

79

+5C

79

79

1621

+5C

79

2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)

1621

+5C

79

0.99 Ph. Eur. U. per mg

0682

+5C

79

99.9% CHNOS

1555

+5C

79

(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid

2019

+5C

79

+5C

79

1621

2019
56

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000238 Perindopril tert-butylamine

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
40 mg
1

Information

Monograph

Leaflet

2019

+5C

Y0000771 Perindopril for peak identification

5 mg

2019

P0550000 Perphenazine

100 mg

0629,0904

Y0001045 Perphenazine for system suitability

5 mg

0629

Yes

Y0000021 Pertussis toxin BRP

0.05 mg

See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329

Yes

P0600000 Pethidine hydrochloride - reference spectrum

n/a

0420

P0600002 Pethidine impurity A

20 mg

P0800000 Phenazone

20 mg

Y0001138 Phenazone impurity A

20 mg

P0850000 Pheniramine maleate

250 mg

New Y0001428 Pheniramine impurity A

1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one

Storage

Yes

Extra
Price
charges
79
a

+5C

79

+5C

79

+5C

79

-20C

g(d)

90

79

0420

+5C

79

0421

+5C

79

0421

+5C

79

1357

+5C

79

1357

+5C

79

0189,0201,06
30

+5C

79

+5C

79

20 mg

2-benzylpyridine

P0900000 Phenobarbital - * psy

200 mg

Batch 3 is valid until 31 August 2011

Y0001350 Phenobarbital impurity A

15 mg

0201

Y0001351 Phenobarbital impurity B

15 mg

0201

+5C

79

P0950000 Phenoxyethanol

2 ml

0781

+5C

79

P1000000 Phenoxymethylpenicillin

250 mg

P1100000 Phenoxymethylpenicillin potassium

250 mg

Y0001127 Phentolamine mesilate

10 mg

Y0001251 Phentolamine mesilate for system suitability

P1109000 Phentolamine mesilate - reference spectrum

P1150000 Phenylalanine

Yes

0148

+5C

79

0113,0114,01
48, 0149

+5C

79

1138

+5C

79

10 mg

1138

+5C

79

n/a

1138

79

60 mg

P1200000 Phenylbutazone

100 mg

Y0000147 Phenylbutazone impurity B

20 mg

P1240000 Phenylephrine

60 mg

P1250000 Phenylephrine hydrochloride

50 mg

Y0000683 Phenylephrine hydrochloride for peak identification

2 mg

Y0000229 Phenylmercuric acetate - reference spectrum

n/a

P1255100 Phenylmercuric borate - reference spectrum

n/a

P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor

50 mg

P1290000 Phenytoin

100 mg

Council of Europe, all rights reserved 2012

99.2% CHKNOS

Batch 3 is valid until 30 November 2011

(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione

Yes

0782,0796,11
61

+5C

79

0422,1574

+5C

79

0422

+5C

79

1035

+5C

79

0632,1205

+5C

79

0632,1035

+5C

79

2042

79

Batch 2 is valid until 30 November 2011

0103
Norephedrin hydrochloride

57

79

0683

+5C

79

1253,1988

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001167 Phenytoin for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
20 mg
1

Information

Monograph

Leaflet

Storage

0521,1253

Yes

+5C

Extra
Price
charges
79
a

P1300000 Phenytoin sodium

250 mg

0521

+5C

79

Y0000493 Phloroglucinol (anhydrous)

210 mg

2301,2302

+5C

79

Y0000761 Pholcodine - * narc

10 mg

0522

+5C

79

Y0000798 Pholcodine for peak identification - * narc

10 mg

0522

+5C

79

Y0000766 Phthalic acid

20 mg

2348

+5C

79

P1500000 Phthalylsulfathiazole

100 mg

0352

+5C

79

P1600000 Physostigmine salicylate

100 mg

0286

+5C

79

P1605000 Physostigmine sulfate

100 mg

0684

+5C

79

P1609000 Phytomenadione

150 mg

+5C

79

P1609010 trans-Epoxyphytomenadione

10 mg

1036

+5C

79

P1645000 Picotamide monohydrate

125 mg

1358

+5C

79

P1645005 Picotamide impurity A

25 mg

4-methoxybenzene-1,3-dicarboxylic acid

1358

+5C

79

Y0000124 Pidolate impurity B

60 mg

(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid

1619

+5C

79

Y0000123 Pidolic acid

125 mg

1619

+5C

79

P1650000 Pilocarpine hydrochloride

50 mg

0633

+5C

79

P1700000 Pilocarpine nitrate

50 mg

0104

+5C

79

Y0000106 Pilocarpine nitrate for system suitability

20 mg

0104,0633

+5C

79

Y0000525 Pimobendan

10 mg

2179

+5C

79

Y0000401 Pimobendan for system suitability

0.1 mg

2179

+5C

79

P1750000 Pimozide

150 mg

1254

+5C

79

P1800000 Pindolol

100 mg

0634,0871,17
89

+5C

79

Y0000061 Pipemidic acid trihydrate - reference spectrum

n/a

1743

79

P1890000 Piperacillin

100 mg

1168,1169

+5C

79

P1900000 Piperazine adipate

250 mg

0423

+5C

79

P2000000 Piperazine citrate

250 mg

0424

+5C

79

P2100000 Piperazine hydrate

250 mg

0425

+5C

79

Y0000288 Piracetam

120 mg

1733

+5C

79

Y0000038 Pirenzepine dihydrochloride monohydrate

250 mg

2001

+5C

79

P2120000 Piretanide

100 mg

1556

+5C

79

10 mg

1556

+5C

79

1556

+5C

79

0944

+5C

79

+5C

79

+5C

79

New Y0001458 Piretanide for system suitability


P2120002 Piretanide impurity A

20 mg

P2130000 Piroxicam

100 mg

P2130100 Piroxicam for system suitability

10 mg

P2150000 Pivampicillin

50 mg

Council of Europe, all rights reserved 2012

benzene-1,2-dicarboxylic acid

87.0% trans-phytomenadione, 12.6% cis-phytomenadione, 0.09% transepoxyphytomenadione CHO; Vitamin K1

Batch 1 is valid until 30 June 2011

94.5% CHNOS

99.8% CHNO

4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid

1036

0944
99.2% CHNOS
58

0808,0852

Yes

Yes

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P2152000 Pivmecillinam hydrochloride

Effective from 2012/1/3


Batch n
2

Quantity Sale
Information
per vial Unit
100 mg
1 99.6% CHClNOS
10 mg
1 methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)
methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate

Monograph

Leaflet

Storage

Extra
Price
charges
79
c

1359

-20C

1359

+5C

79

P2152015 Pivmecillinam impurity C

P2155001 Plastic additive 01

2 ml

(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate

90001,90002,
30114

+5C

79

P2155003 Plastic additive 03

100 mg

N,N'-ethylenedialcanamide

90001,30114

+5C

79

E0800000 Plastic additive 04

500 mg

Epoxidised soya oil

90001,30114

+5C

79

P2155005 Plastic additive 05

500 mg

Epoxidised linseed oil

90001,30114

+5C

79

New P2155008 Plastic additive 08

500 mg

ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate] ;
Batch 2 is valid until 31 March 2012

30103,30104,
30105,30106

+5C

79

P2155009 Plastic additive 09

250 mg

pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate] ;
Batch 2 is valid until 31 January 2012

30103,30105,
30106,30107

+5C

79

P2155010 Plastic additive 10

250 mg

4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]

30103,30105,
30106,30107

+5C

79

P2155011 Plastic additive 11

500 mg

Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate

30103,30105,
30106,30107

+5C

79

P2155012 Plastic additive 12

250 mg

Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R

30103,30105,
30106,30107

+5C

79

P2155013 Plastic additive 13

250 mg

1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione

30103,30105,
30106

+5C

79

P2155014 Plastic additive 14

250 mg

2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R

30103,30105,
30106

+5C

79

P2155015 Plastic additive 15

500 mg

Dioctadecyl disulphide ; Batch 1 is valid until 29 August 2012

30103,30104,
30105,30106

+5C

79

P2155016 Plastic additive 16

250 mg

Didodecyl 3,3'-thiodipropionate R

30103,30105,
30106

+5C

79

P2155017 Plastic additive 17

250 mg

Dioctadecyl 3,3'-thiodipropionate R

30103,30105,
30106

+5C

79

P2155018 Plastic additive 18

100 mg

30103

+5C

79

O0140000 Plastic additive 20

100 mg

Oleamide R

30103,30105,
30106,30107

+5C

79

E1260000 Plastic additive 21

100 mg

Erucamide R

30103,30107

+5C

79

P2155022 Plastic additive 22

100 mg

Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol


Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol

30103

+5C

79

P2155023 Plastic additive 23

200 mg

di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
Tin-content of 15.4%

30110,30111

+5C

79

Council of Europe, all rights reserved 2012

59

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P2160000 Poliomyelitis vaccine (inactivated) BRP

Effective from 2012/1/3


Batch n
2

Quantity Sale
Information
per vial Unit
0.5 ml
5 320-67-282 Ph. Eur. D-Antigen Units per ml for types 1-2-3, respectively

Monograph

Leaflet

Storage

Extra
Price
charges
90
d

0214,2066,20
65,
2328,2061,20
67,
1934,2329,20
720

Yes

-80C

See leaflet,
0215

Yes

-20C

90

P2161000 Poliomyelitis vaccine (oral) BRP

1 ml

P2163920 Poloxamer 124

30 mg

1464

+5C

79

P2164009 Poloxamer 188

100 mg

1464

+5C

79

P2164020 Poloxamer 237

100 mg

1464

+5C

79

P2164021 Poloxamer 338

100 mg

1464

+5C

79

P2164030 Poloxamer 407

100 mg

1464

+5C

79

P2170000 Polyacrylate - reference spectrum

n/a

79

P2400000 Polymyxin B sulfate

25 mg

65.1% polymyxin B1, 12.5% polymyxin, 3.3% polymyxin B3, 9.1% polymyxin
B1-I

+5C

79

Y0000355 Polymyxin B sulfate for microbiological assay

25 mg

205000 IU per vial

-20C

79

Y0000289 Polysorbate 20 - reference spectrum

n/a

0426

79

Y0000290 Polysorbate 40 - reference spectrum

n/a

1914

79

Y0000291 Polysorbate 60 - reference spectrum

n/a

0427

79

Y0000007 Polysorbate 80 - reference spectrum

n/a

0428

79

Y0000792 Poly(vinyl acetate) dispersion 30 per cent

1500 mg

2152

+5C

79

P2600000 Poly(vinyl chloride)

100 mg

90001,90002,
30114

+5C

79

P2649610 Potassium clavulanate - reference spectrum

n/a

1140

79

Y0001168 Potassium clavulanate impurity G

5 mg

1653

-20C

g(c)

79

Y0000315 Potassium hydrogen aspartate hemihydrate

50 mg

2076

+5C

79

P2650000 Potassium sorbate

100 mg

0618

+5C

79

Y0001275 Potassium sucrose octasulfate

100 mg

1796

+5C

79

P2660000 Povidone

50 mg

0685

+5C

79

Y0000466 Povidone (iodinated)

10 mg

1142

+5C

79

Y0001266 Pramipexole dihydrochloride monohydrate

5 mg

2416

+5C

79

Y0001187 Pramipexole for system suitability

15 mg

2416

+5C

79

Y0001267 Pramipexole impurity D

5 mg

+5C

79

Y0000215 Pravastatin sodium - reference spectrum

n/a

79

Y0000223 Pravastatin impurity A

0.1 mg

(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin) ; Batch 4 is valid until 30 September 2011

2059

-20C

79

Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine

30 mg

76.4% CHO

2059

-20C

79

Council of Europe, all rights reserved 2012

log CCID50/ml for types 1,2,3 and total virus content: 6.99, 6.06, 6.83 and
7.20, respectively

0733

(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

0203

2416

Yes

Yes

Yes

2059

60

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P2669000 Prazepam -* psy

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
50 mg
1

Information

Monograph

Leaflet

Storage

1466

+5C

Extra
Price
charges
79
j

P2670000 Praziquantel

150 mg

99.8% CHNO

0855

+5C

79

P2675000 Praziquantel impurity A

10 mg

(11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]
isoquinolin-4-one

0855

+5C

79

P2680000 Prazosin hydrochloride

50 mg

0856

+5C

79

P2698000 Prednicarbate

100 mg

+5C

79

Y0001443 Prednicarbate for system suitability

10 mg

+5C

79

P2698060 Prednicarbate impurity F

10 mg

P2700000 Prednisolone

150 mg

Y0001359 Prednisolone for peak identification

10 mg

Y0001355 Prednisolone for system suitability

10 mg

P2800000 Prednisolone acetate

120 mg

Y0000582 Prednisolone acetate for peak identification

10 mg

0734,0736,09
33,
0975,1467
0734

P2804000 Prednisolone hexanoate

10 mg

1212

P2805000 Prednisolone pivalate

100 mg

P2810000 Prednisolone sodium phosphate

100 mg

P2900000 Prednisone

100 mg

0354

P2920000 Pregnenolone isobutyrate

150 mg

1 mL

P2939000 Prilocaine

150 mg

P2939060 Prilocaine hydrochloride

100 mg

Y0001408 Prilocaine impurity B

80 mg

2-methylbenzenamine hydrochloride

P2939025 Prilocaine impurity E

25 mg

(RS)-N-(methylphenyl)-2-(propylamino)propanamide

P2940000 Primaquine diphosphate

500 mg

New Y0000263 Prekallikrein activator in albumin BRP

New P2950000 Primidone

99.1% CHO

1467
1467

1467
Prednisolone CRS 6 is suitable for monographs 01/2011:0335, 01/2008:0353, 0335,0353,03
01/2008:0354 and 01/2008:0735 only. ; Batch 6 is valid until 31 December
54, 0735
2011

Yes

+5C

79

Yes

+5C

79

0353

Yes

+5C

79

0353

Yes

+5C

79

+5C

79

+5C

79

+5C

79

0734,0736

+5C

79

0549,0735,08
10

+5C

79

+5C

79

-20C

79

-20C

90

1362

+5C

79

1363

+5C

79

1362,1363

+5C

79

1362,1363

+5C

79

0635

+5C

79

1,2-dihydroprednicarbate

Yes

0993
30 IU per ml ; Batch 2 is valid until 30 April 2012

See leaflet,
20615

Yes

150 mg

0584

Yes

+5C

79

Y0000369 Primidone for peak identification

5 mg

0584

Yes

+5C

79

P3000000 Probenecid

100 mg

0243

+5C

79

P3050000 Procainamide hydrochloride

100 mg

0567

+5C

79

P3090000 Procaine benzylpenicillin

250 mg

0115

+5C

79

P3100000 Procaine hydrochloride

100 mg

0050

+5C

79

P3200000 Prochlorperazine maleate

100 mg

0244,20303

+5C

79

P3300000 Progesterone

50 mg

0429

+5C

79

Y0000148 Progesterone impurity C

10 mg

0429

+5C

79

Council of Europe, all rights reserved 2012

99.9% CHNO ; Batch 1 is valid until 31 May 2012

39.7% CHNO (procaine); 96.3% CHNOS

(20R)-20-hydroxypregn-4-en-3-one
61

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000179 Proguanil hydrochloride - reference spectrum

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
n/a
1

Information

Monograph

Leaflet

Storage

2002

Extra
Price
charges
79
l

Y0000181 Proguanil impurity C

10 mg

1,5-bis(4-chlorophenyl)biguanide

2002

+5C

79

Y0000182 Proguanil impurity D

10 mg

1,5-bis(1-methylethyl)biguanide

2002

+5C

79

P3350000 Proline

60 mg

0785,0910,09
11, 1049

+5C

79

P3390000 Promazine hydrochloride

100 mg

0475,1365,20
303

+5C

79

P3400000 Promethazine hydrochloride

50 mg

0524

+5C

79

Y0000769 Promethazine impurity D

10 mg

0524

+5C

79

Y0000797 Promethazine for peak identification

10 mg

0524

+5C

79

P3490000 Propacetamol hydrochloride - reference spectrum

n/a

1366

79

Y0000455 Propafenone hydrochloride

10 mg

Y0000456 Propafenone impurity B

10 mg

Y0000278 Propanol - reference spectrum

n/a

Y0000016 Propofol

290 mg

Y0000017 Propofol for peak identification

0.1 ml

Y0000018 Propofol impurity J

20 mg

P3500000 Propranolol hydrochloride

30 mg

P3600000 Propranolol hydrochloride for performance test

20 mg

0568

Y0000318 Propylene glycol dilaurate

100 mg

2087

Y0000319 Propylene glycol monolaurate

100 mg

P3640000 Propyl gallate

50 mg

P3650000 Propyl parahydroxybenzoate

150 mg

P3700000 Propylthiouracil

100 mg

P3750000 Propyphenazone

200 mg

P3760000 Protirelin

5.03 mg

P3760020 D-His-Protirelin

0.1 mg

P3800000 Proxyphylline

100 mg

P3850000 Pseudoephedrine hydrochloride - * Drug Precursor

100 mg

Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification

100 mg

P3900000 Purpureaglucoside A

25 mg

P4000000 Purpureaglucoside B

25 mg

Y0000402 Pyrantel embonate

10 mg

Y0000403 Pyrantel impurity A

20 mg

P4050000 Pyrazinamide

30 mg

Council of Europe, all rights reserved 2012

(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide

(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one

Yes

2103

+5C

79

2103

+5C

79

79

2036
1558

+5C

79

1558

+5C

79

1558

+5C

79

0568,0923

+5C

79

+5C

79

+5C

79

1915

+5C

79

1039

+5C

79

0431,0852,12
63

+5C

79

0525

+5C

79

0636

+5C

79

5.03 mg per vial of pure protirelin peptide CHNO

1144

-20C

79

approx. 0.1 mg per vial

1144

-20C

79

0526

+5C

79

0487,1367

+5C

79

99.9% CHO
2,6-bis (1-methylethyl)-1,4-benzoquinone

99.9% CHO; batch 2 valid until 31/12/10 for use with monograph 0852
and 1263.

2108

Yes

+5C

79

0117

+5C

79

0117

+5C

79

1680

+5C

79

1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine

1680

+5C

79

Batch 1 is valid until 30 November 2011

0859

+5C

79

Star anise oil

62

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
P4099900 Pyridostigmine bromide

Effective from 2012/1/3


Batch n
3

Quantity Sale
Information
per vial Unit
50 mg
1 Batch 2 is valid until 31 January 2012
20 mg
1 pyridin-3-yl-dimethylcarbamate

Monograph

Leaflet

Storage

Extra
Price
charges
79
g

1255

+5C

1255

+5C

79

0245

+5C

79

0245

+5C

79

P4099910 Pyridostigmine impurity A

P4100000 Pyridoxine hydrochloride

100 mg

Y0001226 Pyridoxine impurity A

5 mg

P4200000 Pyrimethamine

250 mg

0288

+5C

79

Y0000659 Pyrrolidone

20 mg

2180

+5C

79

Y0001009 Quercetin dihydrate

20 mg

+5C

79

Q0100000 Quinidine sulfate

300 mg

0017,0018,00
19

+5C

79

Q0200000 Quinine sulfate

300 mg

0017,0018,00
19

+5C

79

R0100000 Rabies vaccine (inactivated) for veterinary use BRP

86 mg

11 IU per vial

-20C

90

Y0000896 Racecadotril

110 mg

99.9% CHNOS

2171

+5C

79

Y0000897 Racecadotril impurity A

1 ml

ethanethioic acid

2171

+5C

79

Y0000898 Racecadotril impurity G

10 mg

benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate

2171

+5C

79

Y0000902 Racecadotril for peak identification

5 mg

+5C

79

Y0001134 Raloxifene hydrochloride

110 mg

+5C

79

Y0001135 Raloxifene hydrochloride for peak identification

10 mg

2375

+5C

79

R0145000 Ramipril

20 mg

1368

+5C

79

R0145005 Ramipril impurity A

10 mg

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)

1368

+5C

79

R0145010 Ramipril impurity B

10 mg

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester) ; Batch 2 is valid until 31 January 2011

1368

+5C

79

R0145015 Ramipril impurity C

10 mg

(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril) ; Batch 2 is valid until 31 March 2011

1368

+5C

79

R0145020 Ramipril impurity D

10 mg

ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril


diketopiperazine) ; Batch 3 is valid until 30 November 2011

1368

+5C

79

R0150000 Ranitidine hydrochloride

100 mg

Batch 2 is valid until 30 September 2011

0946,1453

+5C

79

Y0000416 Ranitidine impurity J

0.00025
mg

1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine) ; Batch 4 is valid until 1 February 2012

0946

-20C

79

Y0000411 Ranitidine for system suitability

20 mg

Batch 1 is valid until 31 August 2011

0946

+5C

79

Y0000457 Repaglinide

20 mg

2135

+5C

79

Y0000458 Repaglinide for system suitability

6 mg

2135

+5C

79

Council of Europe, all rights reserved 2012

6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol ; Batch 1 is valid until 31 January


2011

1827

92.9% CHO

See leaflet,
0451

2171

Yes

Yes

2375

99.7% CHClNOS

63

Yes

Yes

Yes
Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000459 Repaglinide impurity E
R0200000 Reserpine
New R0250000 Residual solvents solution class 1

Effective from 2012/1/3


Batch n
2

Quantity Sale
Information
per vial Unit
10 mg
1 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid ; Batch 1 is valid until 30 September 2011

Monograph

Extra
Price
charges
79
a

+5C
+5C

79

+5C

79

+5C

79

-20C

79

+5C

79

+5C

79

+5C

79

2109

+5C

79

0292,0786

+5C

79

100 mg

99.8% CHNO

0528

1.4 mL

Batch 3 is valid until 30 April 2012

20424

20 mg

benzene-1,3-diol

2348

R0300000 Retinol acetate

1000 mg

1 050 000 IU per g

R0290000 Retinol esters

100 mg

R0500500 Reviparin sodium

250 mg

150 mg

0218,0219,02
20, 1192,1193

Yes
Yes

0217,0218,02
19, 0220
0828
2109

99.9% CHNO ; Batch 1 is valid until 31 May 2012

Storage

2135

Y0000767 Resorcinol

New Y0000377 Ribavirin

Leaflet

Yes

Y0000353 Ribavirin for system suitability

1 mg

R0600000 Riboflavin

100 mg

Y0000757 Riboflavin for peak identification

0.1 mg

+5C

79

R0630000 Riboflavin sodium phosphate

250 mg

Batch 1 is valid until 31 December 2011

0786

+5C

79

Y0000662 Ribonucleic acid

100 mg

100.0 %

2090

+5C

79

Y0000149 Rifabutin

150 mg

95.5% CHNO

1657

+5C

79

Y0000184 Rifabutin impurity A

20 mg

1-(2-methylpropyl)piperidin-4-one

1657

+5C

79

R0700000 Rifampicin

100 mg

Batch 1 is valid until 31 March 2011

0052

+5C

79

R0800000 Rifampicin quinone

100 mg

0052

+5C

79

R0900000 Rifamycin B

50 mg

0432

+5C

79

R0950000 Rifamycin S

50 mg

0432

+5C

79

R1000000 Rifamycin sodium

300 mg

856 IU per mg

0432,20702

-20C

79

Y0001074 Rifaximin

160 mg

98.0% CHNO

+5C

79

Y0001075 Rifaximin for system suitability

10 mg

2362

+5C

79

Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum

n/a

2020

79

Y0000187 Rilmenidine for system suitability

30 mg

2020

+5C

79

R1000600 Risperidone

50 mg

1559

+5C

79

Y0000370 Risperidone for system suitability

20 mg

1559

+5C

79

Y0001276 Risperidone impurity K

0.015 mg

3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)

1559

+5C

79

Y0000714 Ritonavir

80 mg

99.6% CHNOS

2136

+5C

79

Y0000706 Ritonavir for peak identfication

10 mg

2136

Yes

+5C

79

Y0001302 Rizatriptan benzoate

200 mg

2585

Yes

+5C

79

Y0001303 Rizatriptan for system suitability

15 mg

2585

Yes

+5C

79

R1300000 RK 13 cells

1 ml

0162,1057

Yes

Liquid
nitrogen

100

n/a

Y0000594 Rocuronium bromide - reference spectrum


Council of Europe, all rights reserved 2012

Vitamin B2

0292

Rifamycin impurity A

2362

cell lines (kidney, rabbit) titration of live measles, mumps and rubella
vaccines
64

Yes

Yes

Yes

79
1764
l
For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2012/1/3

Order
Reference Standard
Code
Y0000527 Rocuronium for peak identification

Batch n

Y0000742 Ropivacaine hydrochloride monohydrate

10 mg

Y0000743 Ropivacaine impurity G

5 mg

(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)

Y0000786 Rosmarinic acid

40 mg

95.5% CHO

R1500000 Roxithromycin

125 mg

96.7% CHNO

Y0000220 Roxithromycin for system suitability

5 mg

R2000000 Rubella vaccine (live) BRP

5 uc

3.6 log (ie 4000) infective viral units per vial

Y0000494 Ruscogenins

10 mg

Y0000105 Rutoside trihydrate

100 mg

S0040000 Saccharin

30 mg

S0050000 Saccharin sodium

50 mg

S0100000 Salbutamol

50 mg

Y0000030 Salbutamol impurity B

5 mg

(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol

Y0000071 Salbutamol impurity D

5 mg

5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde

0529,0687

Y0000031 Salbutamol impurity F

5 mg

93.4% CHNO x HSO; 1,1'-[oxybis[methylene(4-hydroxy-1,3phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol]

Y0000034 Salbutamol impurity G

5 mg

Y0000032 Salbutamol impurity I

0.006 mg

Y0001186 Salbutamol impurity J

S0150000 Salbutamol sulfate

50 mg

0687

Y0001288 Salbutamol sulfate for system suitability

10 mg

0687

Y0000669 Salicin

50 mg

S0200000 Salicylic acid

100 mg

Y0000405 Salicylic acid impurity B

10 mg

50 mg

Y0000423 Salmeterol xinafoate for system suitability

25 mg

Y0001052 Santonin

20 mg

99.8% CHO

Y0001049 Saquinavir mesilate

70 mg

99.5% CHNOS

Y0001056 Saquinavir for system suitability

0.3033 mg

Y0000814 Selamectin

100 mg

S0360000 Selegiline hydrochloride

50 mg

S0360090 (RS)-Selegiline hydrochloride

25 mg

New Y0000422 Salmeterol xinafoate

Council of Europe, all rights reserved 2012

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

Storage

1764

Yes

-20C

Extra
Price
charges
79
g(c)

2335

+5C

79

2335

+5C

79

1447,2382,
2524

+5C

79

1146

+5C

79

+5C

79

1057,0162

1146
Yes

-80C

90

38.2% ruscogenin
60.4% neoruscogenin

1847

Yes

+5C

79

87.6% CHO ; Batch 2 is valid until 31 January 2012

1795

Yes

+5C

79

0947

+5C

79

0787

+5C

79

0529,1033

+5C

79

+5C

79

+5C

79

0529,0687

+5C

79

2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxy- methyl)phenyl]
ethanone

0529

+5C

79

(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol ; Batch 3 is valid until 31 March 2011

0529

+5C

79

+5C

79

+5C

79

+5C

79

2312,1583

+5C

79

0366,1185

+5C

79

4-hydroxyisophthalic acid

0366

+5C

79

99.6% CHNO ; Batch 1 is valid until 30 April 2012

1765

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

2268

+5C

79

1260

+5C

79

1260

+5C

79

0.00045 mg 1

0529

0687

99,6% CHO

1765

65

Yes
Yes

Yes

1391,1809
2267
2267

97.6% CHNO

Yes

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
S0400000 Senna extract

Reference Standard

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
50 mg
1

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
c

0206,0207,02
08, 1261

-20C

0788,1027

+5C

79

S0450000 Serine

50 mg

S0460000 Sertaconazole nitrate

125 mg

+5C

79

200 mg

99.9% CHClN ; Batch 1 is valid until 31 March 2012

1705

Yes

+5C

79

Y0001285 Sertraline impurity E

15 mg

Mandelic acid CRS has been labelled as sertraline impurity E CRS in


anticipation of 01/2011:1705 corrected 7.1

1705

Yes

+5C

79

Y0000866 Sertraline for peak identification

5.4 mg

Batch 1 is valid until 31 January 2012

1705

Yes

+5C

79

Y0000867 Sertraline for system suitability

6.18 mg

Batch 1 is valid until 31 March 2012

1705

+5C

79

Y0000371 Sestamibi labelling kit

22 mg

1926

Yes

+5C

79

Y0001046 Sevoflurane

1 ml

2269

Yes

+5C

g(b)

79

S0500000 Silicone elastomer

2000 mg

30109

+5C

79

S0600000 Silicone oil

1 ml

30108

+5C

79

S0650000 Simvastatin

100 mg

Y0001066 Simvastatin for peak identification

10 mg

S0660000 Sisomicin sulfate

50 mg

77.7% CHNOS ; Batch 1 is valid until 29 February 2012

Y0000014 Sodium alendronate

150 mg

83.3% CHNNaOP

S0695000 Sodium amidotrizoate

125 mg

Y0000300 Sodium aminosalicylate dihydrate - reference spectrum

n/a

Y0000039 Sodium ascorbate

S0700000 Sodium calcium edetate

S0710000 Sodium cetostearyl sulfate

S0750000 Sodium cromoglicate

Y0001300 Sodium cromoglicate for system suitability


S0760000 Sodium cyclamate
S0765000 Diclofenac sodium

New Y0000828 Sertraline hydrochloride

New Y0001410 Sodium fusidate

1148

Batch 1 is valid until 30 November 2011


99.4% CHO ; Batch 3 is valid until 31 August 2011

1538,1563

Yes

-20C

g(c)

79

1563

Yes

-20C

g(c)

79

0331, 1351

Yes

-20C

79

1564

+5C

79

1150

+5C

79

1993

79

50 mg

1791

+5C

79

100 mg

0231

+5C

79

100 mg

0847

+5C

79

10 mg

0562

+5C

79

20 mg

0562

+5C

79

100 mg

0774

+5C

79

100 mg

1002,1281

+5C

79

10 mg

0848

+5C

79

S0781000 Sodium hyaluronate - reference spectrum

n/a

1472

79

S0780000 Sodium hyaluronate BRP

300 mg

0912

+5C

79

New Y0001468 Sodium iodohippurate

15 mg

2352

+5C

79

Y0000620 Sodium laurilsulfate

40 mg

0802

+5C

79

Y0000808 Sodium phenylbutyrate

5 mg

2183

+5C

79

Y0000809 Sodium phenylbutyrate impurity C

10 mg

2183

+5C

79

S0785000 Sodium picosulfate

100 mg

1031

+5C

79

Y0001104 Picosulfate for system suitability

0.5 mg

1031

+5C

79

Y0000210 Sodium polystyrene sulfonate - reference spectrum

n/a

1909

79

Y0000268 Sodium propionate - reference spectrum

n/a

2041

79

Council of Europe, all rights reserved 2012

4-cyclohexylbutanoic acid

66

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
S0800000 Sodium salicylate

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
100 mg
1

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
a

0413

+5C

1567

+5C

79

1567

+5C

79

S0808000 Sodium stearyl fumarate

50 mg

S0808060 Sodium stearyl maleate

10 mg

S0900000 Sodium taurocholate BRP

10000 mg

0350

+5C

79

S0930000 Sodium valproate

150 mg

0678

+5C

79

S0945000 Somatostatin

2.32 mg

2.32mg somatostatin peptide per vial CHNOS

S0947000 Somatropin

35 mg

1.69 mg somatropin monomer per vial

Y0000711 Somatropin/desamidosomatropin resolution mixture

33 mg

1.7 mg somatropin per vial

S0950000 Sorbic acid

10 mg

Y0000385 1,4-Sorbitan

50 mg

99.2% CHO

S1000000 Sorbitol

1200 mg

97.9 % CHO

Y0000114 Sotalol hydrochloride

25 mg

Y0000115 Sotalol impurity B

20 mg

Y0001011 Spanish sage oil for peak identification

250 mg

Y0000597 Spectinomycin hydrochloride

100 mg

Y0000549 Spectinomycin for system suitability

20 mg

1152

Y0000655 Spectinomycin sulfate tetrahydrate

10 mg

1658

Y0001126 Spike lavender oil

400 l

S1100000 Spiramycin

200 mg

4500 IU per mg
Spiramycin I: 87.3%, Spiramycin II: 0.2%, Spiramycin III: 4.4%

Y0000381 Spirapril hydrochloride monohydrate

60 mg

95.9% CHClNOS

Y0000332 Spirapril for system suitability

15 mg

S1200000 Spironolactone

150 mg

Y0001295 Spironolactone for system suitability

2.055 mg

Y0000185 Squalane

250 l

99.7% CH

1630

Y0001050 St. John's wort standardised dry extract

500 mg

0.050% of hypericin

Y0001091 Standardised artichoke leaf dry extract

60 mg

S1250000 Stanozolol

125 mg

S1250010 Stanozolol impurity A

10 mg

Y0001420 Stanozolol impurity B

10 mg

Council of Europe, all rights reserved 2012

Batch 1 is valid until 31 March 2012

0949

N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide

-20C

90

See leaflet,
0950,
0951,0952

Yes

-20C

150

0950,0951,09
52

Yes

-20C

150

0592

+5C

79

2048

+5C

79

0435,0436,04
37,
1235,1236,13
37,
1381,1531,20
48

+5C

79

2004

+5C

79

2004

+5C

79

1849

Yes

1152

81.3% CHClNO and CHClNO

Yes

+5C

79

-20C

79

-20C

79

-20C

79

2419

Yes

+5C

79

0179,0293,19
82,
1983,20702
1766

Yes

-20C

79

+5C

79

1766

+5C

79

0688

Yes

+5C

79

0688

Yes

+5C

79

+5C

79

1874

Yes

-20C

79

2389

Yes

-20C

79

1568

+5C

79

1568

+5C

79

1568

+5C

79

99.6% CHOS; Spironolactone CRS 2 is suitable for monograph


01/2008:0688 only.

(5,17)-17-hydroxy-17-methylandrostan-3-one
67

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
S1300000 Starch BRP

Reference Standard

Effective from 2012/1/3


Batch n
4

Quantity Sale
per vial Unit
50000 mg 1

Information

Monograph

Leaflet

0350

Y0000408 Stavudine

100 mg

Y0000421 Stavudine for system suitability

10 mg

S1340000 Stearic acid

100 mg

Plastic additive 19

S1350000 Stearyl alcohol

250 mg

100% CHO

Y0000868 Streptokinase for system suitability

30 l

S1400000 Streptomycin sulfate

100 mg

S1500000 Succinylsulfathiazole

100 mg

Y0001324 Sucralfate

Y0001344 Sucralose

Y0001342 Sucralose impurity B

0.5 mg

S1600000 Sucrose

100 mg

S1608100 Sufentanil - reference spectrum

S1609000 Sufentanil citrate - reference spectrum

Y0000529 Sulbactam sodium


Y0000528 Sulbactam

+5C

2130

99.6% CHNO

2130

Storage

Yes

0229,0882,14
74,
2058,30103,
30105,
30106,
30107
0702,0753,08
01,
0802,0847,09
69,
1123,1340,14
11

Extra
Price
charges
79
a

+5C

79

+5C

79

+5C

79

+5C

79

0356

Yes

-20C

79

Yes

-20C

79

0032,0033,00
53,
0485,20702
0357

+5C

79

10 mg

1796

+5C

79

550 mg

2368

+5C

79

2368

+5C

79

0177,0178,01
87,
0188,0204,02
09,
1061,1570,23
18

+5C

79

n/a

1569

79

n/a

1269

79

10 mg

150 mg

Y0000550 Sulbactam for peak identification

20 mg

2209

S1700000 Sulfacetamide sodium

50 mg

0107

S1800000 Sulfadiazine

100 mg

S1900000 Sulfadimidine

100 mg

S1950000 Sulfadoxine

50 mg

S1975000 Sulfafurazole

100 mg

S1975600 Sulfaguanidine

60 mg

S2000000 Sulfamerazine

100 mg

S2050000 Sulfamethizole

100 mg

Council of Europe, all rights reserved 2012

77 000 IU per vial ; Batch 3 is valid until 31 August 2011

1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose)

Yes

2209

+5C

79

2209

-20C

79

+5C

79

+5C

79

0294

+5C

79

0295

+5C

79

0740

+5C

79

0741

+5C

79

1476

+5C

79

0358,1571

+5C

79

0637

+5C

79

99.7% CHNOS

68

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
S2100000 Sulfamethoxazole

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
50 mg
1

Information

Monograph

Leaflet

Storage

0108

+5C

Extra
Price
charges
79
a

Y0000412 Sulfamethoxazole impurity A

5 mg

N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide

0108

+5C

79

Y0000413 Sulfamethoxazole impurity F

5 mg

4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide

0108

+5C

79

S2150000 Sulfamethoxypyridazine

50 mg

0638

+5C

79

S2151000 Sulfanilamide

100 mg

1571

+5C

79

S2159100 Sulfapyridine

20 mg

S2155000 Sulfasalazine

250 mg

99.9 % CHNOS

S2155010 Sulfasalazine derivative for resolution

20 mg

2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid

S2158000 Sulfathiazole

100 mg

S2159000 Sulfinpyrazone

30 mg

Y0001238 Sulfinpyrazone for system suitability

0.5 mg

S2159010 Sulfinpyrazone impurity A

20 mg

1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione

0790

S2159015 Sulfinpyrazone impurity B

20 mg

1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione

S2160000 Sulfisomidine

50 mg

S2180000 Sulindac

50 mg

S2190000 Sulpiride

100 mg

S2191000 Sulpiride impurity A

20 mg

[(2RS)-1-ethylpyrrolidin-2-yl]methanamine

S2192000 Sulpiride impurity B

20 mg

methyl 2-methoxy-5-sulphamoylbenzoate

Y0000530 Sultamicillin

10 mg

Y0000531 Sultamicillin tosilate

200 mg

Y0000532 Sultamicillin for peak identification

10 mg

Y0000022 Sumatriptan succinate

50 mg

Y0000026 Sumatriptan impurity mixture

Y0000027 Sumatriptan for system suitability

S2200000 Suxamethonium chloride


S2400000 Suxibuzone

0863

+5C

79

0863,1457

+5C

79

0863

+5C

79

0742

+5C

79

0790

+5C

79

+5C

79

+5C

79

0790

+5C

79

0639

+5C

79

0790

Contains 0.3% m/m of E-isomer

Yes

0864

+5C

79

1045,1348

+5C

79

1045,1490

+5C

79

1045

+5C

79

+5C

79

+5C

79

2211
92.5% CHNOS

2211,2212

Yes

2211

Yes

98.8% CHNOS

1573

3 mg

Batch 5 is valid until 1 March 2011

1573

2 mg

Batch 3 is valid until 31 October 2011

1573

1000 mg

50 mg

S2400004 Suxibuzone impurity B

10 mg

S2400006 Suxibuzone impurity C

10 mg

S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.


use) BRP

1 mg

6.5 x10 Cfu per vial

See leaflet,
0064

S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.


use) BRP

1 mg

2.6 x10 Cfu per vial


99.9% CHNO

New Y0001417 Tadalafil

+5C

79

-20C

79

Yes

-20C

79

Yes

-20C

79

0248

+5C

79

1574

+5C

79

(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate

1574

+5C

79

4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione

1574

+5C

79

Yes

+5C

e(b)

90

See leaflet,
0064

Yes

+5C

e(b)

90

2606

Yes

+5C

79

+5C

79

+5C

79

+5C

79

200 mg

T0010000 Talampicillin hydrochloride

50 mg

0808,0852

T0014000 Tamoxifen citrate

80 mg

1046

T0015000 Tamoxifen citrate for performance test

30 mg

1046

Council of Europe, all rights reserved 2012

69

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000650 Tamsulosin hydrochloride

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

Storage

2131

+5C

Extra
Price
charges
79
a

Y0000653 Tamsulosin racemate

10 mg

2131

+5C

79

Y0000651 Tamsulosin impurity D

10 mg

2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide

2131

+5C

79

Y0000652 Tamsulosin impurity H

10 mg

(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine

2131

+5C

79

Y0001102 Teicoplanin

52 mg

51550 IU per ampoule

2358

-20C

79

Y0001047 Teicoplanin for identification

40 mg

2358

-20C

79

Y0000648 Telmisartan

30 mg

2154

+5C

79

Y0000649 Telmisartan for peak identification

10 mg

2154

Yes

+5C

79

Y0001003 Telmisartan for system suitability

0.26 mg

2154

Yes

T0040000 Temazepam - * psy

50 mg

Y0000344 Temazepam impurity C

5 mg

Y0000345 Temazepam impurity D

5 mg

Y0000346 Temazepam impurity F

Y0000347 Temazepam impurity G

Yes

+5C

79

0879

+5C

79

(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate

0954

+5C

79

(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one

0954

+5C

79

5 mg

(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione

0954

+5C

79

5 mg

(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione

0954

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

+5C

79

Batch 1 is valid until 31 July 2011

T0040800 Tenoxicam

100 mg

1156

Y0001114 Tenoxicam impurity mixture

0.0042 mg

1156

Y0000621 Terazosin hydrochloride dihydrate

40 mg

2021

Y0000666 Terazosin for system suitability

0.5 mg

2021

Y0000622 Terazosin impurity A

10 mg

2-chloro-6,7-dimethoxyquinazolin-4-amine

2021

Y0000665 Terazosin impurity E

10 mg

2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)

2021

Y0000623 Terazosin impurity L

10 mg

1-(furan-2-ylcarbonyl)piperazine

2021

Y0000624 Terazosin impurity N

10 mg

1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine

2021

Y0000535 Terbinafine hydrochloride

10 mg

1734

Y0001143 Terbinafine for system suitability

10 mg

1734

T0050000 Terbutaline sulfate

100 mg

0690

+5C

79

T0050015 Terbutaline impurity C

15 mg

1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone

0690

+5C

79

T0060000 Terconazole

250 mg

Batch 1 is valid until 31 January 2011

1270

+5C

79

T0071000 Terfenadine

100 mg

0955

+5C

79

T0080000 Terfenadine impurity A

20 mg

0955

+5C

79

T0100000 Testosterone

30 mg

1373

+5C

79

T0200000 Testosterone acetate

10 mg

0297

+5C

79

T0210000 Testosterone caproate

50 mg

1048

+5C

79

Council of Europe, all rights reserved 2012

1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
butan-1-one

70

Yes
Yes
Yes
Yes
Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
T0240000 Testosterone decanoate

Effective from 2012/1/3


Batch n
2

Quantity Sale
per vial Unit
50 mg
1 99.8% CHO

Information

Monograph

Leaflet

1048, 1736

Y0000696 Testosterone decanoate for system suitability

0.4 mg

1736

T0250000 Testosterone enantate

100 mg

1048

Y0001317 Testosterone enantate for system suitability

2 mg

1048

Y0001312 Testosterone enantate for peak identification

10 mg

1048

Y0001313 Testosterone enantate impurity H

10 mg

delta-5-testosterone-3,17-dienantate

Y0000342 Testosterone for impurity D identification

20 mg

Batch 1 is valid until 31 January 2011

Y0000343 Testosterone for system suitability

20 mg

T0260000 Testosterone isocaproate

50 mg

Y0000716 Testosterone isocaproate for system suitability

5 mg

T0300000 Testosterone propionate

50 mg

Y0000170 Testosterone propionate - reference spectrum

n/a

0297

New Y0001409 Testosterone propionate for system suitability

5 mg

0297

T0400000 Tetanus vaccine (adsorbed)

30 mg

490 IU per ampoule for challenge assays in guinea-pigs


260 IU per ampoule for challenge assays in mice ; Batch 2 is valid until 31
July 2011

See leaflet,
20708

Y0001087 Tetra-O-acetyl-mannose triflate

60 mg

100.0% CHFOS

99.9% CHO

-20C
Yes

Extra
Price
charges
79
g(c)

-20C

g(c)

79

-20C

g(c)

79

Yes

-20C

g(c)

79

Yes

-20C

g(c)

79

1048

-20C

g(c)

79

1373

+5C

79

1373

+5C

79

1048,1737

+5C

79

+5C

79

+5C

79

79

Yes

+5C

79

Yes

-20C

90

-20C

79

1737
Testosterone propionate CRS 1 is suitable for 01/2008:1048 only

Storage

Yes

1048

2294

T0500000 Tetracaine hydrochloride

100 mg

0057

+5C

79

Y0001002 Tetracaine for system suitability

2 mg

0057

Yes

+5C

79

T0550000 Tetracosactide

0.366 mg

366 g per vial of CHNOS

0644

Yes

T0600000 Tetracycline hydrochloride

100 mg

96.7% CHClNO

Y0001165 Tetrandrine

20 mg

Y0000015 Tetrazepam - reference spectrum

n/a

Y0000008 Tetrazepam impurity C

20 mg

Y0000460 Tetryzoline hydrochloride

10 mg

Y0000723 Thebaine - * narc

10 mg

T0700000 Theobromine

100 mg

T0800000 Theophylline

100 mg

Y0000294 Theophylline - reference spectrum

Y0000336 Thiamazole

Y0000372 Thiamazole impurity A

15 mg

Y0000373 Thiamazole impurity C

20 mg

Y0000467 Thiamine hydrochloride

10 mg

Y0000059 Thiamine impurity E

10 mg

Council of Europe, all rights reserved 2012

-20C

79

0173,0198,01
99,
0210,0211,16
54

+5C

79

2478

+5C

79

79

1738

+5C

79

1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

2101

+5C

79

1839,1841

+5C

79

0298

+5C

79

0300,0301

+5C

79

n/a

0299,0302

79

125 mg

1706

+5C

79

2,2-dimethoxy-N-methylethanamine

1706

+5C

79

1-methyl-2-(methylsulphanyl)-1H-imidazole

1706

+5C

79

0303

+5C

79

0303,0531

+5C

79

99.5% CHNO

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione
71

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000060 Thiamine nitrate - reference spectrum

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
n/a
1

Information

Monograph

Storage

0531

T1100000 Thiamphenicol

125 mg

Y0000546 Thioctic acid

110 mg

Y0000592 Thioctic acid for system suitability

10 mg

Y0000545 Thioctic acid containing impurity B

30 mg

Y0000109 Thiomersal

T1200000 Thiopental

Y0000704 Thioridazine

T1300000 Thioridazine hydrochloride

Y0000541 Thioridazine for system suitability

0.21 mg

T1305100 Thioxanthene

20 mg

T1305000 Thioxanthone

10 mg

T1340000 Threonine

50 mg

T1350000 Thymol

50 mg

T1410000 Tiabendazole

50 mg

Y0000414 Tiamulin for peak identification

10 mg

Y0000333 Tiamulin hydrogen fumarate

500 mg

Y0000379 Tiamulin - reference spectrum

n/a

Y0000151 Tianeptine sodium - reference spectrum

n/a

Y0000152 Tianeptine for system suitability

30 mg

Y0000153 Tianeptine impurity A

20 mg

T1405000 Tiapride hydrochloride

60 mg

T1405050 Tiapride N-oxide

20 mg

T1410900 Tiaprofenic acid

50 mg

T1410910 Tiaprofenic acid impurity C

20 mg

Y0000748 Tibolone - reference spectrum

n/a

1739

Y0000668 Tibolone for system suitability

10 mg

1739

Y0000465 Ticarcillin monosodium

250 mg

93.2% CHNNaOS
Correction factor 1.054

T1420010 Ticarcillin impurity A

50 mg

89.8% CHNOS; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)


acetyl]-amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(decarboxyticarcillin)

T1423000 Ticlopidine hydrochloride

50 mg

Extra
Price
charges
79
l

0109

+5C

79

1648

+5C

79

1648

+5C

79

1648

+5C

79

30 mg

1625

+5C

79

500 mg

0212

+5C

79

10 mg

2005

+5C

79

100 mg

0586

+5C

79

99.8% CHOS

+5C

79

1347

+5C

79

1347

+5C

79

0785,1049

+5C

79

0791

+5C

79

0866

+5C

79

0586, 2005
Batch 2 is valid until 30 November 2011

Batch 1 is valid until 30 November 2011

98.6% CHNOS ; Batch 1 is valid until 31 July 2011

Yes

1659

Yes

+5C

79

1659,1660

Yes

+5C

79

1660

79

2022

79

2022

+5C

79

2022

+5C

79

1575

+5C

79

1575

+5C

79

1157

+5C

79

1157

+5C

79

79

+5C

79

0956

+5C

79

0956

+5C

79

1050

+5C

79

1050

+5C

79

79

T1423025 Ticlopidine impurity F

10 mg

Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum

n/a

T1450000 Timolol maleate

100 mg

Y0000644 (R)-timolol

20 mg

Council of Europe, all rights reserved 2012

Leaflet

ethyl 7-bromoheptanoate

(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid

6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine

Yes

1767
Batch 2 is valid until 31 August 2011
72

0572

+5C

79

0572

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0001270 Timolol for system suitability

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
5.045 mg 1

Information

Monograph

Leaflet

Storage

0572

Yes

+5C

Extra
Price
charges
79
a

T1470000 Tinidazole

100 mg

1051

+5C

79

Y0000899 Tinidazole impurity A

10 mg

2-methyl-5-nitro-1H-imidazole

1051

+5C

79

T1471000 Tinidazole impurity B

20 mg

1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole

1051

+5C

79

T1490000 Tinzaparin sodium

250 mg

0828

+5C

79

Y0000292 Tioconazole - reference spectrum

n/a

2074

79

Y0000282 Tioconazole for system suitability

50 mg

2074

+5C

79

Y0001188 Tiotropium bromide monohydrate

10 mg

2420

+5C

79

Y0001189 Tiotropium for system suitability

10 mg

2420

+5C

79

Y0001179 Tiotropium impurity mixture

0.08 mg

2420

+5C

79

Y0001216 Tiotropium impurity F

10 mg

dithiophen-2-ylmethanone

2420

+5C

79

T1500000 Tobramycin

49 mg

49 mg per vial of CHNO; Suitable for LC assay only ; Batch 3 is valid until
1 August 2011

0645

Yes

+5C

79

Y0000383 All-rac-alpha-tocopherol for peak identification

15 mg

0692

Yes

+5C

79

Y0000384 All-rac-alpha-tocopheryl acetate for peak identification

30 mg

Batch 1 is valid until 31 December 2011

0439

Yes

+5C

79

T1550000 alpha-Tocopherol

500 mg

97.4% CHO ; Vitamin E

0692,1256,20
432

+5C

79

T1600000 alpha-Tocopheryl acetate

500 mg

97.8% CHO

0439,0691,12
57

+5C

79

Y0001210 Tobramycin for identification

250 mg

Suitable for identification tests only

T1610000 RRR-alpha-Tocopheryl hydrogen succinate

125 mg

98.6% CHO

Yes
Yes

0645

+5C

79

1258,1259

+5C

79

T1700000 Tolbutamide

100 mg

0304

+5C

79

Y0000154 Tolfenamic acid

100 mg

2039

+5C

79

T1707000 Tolnaftate

60 mg

1158

+5C

79

Y0001123 Tolnaftate for system suitability

10 mg

1158

+5C

79

Y0000461 Torasemide anhydrous

10 mg

2132

+5C

79

Y0001366 Torasemide impurity E

0.0006 mg

ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate

2132

+5C

79

Y0000462 Torasemide for system suitability

5 mg

Batch 1 is valid until 31 December 2011

2132

Y0000155 Tramadol hydrochloride

75 mg

Y0000156 Tramadol impurity A

15 mg

Y0000157 Tramadol impurity E

15 mg

Y0000072 Tramazoline hydrochloride monohydrate

20 mg

Y0000065 Tramazoline impurity A

10 mg

Y0000066 Tramazoline impurity B

10 mg

Y0000501 Trandolapril

10 mg

Council of Europe, all rights reserved 2012

+5C

79

1681

+5C

79

(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol

1681

+5C

79

(2RS)-2-[(dimethylamino)methyl]cyclohexanone ; Batch 2 is valid until 31


August 2011

1681

+5C

79

1597

+5C

79

N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine

1597

+5C

79

75% CHNO; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1yl)-4,5-dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one

1597

+5C

79

2245

+5C

79

73

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000495 Trandolapril impurity C

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
Monograph
per vial Unit
10 mg
1 (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
2245
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)

Y0000496 Trandolapril impurity D

10 mg

T1810000 Tranexamic acid

50 mg

0875

T1820000 Trapidil

50 mg

1576

T1820002 Trapidil impurity A

20 mg

5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol

T1820004 Trapidil impurity B

20 mg

1,2,4-triazol-3-amine

Y0001172 Trehalose dihydrate

250 mg

89.8% CHO,2HO

T1850000 Tretinoin

50 mg

T1899000 3,4,6-Tri-O-acetyl-D-glucal - reference spectrum

n/a

1325

G0400010 Triacetin - reference spectrum

n/a

T1899990 Triamcinolone

150 mg

Batch 1 is valid until 28 February 2011

T1900000 Triamcinolone acetonide

100 mg

Batch 3 is valid until 31 March 2011

New Y0001459 Triamcinolone acetonide for system suitability

ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)

Leaflet

Storage
+5C

2245

Extra
Price
charges
79
a

+5C

79

+5C

79

+5C

79

1576

+5C

79

1576

+5C

79

2297

+5C

79

0693,1019,13
85

+5C

g(b)

79

79

Yes

79

1376

1106
+5C

79

0533,0867,10
75

+5C

79

10 mg

0533

+5C

79

T1950000 Triamcinolone hexacetonide

100 mg

0533,0867

+5C

79

Y0000050 Triamcinolone impurity C

10 mg

1376

+5C

79

Y0000837 Triamterene

10 mg

0058

+5C

79

Y0000870 Triamterene impurity B

0.5 mg

+5C

79

T1975000 Triazolam - * psy

10 mg

+5C

79

Y0000165 Tribenoside

150 mg

98.9% CHO

1740

Y0000166 Tribenoside impurity A

60 mg

90.2% CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose ; Batch 2 is valid until 31 January 2012

1740

Y0001055 Tributyl acetylcitrate

1 mL

Batch 1 is valid until 30 June 2011

1770

Y0000279 Tri-n-butyl phosphate

300 l

1682

Y0000799 Tributyl acetylcitrate for peak identification

25 mg

1770

T1977990 Tricaprin

150 mg

T1977995 Tricaproin

40 mg

9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione

0058

2,7-diamino-6-phenylpteridin-4-ol

Yes

Yes

1065

+5C

79

-20C

g(c)

79

+5C

79

+5C

79

+5C

79

1410

-20C

79

1410

-20C

79

-20C

79

79

79

79

Yes

Yes

T1978000 Tricaprylin

225 mg

1410

Y0000111 Trichloroacetic acid - reference spectrum

n/a

1967

T1985000 Trichlorotrifluoroethane

2.5 ml

0393

T1986000 Triethyl citrate - reference spectrum

n/a

1479

T2000000 Trifluoperazine hydrochloride

100 mg

0059,20303

+5C

79

T2005000 Triflusal

50 mg

1377

+5C

79

T2005010 Triflusal impurity B

25 mg

1377

+5C

79

Council of Europe, all rights reserved 2012

2-hydroxy-4-(trifluoromethyl)benzoic acid
74

Yes

+5C

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000720 Triglycerol diisostearate

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
200 mg
1

Y0000108 Trihexyphenidyl hydrochloride

100 mg

Y0000068 Trihexyphenidyl impurity A

20 mg

Information

Monograph

1-phenyl-3-(piperidin-1-yl)propan-1-one

Leaflet

Storage

Extra
Price
charges
79
a

2032

+5C

1626

+5C

79

1626

+5C

79

T2009000 Trilaurin

1250 mg

1410

-20C

79

Y0001319 Trimebutine maleate

10 mg

2182

+5C

79

Y0001260 Trimebutine for system suitability

1.017 mg

2181,2182

+5C

79

Y0000092 Trimetazidine dihydrochloride - reference spectrum

n/a

1741

79

Y0000093 Trimetazidine for system suitability

50 mg

T2100000 Trimethadione

250 mg

50 mg

Yes

1741

+5C

79

0440

+5C

79

0060

+5C

79

0.00075 mg 1

0060

+5C

79

0060

+5C

79

100% CHNO

T2200000 Trimethoprim

Y0000684 Trimethoprim for system suitability

T2200010 Trimethoprim impurity B

10 mg

T2450000 Trimethyltetradecylammonium bromide

200 mg

0378

+5C

79

T2500000 Trimipramine maleate

100 mg

0534

+5C

79

Y0000759 Trimipramine for peak identification

0.51 mg

0534

+5C

79

T2500100 Trimyristin

500 mg

1410

-20C

79

T2501200 Tristearin

100 mg

1410

-20C

79

T2545000 Trolamine

2250 mg

1577

+5C

79

Y0001184 Trolamine impurity A

250 mg

Ethanolamine

1577

+5C

79

Y0001183 Trolamine impurity B

1 ml

Diethanolamine

1577

+5C

79

T2550000 Trometamol

100 mg

1053

+5C

79

T2580000 Tropicamide

50 mg

1159,1197

+5C

79

Y0001247 Tropicamide impurity C

10 mg

(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)

1159

+5C

79

Y0001248 Tropicamide impurity D

10 mg

Phenylacetic acid

1159

+5C

79

Y0001316 Tropicamide for peak identification

10 mg

1159

+5C

79

Y0000616 Tropisetron hydrochloride

40 mg

2102

+5C

79

Y0000618 Tropisetron impurity B

10 mg

2102

+5C

79

T2580300 Tropine

50 mg

1308

+5C

79

Y0000429 Trospium chloride

10 mg

1798

+5C

79

Y0000432 Trospium impurity A

20 mg

hydroxydiphenylacetic acid (benzilic acid)

1798

+5C

79

Y0000431 Trospium impurity B

15 mg

(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate

1798

+5C

79

Y0000430 Trospium impurity C

5 mg

(1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]

1798

+5C

79

Y0000497 Troxerutin

30 mg

T2600000 Trypsin BRP

100 mg

T2610000 Tryptophan

100 mg

Council of Europe, all rights reserved 2012

(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone ; Batch 3 is
valid until 2 February 2012

1H-indole-3-carboxylic acid

0.707 microkatal per mg

75

Yes

2133

+5C

79

0476,0579,05
80, 0694

+5C

79

1272

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
T2800000 Tubocurarine chloride

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
100 mg
1 87.75% CHClNO
150 mg
1 1035 IU per mg

Information

Monograph

Leaflet

Storage

Extra
Price
charges
79
g

0305

+5C

1273,1274,16
61, 20702

+5C

79

+5C

79

+5C

79

79

+5C

79

+5C

79

T2880000 Tylosin

T2880100 Tylosin D

5 mg

1273,1274,16
61

Y0000498 Tylosin phosphate for peak identification

10 mg

1273,1274,16
61

T2880200 Tylosin tartrate - reference spectrum

n/a

1274

T2900000 Tyrosine

50 mg

T3000000 Tyrothricin

20 mg

0782,0895,11
61,
1272,1384
0907,1662

U0020000 Ubidecarenone

50 mg

1578

+5C

79

U0020001 Ubidecarenone for system suitability

1 mg

Batch 2 is valid until 30 September 2011

1578

+5C

79

U0020008 Ubidecarenone impurity D

5 mg

5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione ; Batch 1 is valid until 31 August 2011

1578

+5C

79

U0100000 Uracil arabinoside

60 mg

Batch 1 is valid until 31 October 2011

0760

+5C

79

U0600000 Urea

100 mg

0743

+5C

79

U0800000 Ursodeoxycholic acid

100 mg

1189,1275

+5C

79

Y0001163 Ursodeoxycholic acid for system suitability

1.26 mg

1275

Yes

+5C

79

Y0000834 Valaciclovir hydrochloride (anhydrous)

100 mg

1768

Yes

+5C

79

Y0001225 Valaciclovir for system suitability

10 mg

1768

Yes

+5C

79

Y0001096 Valaciclovir impurity D

10 mg

2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate

1768

+5C

79

Y0001097 Valaciclovir impurity E

10 mg

2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate

1768

+5C

79

Y0001098 Valaciclovir impurity F para-toluenesulfonate

12 mg

2-hydroxyethyl L-valinate

1768

+5C

79

Y0001099 Valaciclovir impurity G

10 mg

N,N-dimethylpyridin-4-amine

1768

+5C

79

Y0000583 Valerian standardised dry extract

400 mg

0.38% CHO

-20C

79

V0030000 Valine

50 mg

0770,0771,07
96

+5C

79

Y0000584 Valnemulin hydrochloride

10 mg

2137

+5C

79

Y0000533 Valnemulin hydrogen tartrate

120 mg

2137

+5C

79

Y0000585 Valnemulin for peak identification

20 mg

+5C

79

Y0000586 Valnemulin impurity E

10 mg

+5C

79

V0033000 Valproic acid

100 mg

1378

+5C

79

Y0001422 Valproic acid for system suitability

10 mg

1378,0678

+5C

79

Council of Europe, all rights reserved 2012

Batch 1 is valid until 31 January 2011

Batch 1 is valid until 31 May 2011

0453,1898,18
99,2400,2526

98.7% CHNOS

2137
(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)

76

Yes

Yes

Yes

Yes

2137

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Code
Y0001132 Valsartan

Reference Standard

Effective from 2012/1/3


Batch n
1

Quantity Sale
per vial Unit
10 mg
1

Information

Monograph

Leaflet

2423

Storage
+5C

Extra
Price
charges
79
a

Y0001131 Valsartan for peak identification

10 mg

2423

Yes

+5C

79

Y0001145 Valsartan for system suitability

0.202 mg

2423

Yes

+5C

79

V0045000 Vancomycin hydrochloride

100 mg

1058,20702

Yes

-20C

79

V0050000 Vanillin

100 mg

0747

+5C

79

Y0001198 Varicella vaccine ( live)

420 mg

0648

-80C

90

Y0000561 Vecuronium bromide

10 mg

1769

+5C

79

Y0000625 Vecuronium for peak identification

10 mg

1769

+5C

79

Y0001093 Vedaprofen

5 mg

2248

+5C

79

Y0001118 Vedaprofen impurity mixture

0.006 mg

50 mg

New Y0000587 Venlafaxine hydrochloride

102000 IU per vial ; Batch 2 is valid until 31 July 2011

2248
Batch 1 is valid until 31 March 2012

Yes
Yes

+5C

79

2119

Yes

+5C

79

Y0000588 Venlafaxine for system suitability

1 mg

2119

+5C

79

V0100000 Verapamil hydrochloride

100 mg

0573

+5C

79

V0100018 Verapamil impurity I

5 mg

(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride

0573

+5C

79

V0100026 Verapamil impurity M

10 mg

5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]

0573

+5C

79

Y0000661 Verbenalin

11 mg

0.97 mg per vial of CHO

V0180000 VERO cells

1 ml

Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of


live measles, mumps and rubella vaccines

New Y0001400 Vigabatrin

10 mg

New Y0001401 Vigabatrin impurity A

25 mg

94.7% CHNO; (5RS)-5-ethenylpyrrolidin-2-one

2305

New Y0001402 Vigabatrin impurity B

20 mg

(2E)-2-(2-aminoethyl)but-2-enoic acid

2305

New Y0001404 Vigabatrin impurity D

50 mg

4-aminobutanoic acid

New Y0001403 Vigabatrin impurity E

n/a

10 mg

2-[(2RS)-2-aminobut-3-enyl]propanedioic acid

V0300000 Vinblastine sulfate

5 mg

5.01 mg per vial of CHNOS

V0305000 Vinblastine sulfate - reference spectrum

n/a

V0400000 Vincristine sulfate

4.98 mg

V0405000 Vincristine sulfate - reference spectrum

n/a

V0500000 Vindesine sulfate

5.11 mg

V0500010 Vindesine sulfate - reference spectrum

n/a

Y0000463 Vinorelbine tartrate

50 mg

Y0000464 Vinorelbine impurity B

7 mg

Y0000589 Vinpocetine

10 mg

Y0000590 Vinpocetine impurity A

10 mg

Council of Europe, all rights reserved 2012

1854

+5C

79

Liquid
nitrogen

100

+5C

79

-20C

79

+5C

79

2305

+5C

79

2305

+5C

79

0748,0749

-80C

g(d)

79

79

79

79

g(d)

79

79

0213,0538,10
57

Yes

2305
Yes

0748
4.98 mg per vial of CHNOS ; Batch 4 is valid until 31 January 2011

0748,0749

-80C

0749
1276

5.11 mg per vial of CHNOS

-80C

1276
4-O-deacetylvinorelbine ; Batch 2 is valid until 31 March 2011
(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)
77

2107

-80C

g(d)

79

2107

-80C

g(d)

79

2139

+5C

79

2139

+5C

79

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Y0000591 Vinpocetine impurity B

Effective from 2012/1/3


Batch n
1

Quantity Sale
Information
Monograph
per vial Unit
10 mg
1 (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
2139
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)

Leaflet

+5C

Y0000790 Vinpocetine impurity C

10 mg

ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine)

2139

Y0000760 Vinpocetine impurity D

10 mg

(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)

Y0000793 Vinyl acetate

200 mg

Y0001395 Voriconazole

120 mg

Y0001396 Voriconazole impurity B

10 mg

(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol

2576

Y0001398 Voriconazole impurity D

10 mg

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)

Y0001397 Voriconazole impurity E

50 mg

[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)

W0100000 Warfarin sodium

10 mg

Y0000778 Warfarin sodium clathrate

X0075000 Xylazine hydrochloride

Y0000158 Xylazine impurity C

50 mg

2,6-dimethylphenyl isothiocyanate

1481

Y0000159 Xylazine impurity E

15 mg

87.5% CHNS ; methyl (2,6-dimethylphenyl)carbamodithioate ; Batch 1 is


valid until 31 May 2011

1481

Yes

Y0001224 Xylazine impurity mixture

0.02 mg

1481

Yes

X0080000 Xylitol

500 mg

X0100000 Xylometazoline hydrochloride

100 mg

X0101000 Xylometazoline impurity A

10 mg

X0200000 Xylose

100 mg

Y0000656 Yohimbine hydrochloride

20 mg

99.1% CHClNO

2172

Z1900000 Zidovudine

60 mg

99.5% CHNO

1059

Z1902000 Zidovudine impurity A

10 mg

1-[(2,5)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methyl pyrimidine-2,4
(1,3)-dione

Z1904000 Zidovudine impurity B

10 mg

1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione

Z2000000 Zinc acexamate

50 mg

Z2000010 Zinc acexamate impurity A

50 mg

6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid

Y0001286 Ziprasidone hydrochloride monohydrate

100 mg

95.6% CHClNOS

2421

Y0001272 Ziprasidone for system suitability 1

10 mg

2421

Y0001241 Ziprasidone for system suitability 2

0.465 mg

2421

Z2500000 Zolpidem tartrate - * psy

200 mg

1280

Council of Europe, all rights reserved 2012

Storage

+5C

79

2139

+5C

79

2152

+5C

79

+5C

79

+5C

79

2576

+5C

79

2576

+5C

79

0698,0699

+5C

79

10 mg

0699

+5C

79

125 mg

1481

+5C

79

+5C

79

+5C

79

+5C

79

2576

99.2% CHO
N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide

78

Yes

Extra
Price
charges
79
a

Yes

1381

+5C

79

0972,1162

+5C

79

1162

+5C

79

1278

+5C

79

+5C

79

+5C

79

1059

+5C

79

1059

+5C

79

1279

+5C

79

1279

+5C

79

Yes

+5C

79

Yes

+5C

79

Yes

+5C

79

+5C

79

Yes

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards


Order
Reference Standard
Code
Z2500010 Zolpidem impurity A

Effective from 2012/1/3


Batch n
3

Quantity Sale
Information
per vial Unit
10 mg
1 N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide

Monograph

Leaflet

Storage

1280

+5C

Extra
Price
charges
79
a

Z3000000 Zopiclone -* psy

60 mg

1060

+5C

79

Z3001000 Zopiclone oxide

20 mg

1060

+5C

79

Y0000062 Zuclopenthixol decanoate - reference spectrum

n/a

1707

79

Y0000534 Zuclopenthixol for system suitability

0.26 mg

+5C

79

Y0000083 Zuclopenthixol impurity B

10 mg

+5C

79

Council of Europe, all rights reserved 2012

1707
2-chloro-9H-thioxanthen-9-one

79

1707

Yes

For extra charges, please see supply terms and conditions.